<!DOCTYPE html>
 <!--[if lt IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8 lt-ie7"> <![endif]--> <!--[if IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8"> <![endif]--> <!--[if IE 8]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9"> <![endif]--> <!--[if gt IE 8]><!--> <html class="aui ltr" dir="ltr" lang="en-US" prefix="og: http://ogp.me/ns#"> <!--<![endif]--> <head> <title>Industry sponsorship and research outcome - Lundh, A - 2017 | Cochrane Library</title> <meta content="Industry sponsorship and research outcome - Lundh, A - 2017 | Cochrane Library" property="og:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.MR000033.pub3/full" property="og:url"/> <meta content="article" property="og:type"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" property="og:image"/> <meta content="summary_large_image" name="twitter:card"/> <meta content="Industry sponsorship and research outcome - Lundh, A - 2017 | Cochrane Library" name="twitter:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.MR000033.pub3/full" name="twitter:url"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" name="twitter:image"/> <meta content="initial-scale=1.0, width=device-width" name="viewport"/> <meta content="10.1002/14651858.MR000033.pub3" name="dc.identifier" scheme="DOI"/> <meta content="Industry sponsorship and research outcome" name="citation_title"/> <meta content="Andreas Lundh" name="citation_author"/> <meta content="Odense University Hospital and University of Southern Denmark" name="citation_author_institution"/> <meta content="andreas.hover.lundh@rsyd.dk" name="citation_author_email"/> <meta content="Joel Lexchin" name="citation_author"/> <meta content="York University" name="citation_author_institution"/> <meta content="Barbara Mintzes" name="citation_author"/> <meta content="The University of Sydney" name="citation_author_institution"/> <meta content="Jeppe B Schroll" name="citation_author"/> <meta content="Herlev Hospital" name="citation_author_institution"/> <meta content="Lisa Bero" name="citation_author"/> <meta content="Charles Perkins Centre and Faculty of Pharmacy, University of Sydney" name="citation_author_institution"/> <meta content="Cochrane Database of Systematic Reviews" name="citation_journal_title"/> <meta content="John Wiley &amp; Sons, Ltd" name="citation_publisher"/> <meta content="2" name="citation_issue"/> <meta content="10.1002/14651858.MR000033.pub3" name="citation_doi"/> <meta content="2017" name="citation_date"/> <meta content="2017/02/16" name="citation_online_date"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.MR000033.pub3/abstract" name="citation_abstract_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.MR000033.pub3/full" name="citation_fulltext_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.MR000033.pub3/pdf/full" name="citation_pdf_url"/> <meta content="1465-1858" name="citation_issn"/> <meta content="en" name="citation_language"/> <meta content="*Conflict of Interest; *Equipment and Supplies; *Industry; Data Interpretation, Statistical; Drug Industry; Publication Bias; Research Report [*standards]; Research Support as Topic [*standards]; Treatment Outcome" name="citation_keywords"/> <link href="https://fonts.googleapis.com/css?family=Source+Sans+Pro:400,700,600,900" rel="stylesheet"/> <script src="https://cmp.osano.com/AzZdRbSORDOOzF9W/d594efc1-9663-477d-9528-6576640e64fd/osano.js"></script> <style> .osano-cm-widget{display: none;} </style> <script src="https://static.addtoany.com/menu/page.js"></script> <script async="" charset="utf-8" src="https://platform.twitter.com/widgets.js"></script> <script async="async" src="//script.crazyegg.com/pages/scripts/0056/6375.js" type="text/javascript"></script> <script type="text/javascript">window.dataLayer={};var xtend=function(){var a={};var b=false;var c=0;var d=arguments.length;if(Object.prototype.toString.call(arguments[0])==="[object Boolean]"){b=arguments[0];c++}var f=function(g){for(var h in g){if(Object.prototype.hasOwnProperty.call(g,h)){if(b&&Object.prototype.toString.call(g[h])==="[object Object]"){a[h]=xtend(true,a[h],g[h])}else{a[h]=g[h]}}}};for(;c<d;c++){var e=arguments[c];f(e)}return a};</script> <!-- Global site tag (gtag.js) - Google Analytics --> <script src="https://www.googletagmanager.com/gtag/js?id=UA-189672-63&amp;l=gDataLayer"></script> <script>window.gDataLayer=window.gDataLayer||[];function gtag(){gDataLayer.push(arguments)}gtag("js",new Date());gtag("config","UA-189672-63");</script> <script type="text/javascript">var o={auth:{customerIds:[],individualId:null,brandedCustomer:null,roles:["Guest"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <script type="text/javascript">var o={page:{siteSection:"Content",languageCode:"en",cms:{pageTitle:"Content"}}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <meta content="text/html; charset=utf-8" http-equiv="content-type"/> <link href="https://www.cochranelibrary.com/cochrane-theme/images/favicon.ico" rel="Shortcut Icon"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.MR000033.pub3&amp;doi=10.1002/14651858.MR000033.pub3&amp;type=cdsr&amp;contentLanguage=" rel="canonical"/> <link href="https://www.cochranelibrary.com/zh/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.MR000033.pub3&amp;doi=10.1002/14651858.MR000033.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANS" rel="alternate"/> <link href="https://www.cochranelibrary.com/zh_HANT/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.MR000033.pub3&amp;doi=10.1002/14651858.MR000033.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANT" rel="alternate"/> <link href="https://www.cochranelibrary.com/hr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.MR000033.pub3&amp;doi=10.1002/14651858.MR000033.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="hr-HR" rel="alternate"/> <link href="https://www.cochranelibrary.com/nl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.MR000033.pub3&amp;doi=10.1002/14651858.MR000033.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="nl-NL" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.MR000033.pub3&amp;doi=10.1002/14651858.MR000033.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="x-default" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.MR000033.pub3&amp;doi=10.1002/14651858.MR000033.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="en-US" rel="alternate"/> <link href="https://www.cochranelibrary.com/fr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.MR000033.pub3&amp;doi=10.1002/14651858.MR000033.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="fr-FR" rel="alternate"/> <link href="https://www.cochranelibrary.com/de/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.MR000033.pub3&amp;doi=10.1002/14651858.MR000033.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="de-DE" rel="alternate"/> <link href="https://www.cochranelibrary.com/hi/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.MR000033.pub3&amp;doi=10.1002/14651858.MR000033.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="hi-HI" rel="alternate"/> <link href="https://www.cochranelibrary.com/hu/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.MR000033.pub3&amp;doi=10.1002/14651858.MR000033.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="hu-HU" rel="alternate"/> <link href="https://www.cochranelibrary.com/in/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.MR000033.pub3&amp;doi=10.1002/14651858.MR000033.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="in-ID" rel="alternate"/> <link href="https://www.cochranelibrary.com/ja/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.MR000033.pub3&amp;doi=10.1002/14651858.MR000033.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ja-JP" rel="alternate"/> <link href="https://www.cochranelibrary.com/ko/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.MR000033.pub3&amp;doi=10.1002/14651858.MR000033.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ko-KR" rel="alternate"/> <link href="https://www.cochranelibrary.com/ms/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.MR000033.pub3&amp;doi=10.1002/14651858.MR000033.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ms-MY" rel="alternate"/> <link href="https://www.cochranelibrary.com/fa/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.MR000033.pub3&amp;doi=10.1002/14651858.MR000033.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="fa-IR" rel="alternate"/> <link href="https://www.cochranelibrary.com/pl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.MR000033.pub3&amp;doi=10.1002/14651858.MR000033.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="pl-PL" rel="alternate"/> <link href="https://www.cochranelibrary.com/pt/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.MR000033.pub3&amp;doi=10.1002/14651858.MR000033.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="pt-PT" rel="alternate"/> <link href="https://www.cochranelibrary.com/ro/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.MR000033.pub3&amp;doi=10.1002/14651858.MR000033.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ro-RO" rel="alternate"/> <link href="https://www.cochranelibrary.com/ru/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.MR000033.pub3&amp;doi=10.1002/14651858.MR000033.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ru-RU" rel="alternate"/> <link href="https://www.cochranelibrary.com/es/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.MR000033.pub3&amp;doi=10.1002/14651858.MR000033.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="es-ES" rel="alternate"/> <link href="https://www.cochranelibrary.com/ta/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.MR000033.pub3&amp;doi=10.1002/14651858.MR000033.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ta-IN" rel="alternate"/> <link href="https://www.cochranelibrary.com/th/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.MR000033.pub3&amp;doi=10.1002/14651858.MR000033.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="th-TH" rel="alternate"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" rel="stylesheet" type="text/css"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/aui.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" rel="stylesheet" type="text/css"/> <link href="/html/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772874000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/scolaris-content-display/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/notifications-portlet/notifications/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772751000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/html/portlet/login/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772901000" rel="stylesheet" type="text/css"/> <script type="text/javascript">var Liferay={Browser:{acceptsGzip:function(){return false},getMajorVersion:function(){return 80},getRevision:function(){return"537.36"},getVersion:function(){return"80.0"},isAir:function(){return false},isChrome:function(){return true},isFirefox:function(){return false},isGecko:function(){return true},isIe:function(){return false},isIphone:function(){return false},isLinux:function(){return true},isMac:function(){return false},isMobile:function(){return false},isMozilla:function(){return false},isOpera:function(){return false},isRtf:function(){return true},isSafari:function(){return true},isSun:function(){return false},isWap:function(){return false},isWapXhtml:function(){return false},isWebKit:function(){return true},isWindows:function(){return false},isWml:function(){return false}},Data:{NAV_SELECTOR:"#navigation",isCustomizationView:function(){return false},notices:[null]},ThemeDisplay:{getLayoutId:function(){return"7"},getLayoutURL:function(){return"https://www.cochranelibrary.com/en/content"},getParentLayoutId:function(){return"0"},isPrivateLayout:function(){return"false"},isVirtualLayout:function(){return false},getBCP47LanguageId:function(){return"en-US"},getCDNBaseURL:function(){return"https://www.cochranelibrary.com"},getCDNDynamicResourcesHost:function(){return""},getCDNHost:function(){return""},getCompanyId:function(){return"20155"},getCompanyGroupId:function(){return"20195"},getDefaultLanguageId:function(){return"en_US"},getDoAsUserIdEncoded:function(){return""},getLanguageId:function(){return"en_US"},getParentGroupId:function(){return"20182"},getPathContext:function(){return""},getPathImage:function(){return"/image"},getPathJavaScript:function(){return"/html/js"},getPathMain:function(){return"/en/c"},getPathThemeImages:function(){return"https://www.cochranelibrary.com/cochrane-theme/images"},getPathThemeRoot:function(){return"/cochrane-theme"},getPlid:function(){return"20757"},getPortalURL:function(){return"https://www.cochranelibrary.com"},getPortletSetupShowBordersDefault:function(){return true},getScopeGroupId:function(){return"20182"},getScopeGroupIdOrLiveGroupId:function(){return"20182"},getSessionId:function(){return""},getSiteGroupId:function(){return"20182"},getURLControlPanel:function(){return"/group/control_panel?refererPlid=20757"},getURLHome:function(){return"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane"},getUserId:function(){return"20159"},getUserName:function(){return""},isAddSessionIdToURL:function(){return false},isFreeformLayout:function(){return false},isImpersonated:function(){return false},isSignedIn:function(){return false},isStateExclusive:function(){return false},isStateMaximized:function(){return false},isStatePopUp:function(){return false}},PropsValues:{NTLM_AUTH_ENABLED:false}};var themeDisplay=Liferay.ThemeDisplay;Liferay.AUI={getAvailableLangPath:function(){return"available_languages.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513679709000"},getCombine:function(){return true},getComboPath:function(){return"/combo/?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513679709000&"},getFilter:function(){return"min"},getJavaScriptRootPath:function(){return"/html/js"},getLangPath:function(){return"aui_lang.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513679709000"},getStaticResourceURLParams:function(){return"?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513679709000"}};Liferay.authToken="8ranHhTh";Liferay.currentURL="\x2fweb\x2fcochrane\x2fcontent\x3ftemplateType\x3dfull\x26urlTitle\x3d\x2fcdsr\x2fdoi\x2f10\x2e1002\x2f14651858\x2eMR000033\x2epub3\x26doi\x3d10\x2e1002\x2f14651858\x2eMR000033\x2epub3\x26type\x3dcdsr\x26contentLanguage\x3d";Liferay.currentURLEncoded="\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eMR000033\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eMR000033\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D";</script> <script src="/html/js/barebone.jsp?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;colorSchemeId=01&amp;minifierType=js&amp;minifierBundleId=javascript.barebone.files&amp;languageId=en_US&amp;b=6210&amp;t=1513679709000" type="text/javascript"></script> <script type="text/javascript"></script> <script type="text/javascript">var o={database:"CDSR",page:{pageType:"Article Full Text HTML"},article:{availableLanguage:["en","es","de","ru","ja","hr","pl","fr","zh_HANT","fa","ko","pt","ms","zh_HANS"],languageCode:"en",accessStatus:"delayed-free",doi:"10.1002/14651858.MR000033.pub3",title:"Industry sponsorship and research outcome",firstPublishedDate:"Feb 16, 2017 12:00:00 AM",isCurrentVersion:true,editorialGroup:"Cochrane Methodology Review Group",availableParts:["PDF Full","PDF Standard","PDF Abstract","HTML","Comments","Information","References","Stats","Related Content"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/custom.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" rel="stylesheet" type="text/css"/> <style type="text/css"></style> <script async="" src="https://assets.adobedtm.com/59640f9fa510/7cad07cf7779/launch-a215d9c51521.min.js"></script> <!--[if lt IE 9]> <script src="/cochrane-theme/vendor/respond/dest/respond.min.js?t=1738734064000" type="text/javascript"></script> <![endif]--> </head> <body class="yui3-skin-sam controls-visible guest-site signed-out public-page site"> <div class="site-container"> <a href="#main-content" id="skip-to-content">Skip to Content</a> <div class="cookie-message cookie-message--hidden system-message-container" id="js-cookie-message"> <div class="container"> <a aria-label="Close cookies message" class="fa fa-times js-cookie-close pull-right" href="#"></a> <div class="system-message-wrapper container"> <i aria-hidden="true" class="fa fa-exclamation-triangle"></i> <div class="system-message-title">Cookies</div> <div class="system-message-description"> <p> Our site uses cookies to improve your experience. You can find out more about our use of cookies in About Cookies, including instructions on how to turn off cookies if you wish to do so. By continuing to browse this site you agree to us using cookies as described in <a href="http://olabout.wiley.com/WileyCDA/Section/id-813473.html">About Cookies</a>. </p> <a class="btn secondary js-cookie-close js-cookie-accept" href="#">I accept</a> </div> </div> </div> </div> <script>document.body.className=document.body.className+" js_enabled";</script><header> <div class="container"> <div class="branding"> <h1 class="brand-container"> <a href="https://www.cochranelibrary.com/en/"> <span class="brand-name">The Cochrane Library</span> <img alt="Cochrane Library logo" class="brand-logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_logo.png" title="Cochrane Library"/> </a> </h1> <span class="additional-branding"> <p class="brand-message"> <em>Trusted evidence.</em> <em>Informed decisions.</em> <em>Better health.</em> </p> </span> </div> <div class="desktop-search basic-search-container"> <div class="desktop-search-form"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="owel__null__null" src="/scolaris-search/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=8ranHhTh&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"/> <input name="facetDisplayName" type="hidden" value=""/> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.MR000033.pub3&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.MR000033.pub3';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<div class="search-tools-nav">
<a class="btn secondary" href="/en/browse-by-topic">Browse</a>
<a class="btn primary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
</div>
<a class="toggle-menu-switch" href="#"><i aria-hidden="true" class="fa fa-bars"></i> <div class="toggle-menu-text">Open menu</div></a>
</div>
<div class="auxiliary-container">
<div class="container">
<div class="header-auxiliary-menu">
<div class="auxiliary-menu-item language-selector">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="bvrs__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> Review language : English </a> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> Website language : English </a> </div> <div class="language-selector-modal-content" data-modal-title="Language selection" data-size="large" style="display: none;"> <div class="form-content language-selector-modal"> <div class="row-fluid"> <div> <table class="mytable" style="border: 1px solid #f0f0f0" width="90%"> <tbody> <tr class="row-box"> <td><i class="fa fa-file-text icon-size"></i></td> <td><h3>Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> </td> <td> <div> <select id="contentLanguageSelector" onchange="updateLang(this.value)"> <option class="content-language-option" data-languagecode="de" value="de"> Deutsch </option> <option class="content-language-option" data-languagecode="en" selected="" value="en"> English </option> <option class="content-language-option" data-languagecode="es" value="es"> Español </option> <option class="content-language-option" data-languagecode="fa" value="fa"> فارسی </option> <option class="content-language-option" data-languagecode="fr" value="fr"> Français </option> <option class="content-language-option" data-languagecode="hi" value="hi"> हिन्दी </option> <option class="content-language-option" data-languagecode="hr" value="hr"> Hrvatski </option> <option class="content-language-option" data-languagecode="id" value="id"> Bahasa Indonesia </option> <option class="content-language-option" data-languagecode="ja" value="ja"> 日本語 </option> <option class="content-language-option" data-languagecode="ko" value="ko"> 한국어 </option> <option class="content-language-option" data-languagecode="hu" value="hu"> Magyar </option> <option class="content-language-option" data-languagecode="ms" value="ms"> Bahasa Malaysia </option> <option class="content-language-option" data-languagecode="nl" value="nl"> Nederlands </option> <option class="content-language-option" data-languagecode="pl" value="pl"> Polski </option> <option class="content-language-option" data-languagecode="pt" value="pt"> Português </option> <option class="content-language-option" data-languagecode="ru" value="ru"> Русский </option> <option class="content-language-option" data-languagecode="ro" value="ro"> Română </option> <option class="content-language-option" data-languagecode="ta" value="ta"> தமிழ் </option> <option class="content-language-option" data-languagecode="th" value="th"> ภาษาไทย </option> <option class="content-language-option" data-languagecode="zh_HANT" value="zh_HANT"> 繁體中文 </option> <option class="content-language-option" data-languagecode="zh_HANS" value="zh_HANS"> 简体中文 </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> <tr class="row-box"> <td><i class="fa fa-globe icon-size"></i></td> <td> <div class="language-info"> <h3>Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> </div> </td> <td> <div class="language-dropdown"> <select id="portalLanguageSelector"> <option class="portal-language-selector" data-portallanguage="en" selected="" value="/en/cdsr/doi/10.1002/14651858.MR000033.pub3/full/en"> English </option> <option class="portal-language-selector" data-portallanguage="es" value="/es/cdsr/doi/10.1002/14651858.MR000033.pub3/full/es"> Español </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> </tbody> </table> </div> </div> <div style="text-align: right;"> <button class="btn primary btn-cancel" style="margin-left: 10px;" type="button">Cancel</button> <a class="btn secondary ok-btn" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<a class="auxiliary-menu-item signin last" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.MR000033.pub3%2Ffull" rel="nofollow">
<i class="icon fa fa-user"></i> Sign In
    </a>
<span class="auxiliary-container-extended"></span>
</div>
</div>
</div>
</header>
<div class="main-nav-wrapper">
<span class="main-nav-left-extended"></span>
<nav class="main container">
<ul>
<li class="nav-root-item parent">
<a href="#">Cochrane reviews<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_14" role="presentation">
<a aria-labelledby="layout_14" href="https://www.cochranelibrary.com/en/cdsr/reviews" role="menuitem">
            Search reviews (CDSR)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_15" role="presentation">
<a aria-labelledby="layout_15" href="https://www.cochranelibrary.com/en/cdsr/reviews/topics" role="menuitem">
            Browse reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_18" role="presentation">
<a aria-labelledby="layout_18" href="https://www.cochranelibrary.com/en/cdsr/table-of-contents" role="menuitem">
            Issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_17" role="presentation">
<a aria-labelledby="layout_17" href="https://www.cochranelibrary.com/en/cdsr/editorials" role="menuitem">
            Editorials
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_19" role="presentation">
<a aria-labelledby="layout_19" href="https://www.cochranelibrary.com/en/special-collections" role="menuitem">
            Special Collections
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_20" role="presentation">
<a aria-labelledby="layout_20" href="https://www.cochranelibrary.com/en/cdsr/supplements" role="menuitem">
            Supplements
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_121" role="presentation">
<a aria-labelledby="layout_121" href="https://www.cochranelibrary.com/en/about/about-cochrane-reviews" role="menuitem">
            About Cochrane reviews
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Searching for trials<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_254" role="presentation">
<a aria-labelledby="layout_254" href="https://www.cochranelibrary.com/en/search/releases" role="menuitem">
            What's new (search and CENTRAL)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_266" role="presentation">
<a aria-labelledby="layout_266" href="https://www.cochranelibrary.com/en/search-help" role="menuitem">
            Search help
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_252" role="presentation">
<a aria-labelledby="layout_252" href="https://www.cochranelibrary.com/en/search-help-quick-guides" role="menuitem">
            Search help quick guides
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_251" role="presentation">
<a aria-labelledby="layout_251" href="https://www.cochranelibrary.com/en/search-faqs" role="menuitem">
            Search FAQs
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_114" role="presentation">
<a aria-labelledby="layout_114" href="https://www.cochranelibrary.com/en/central/about-central" role="menuitem">
            About CENTRAL
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_115" role="presentation">
<a aria-labelledby="layout_115" href="https://www.cochranelibrary.com/en/central/central-creation" role="menuitem">
            How CENTRAL is created
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_241" role="presentation">
<a aria-labelledby="layout_241" href="https://www.cochranelibrary.com/en/retracted-trials" role="menuitem">
            Retracted publications in CENTRAL
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Clinical Answers<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_29" role="presentation">
<a aria-labelledby="layout_29" href="https://www.cochranelibrary.com/en/cca" role="menuitem">
            Browse Clinical Answers
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_91" role="presentation">
<a aria-labelledby="layout_91" href="https://www.cochranelibrary.com/en/cca/about" role="menuitem">
            About Clinical Answers
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">About<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_116" role="presentation">
<a aria-labelledby="layout_116" href="https://www.cochranelibrary.com/en/about/about-cochrane-library" role="menuitem">
            About the Cochrane Library
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_13" role="presentation">
<a aria-labelledby="layout_13" href="https://www.cochranelibrary.com/en/cdsr/about-cdsr" role="menuitem">
            Cochrane Database of Systematic reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_198" role="presentation">
<a aria-labelledby="layout_198" href="https://www.cochranelibrary.com/en/cdsr/editorial-policies" role="menuitem">
            Editorial policies
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_92" role="presentation">
<a aria-labelledby="layout_92" href="https://www.cochranelibrary.com/en/about/author-information" role="menuitem">
            Information for authors
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_212" role="presentation">
<a aria-labelledby="layout_212" href="https://www.cochranelibrary.com/en/about-pico" role="menuitem">
            About PICO
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_207" role="presentation">
<a aria-labelledby="layout_207" href="https://www.cochranelibrary.com/en/about/about-translations" role="menuitem">
            About translations
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_188" role="presentation">
<a aria-labelledby="layout_188" href="https://www.cochranelibrary.com/en/about/releases" role="menuitem">
            What's new
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_216" role="presentation">
<a aria-labelledby="layout_216" href="https://www.cochranelibrary.com/en/data" role="menuitem">
            Data reuse
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_235" role="presentation">
<a aria-labelledby="layout_235" href="https://www.cochranelibrary.com/en/about/about-cochrane-library/editorial-board" role="menuitem">
            Cochrane Library Editorial Board
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Help<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_259" role="presentation">
<a aria-labelledby="layout_259" href="https://m.info.wiley.com/webApp/cochranenewsletter?id=0" role="menuitem">
            Newsletter
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_177" role="presentation">
<a aria-labelledby="layout_177" href="https://www.wiley.com/en-us/customer-success/cochrane-library-training-hub" role="menuitem">
            Cochrane Library Training
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_44" role="presentation">
<a aria-labelledby="layout_44" href="https://www.cochranelibrary.com/en/help/access" role="menuitem">
            Access
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_150" role="presentation">
<a aria-labelledby="layout_150" href="https://www.cochranelibrary.com/en/help/permissions" role="menuitem">
            Permissions and reprints
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_93" role="presentation">
<a aria-labelledby="layout_93" href="https://www.cochranelibrary.com/en/help/media" role="menuitem">
            Media information
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_97" role="presentation">
<a aria-labelledby="layout_97" href="https://www.cochranelibrary.com/en/help/contact-us" role="menuitem">
            Contact us
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_125" role="presentation">
<a aria-labelledby="layout_125" href="https://www.cochranelibrary.com/en/about/terms-and-conditions" role="menuitem">
            Terms and conditions
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_176" role="presentation">
<a aria-labelledby="layout_176" href="https://cochranesupport.wiley.com/s/article/cochrane-library-known-issues" role="menuitem">
            Known issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_270" role="presentation">
<a aria-labelledby="layout_270" href="https://www.cochranelibrary.com/search-help" role="menuitem">
            Search help
        </a>
</li>
</ul>
</li>
<li class="about-link"><a href="https://www.cochrane.org/about-us" target="_blank"><span>About Cochrane</span><i class="fa fa-caret-right"></i></a></li>
</ul>
</nav>
</div>
<div class="portlet-boundary portlet-boundary_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_">
<span id="p_scolariscontentlanguagebanner_WAR_scolarislanguageportlet"></span>
<section class="portlet" id="portlet_scolariscontentlanguagebanner_WAR_scolarislanguageportlet">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Language\x20Banner\x20Portlet')">
<img alt="" id="etlj__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Language Banner Portlet</span> </span> <span class="portlet-title-text">Scolaris Content Language Banner Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentlanguagebanner_WAR_scolarislanguageportlet" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="" id="content">
<div class="columns-1" id="main-content" role="main">
<div class="portlet-layout row-fluid">
<div class="portlet-column portlet-column-only span12" id="column-1">
<div class="portlet-dropzone portlet-column-content portlet-column-content-only" id="layout-column_column-1">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="rjus__column1__0" src="/scolaris-content-display/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="publication cdsr container"> <div class="article-navigation-container" id="cdsr-nav"> <nav class="article-navigation"> <ul class="tools-row"> <li> <li class="tools pdf pulldown-menu readcube-menu closed en_US"> <a class="pulldown-menu-trigger" href="#0"> <span class="pdf-icon"> <i class="icon fa fa-file-pdf-o"></i> <span>Download PDF</span> </span> <i aria-hidden="true" class="fa fa-caret-down"></i> </a> <ul class="pulldown-menu-items"> <li class=""> <a class="download media pdf-link-full pdf-link" href="/cdsr/doi/10.1002/14651858.MR000033.pub3/pdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> <a class="download media pdf-link-full readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.MR000033.pub3/epdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> </li> <li class=""> <a class="download media pdf-link-abstract pdf-link" href="/cdsr/doi/10.1002/14651858.MR000033.pub3/pdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> <a class="download media pdf-link-abstract readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.MR000033.pub3/epdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> </li> </ul> </li> <li class="tools cite cite-article-link" data-article-id="MR000033.PUB3" data-modal-title="Cite this review"> <span><i aria-hidden="true" class="icon fa fa-share"></i></span> <span>Cite this review</span> </li> </li> </ul> <ul class="tools-row tools-secondary"> <li> <li class="tools print print-cdsr-link" data-content-language="en" data-indicator-tooltip="scolaris.print.modal.language.tooltip.en" data-print-options="[{&quot;param&quot;: &quot;abstract&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Abstract&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;چکیده&quot;},{&quot;language&quot;:&quot;fr&quot;,&quot;title&quot;:&quot;Résumé scientifique&quot;},{&quot;language&quot;:&quot;ko&quot;,&quot;title&quot;:&quot;초록&quot;},{&quot;language&quot;:&quot;pt&quot;,&quot;title&quot;:&quot;Resumo&quot;},{&quot;language&quot;:&quot;zh_HANS&quot;,&quot;title&quot;:&quot;摘要&quot;}]},{&quot;param&quot;: &quot;pls&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Plain language summary&quot;},{&quot;language&quot;:&quot;de&quot;,&quot;title&quot;:&quot;Laienverständliche Zusammenfassung&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen en términos sencillos&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;خلاصه به زبان ساده&quot;},{&quot;language&quot;:&quot;fr&quot;,&quot;title&quot;:&quot;Résumé simplifié&quot;},{&quot;language&quot;:&quot;hr&quot;,&quot;title&quot;:&quot;Laički sažetak&quot;},{&quot;language&quot;:&quot;ja&quot;,&quot;title&quot;:&quot;一般語訳&quot;},{&quot;language&quot;:&quot;ko&quot;,&quot;title&quot;:&quot;쉬운 말 요약&quot;},{&quot;language&quot;:&quot;ms&quot;,&quot;title&quot;:&quot;Ringkasan bahasa mudah&quot;},{&quot;language&quot;:&quot;pl&quot;,&quot;title&quot;:&quot;Streszczenie prostym językiem&quot;},{&quot;language&quot;:&quot;pt&quot;,&quot;title&quot;:&quot;Resumo para leigos&quot;},{&quot;language&quot;:&quot;ru&quot;,&quot;title&quot;:&quot;Резюме на простом языке&quot;},{&quot;language&quot;:&quot;zh_HANS&quot;,&quot;title&quot;:&quot;简语概要&quot;},{&quot;language&quot;:&quot;zh_HANT&quot;,&quot;title&quot;:&quot;淺顯易懂的口語結論&quot;}]},{&quot;param&quot;: &quot;conclusions&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors' conclusions&quot;}]},{&quot;param&quot;: &quot;summaryOfFindings&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Summary of findings&quot;}]},{&quot;param&quot;: &quot;background&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Background&quot;}]},{&quot;param&quot;: &quot;objectives&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Objectives&quot;}]},{&quot;param&quot;: &quot;methods&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Methods&quot;}]},{&quot;param&quot;: &quot;results&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Results&quot;}]},{&quot;param&quot;: &quot;discussion&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Discussion&quot;}]},{&quot;param&quot;: &quot;references&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;References&quot;}]},{&quot;param&quot;: &quot;appendices&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Appendices&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Search strategies&quot;}]},{&quot;param&quot;: &quot;characteristics&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Characteristics of studies&quot;}]},{&quot;param&quot;: &quot;data&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Analyses&quot;}]},{&quot;param&quot;: &quot;information&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Information&quot;}]},{&quot;param&quot;: &quot;authors&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors&quot;}]},{&quot;param&quot;: &quot;history&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;}]}]" data-print-urlbase="/cdsr/doi/10.1002/14651858.MR000033.pub3/print"> <span><i class="icon fa fa-print"></i></span> <span>Print</span> </li> <li class="js-old-version-modal-trigger tools comments comment-on-review" data-article-id="MR000033.PUB3" data-english-only-message="Please note, that commenting is available in English only. Apologies for any inconvenience." data-href="/cdsr/doi/10.1002/14651858.MR000033.pub3/read-comments" data-new-version="" id="comment-on-review"> <span class="comment-icon"><i class="icon fa fa-comment"></i></span> <span class="comments-count">0</span> <span>Comment</span> </li> <li class="tools share-cdsr-link" data-share-url="/cdsr/doi/10.1002/14651858.MR000033.pub3/full"> <span><i class="icon fa fa-share-alt"></i></span> <span>Share</span> </li> <li class="tools follow"> <span class="article-not-followed cochrane-link signin follow-wrapper"> <span> <i class="icon fa fa-plus"></i> </span> <span> Follow </span> </span> </li> </li> </ul> <div class="metrics-wrapper"> <div class="metrics-count"> <span>Full text views: </span> <span>21861 <i class="icon fa fa-info-circle custom-tooltip" style="padding-left: 2px;color: #962d91;" title="Usage represents full text views on Cochrane Library since January 2022 or 2023. For articles published after this date, the usage represents views since the article was first published on Cochrane Library."> </i> </span> </div> </div> <div class="metrics-wrapper nav-link-section"> <div class="altmetric-embed" data-badge-type="1" data-condensed="true" data-doi="10.1002/14651858.MR000033.pub3" data-link-target="_blank"></div> <div class="inline-status-wrapper guidelines-count" data-count-plural="Cited in $1 guidelines" data-count-single="Cited in 1 guideline"> <a href="related-content#guidelines_data" title="Guidelines"></a> </div> </div> <ul class="nav-section-header"> <li> <h3>Contents</h3> </li> </ul> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.MR000033.pub3/full"> Abstract </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.MR000033.pub3/full#MR000033-abs-0003"> Plain language summary </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.MR000033.pub3/full#MR000033-sec-0092"> Authors' conclusions </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.MR000033.pub3/full#MR000033-sec-0043"> Summary of findings </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.MR000033.pub3/full#MR000033-sec-0044"> Background </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.MR000033.pub3/full#MR000033-sec-0047"> Objectives </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.MR000033.pub3/full#MR000033-sec-0048"> Methods </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.MR000033.pub3/full#MR000033-sec-0070"> Results </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.MR000033.pub3/full#MR000033-sec-0085"> Discussion </a> </li> <li class="cdsr-nav-link"> <a class="figures-and-tables-link" href="/cdsr/doi/10.1002/14651858.MR000033.pub3/#"> Figures and tables </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.MR000033.pub3/references"> References </a> </li> </ul> <div class="nav-section-header"> <h3>Supplementary materials</h3> </div> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.MR000033.pub3/appendices#MR000033-sec-0096"> Search strategies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.MR000033.pub3/references#characteristicStudies"> Characteristics of studies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.MR000033.pub3/references#dataAndAnalyses"> Analyses </a> </li> <li class="cdsr-nav-link download-stats-data-link" data-download-href="/cdsr/doi/10.1002/14651858.MR000033.pub3/media/CDSR/MR000033/table_n/MR000033StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> <a href="/cdsr/doi/10.1002/14651858.MR000033.pub3/media/CDSR/MR000033/table_n/MR000033StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> Download data </a> </li> </ul> <ul class="tools-row"> <li> </li> </ul> <ul class="nav-section-header"> <li><h3>Related</h3></li> </ul> <ul class="linked-content linked-content-dropdown" id="linked-content-articles" tabindex="0"> <li class="linked-cca" data-type="cca"> <div class="linked-content-section"> <span class="linked-type">Cochrane Clinical Answers<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-editorials" data-type="editorial"> <div class="linked-content-section"> <span class="linked-type">Editorials<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-podcasts" data-type="podcast"> <div class="linked-content-section"> <span class="linked-type">Podcasts<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-sc" data-type="sc"> <div class="linked-content-section"> <span class="linked-type">Special Collections<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> </ul> <div class="nav-section-header"> <h3>About this review</h3> </div> <ul class="nav-long-form nav-info nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.MR000033.pub3/information"> <i> <svg viewbox="0 0 24 24"> <path d="M11,9H13V7H11M12,20C7.59,20 4,16.41 4,12C4,7.59 7.59,4 12,4C16.41,4 20,7.59 20,12C20,16.41 16.41,20 12,20M12,2A10,10 0 0,0 2,12A10,10 0 0,0 12,22A10,10 0 0,0 22,12A10,10 0 0,0 12,2M11,17H13V11H11V17Z"></path> </svg> </i> Information </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.MR000033.pub3/information#authors"> <i> <svg viewbox="0 0 24 24"> <path d="M12,5.5A3.5,3.5 0 0,1 15.5,9A3.5,3.5 0 0,1 12,12.5A3.5,3.5 0 0,1 8.5,9A3.5,3.5 0 0,1 12,5.5M5,8C5.56,8 6.08,8.15 6.53,8.42C6.38,9.85 6.8,11.27 7.66,12.38C7.16,13.34 6.16,14 5,14A3,3 0 0,1 2,11A3,3 0 0,1 5,8M19,8A3,3 0 0,1 22,11A3,3 0 0,1 19,14C17.84,14 16.84,13.34 16.34,12.38C17.2,11.27 17.62,9.85 17.47,8.42C17.92,8.15 18.44,8 19,8M5.5,18.25C5.5,16.18 8.41,14.5 12,14.5C15.59,14.5 18.5,16.18 18.5,18.25V20H5.5V18.25M0,20V18.5C0,17.11 1.89,15.94 4.45,15.6C3.86,16.28 3.5,17.22 3.5,18.25V20H0M24,20H20.5V18.25C20.5,17.22 20.14,16.28 19.55,15.6C22.11,15.94 24,17.11 24,18.5V20Z"></path> </svg> </i> Authors </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.MR000033.pub3/information#history"> <i> <svg viewbox="0 0 24 24"> <path d="M13.5,8H12V13L16.28,15.54L17,14.33L13.5,12.25V8M13,3A9,9 0 0,0 4,12H1L4.96,16.03L9,12H6A7,7 0 0,1 13,5A7,7 0 0,1 20,12A7,7 0 0,1 13,19C11.07,19 9.32,18.21 8.06,16.94L6.64,18.36C8.27,20 10.5,21 13,21A9,9 0 0,0 22,12A9,9 0 0,0 13,3"></path> </svg> </i> Version history </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.MR000033.pub3/information#keywords"> <i> <svg viewbox="0 0 24 24"> <path d="M11 3C10.18 3 9.44 3.5 9.14 4.27L3.64 18.27C3.12 19.58 4.09 21 5.5 21H7.75C8.59 21 9.33 20.5 9.62 19.7L10.26 18H13.74L14.38 19.7C14.67 20.5 15.42 21 16.25 21H18.5C19.91 21 20.88 19.58 20.36 18.27L14.86 4.27C14.56 3.5 13.82 3 13 3M11 5H13L18.5 19H16.25L15.12 16H8.87L7.75 19H5.5M12 7.67L9.62 14H14.37Z"></path> </svg> </i> Keywords (MeSH, PICOs) </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.MR000033.pub3/related-content"> <i class="icon fa fa-sitemap fa-rotate-270"></i> Related content </a> </li> <li class="cdsr-nav-link translation-notes-link"> <a href="/cdsr/doi/10.1002/14651858.MR000033.pub3/#"> <i> <svg viewbox="0 0 24 24"> <path d="M12.87,15.07L10.33,12.56L10.36,12.53C12.1,10.59 13.34,8.36 14.07,6H17V4H10V2H8V4H1V6H12.17C11.5,7.92 10.44,9.75 9,11.35C8.07,10.32 7.3,9.19 6.69,8H4.69C5.42,9.63 6.42,11.17 7.67,12.56L2.58,17.58L4,19L9,14L12.11,17.11L12.87,15.07M18.5,10H16.5L12,22H14L15.12,19H19.87L21,22H23L18.5,10M15.88,17L17.5,12.67L19.12,17H15.88Z"></path> </svg> </i> Translation notes </a> </li> <li class="cdsr-nav-link"> <a class="request-permissions" data-copyright="Copyright © 2017 The Cochrane Collaboration. Published by John Wiley &amp; Sons, Ltd." data-creative-commons="false" href="/cdsr/doi/10.1002/14651858.MR000033.pub3/#"> <span class="request-permissions-icon"></span> Request permissions </a> </li> <li class="cdsr-nav-link"> <a href="/data"> <i class="icon fa fa-database"></i> Request data reuse </a> </li> </ul> </nav> </div> <article> <div class="cdsr-header-top"> <div class="cdsr-header-left"> <a class="publish-database" href="/">Cochrane Database of Systematic reviews</a> <span class="publish-type">Review - Methodology</span> </div> <div class="cdsr-header-right"> <div class="inline-status-wrapper"> <ul class="cochrane-status"> <li aria-label="A new search for studies has been conducted." class="status-item up-to-date custom-tooltip" data-status="newsearch" title="A new search for studies has been conducted."> <a class="btn secondary" href="information#history">New search</a> </li> </ul> </div> </div> </div> <header class="publication-header"> <h1 class="publication-title" lang="en">Industry sponsorship and research outcome</h1> <div class="publication-metadata-block"> <div class="publication-authors"> <div class="publish-meta-wrapper"> <ul class="authors"> <li class="author"><a href="/cdsr/doi/10.1002/14651858.MR000033.pub3/information#MR000033-cr-0002"><i class="icon corresponding-author fa fa-envelope"></i>Andreas Lundh</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.MR000033.pub3/information#MR000033-cr-0003">Joel Lexchin</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.MR000033.pub3/information#MR000033-cr-0004">Barbara Mintzes</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.MR000033.pub3/information#MR000033-cr-0005">Jeppe B Schroll</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.MR000033.pub3/information#MR000033-cr-0006">Lisa Bero</a></li> </ul> <span class="author declaration"> <a class="declarationsOfInterestLink" href="/cdsr/doi/10.1002/14651858.MR000033.pub3/information/en#MR000033-sec-0100">Authors' declarations of interest</a> </span> </div> </div> </div> <div class="publication-metadata-block"> <p> <span class="publish-date">Version published: 16 February 2017 </span> <a class="whatsNewLink" href="/cdsr/doi/10.1002/14651858.MR000033.pub3/information/en#versionTable">Version history</a> </p> <div class="doi-header"> <a href="https://doi.org/10.1002/14651858.MR000033.pub3">https://doi.org/10.1002/14651858.MR000033.pub3</a> </div> </div> </header> <div class="publication-control-bar"> <span class="publication-control-button publication-control-collapse"> Collapse all </span> <span class="publication-control-button publication-control-expand"> Expand all </span> </div> <section class="abstract"> <div class="section-header section-collapse-header" id="MR000033-abs-0001" lang="en"> <h2 class="title section-collapse-title"> Abstract <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#MR000033-abs-0001">English</a> </li> <li class="section-language"> <a class="" href="full/es#MR000033-abs-0018">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#MR000033-abs-0011">فارسی</a> </li> <li class="section-language"> <a class="" href="full/fr#MR000033-abs-0002">Français</a> </li> <li class="section-language"> <a class="" href="full/ko#MR000033-abs-0013">한국어</a> </li> <li class="section-language"> <a class="" href="full/pt#MR000033-abs-0015">Português</a> </li> <li class="section-language"> <a class="" href="full/zh_HANS#MR000033-abs-0020">简体中文</a> </li> </nav> </div> </div> <div class="abstract full_abstract" id="MR000033-abs-0001" lang="en"> <section id="MR000033-sec-0001"> <h3 class="title" id="MR000033-sec-0001">Background</h3> <p>Clinical research affecting how doctors practice medicine is increasingly sponsored by companies that make drugs and medical devices. Previous systematic reviews have found that pharmaceutical‐industry sponsored studies are more often favorable to the sponsor’s product compared with studies with other sources of sponsorship. A similar association between sponsorship and outcomes have been found for device studies, but the body of evidence is not as strong as for sponsorship of drug studies. This review is an update of a previous Cochrane review and includes empirical studies on the association between sponsorship and research outcome. </p> </section> <section id="MR000033-sec-0002"> <h3 class="title" id="MR000033-sec-0002">Objectives</h3> <p>To investigate whether industry sponsored drug and device studies have more favorable outcomes and differ in risk of bias, compared with studies having other sources of sponsorship. </p> </section> <section id="MR000033-sec-0003"> <h3 class="title" id="MR000033-sec-0003">Search methods</h3> <p>In this update we searched MEDLINE (2010 to February 2015), Embase (2010 to February 2015), the Cochrane Methodology Register (2015, Issue 2) and Web of Science (June 2015). In addition, we searched reference lists of included papers, previous systematic reviews and author files. </p> </section> <section id="MR000033-sec-0004"> <h3 class="title" id="MR000033-sec-0004">Selection criteria</h3> <p>Cross‐sectional studies, cohort studies, systematic reviews and meta‐analyses that quantitatively compared primary research studies of drugs or medical devices sponsored by industry with studies with other sources of sponsorship. We had no language restrictions. </p> </section> <section id="MR000033-sec-0005"> <h3 class="title" id="MR000033-sec-0005">Data collection and analysis</h3> <p>Two assessors screened abstracts and identified and included relevant papers. Two assessors extracted data, and we contacted authors of included papers for additional unpublished data. Outcomes included favorable results, favorable conclusions, effect size, risk of bias and whether the conclusions agreed with the study results. Two assessors assessed risk of bias of included papers. We calculated pooled risk ratios (RR) for dichotomous data (with 95% confidence intervals (CIs)). </p> </section> <section id="MR000033-sec-0006"> <h3 class="title" id="MR000033-sec-0006">Main results</h3> <p>Twenty‐seven new papers were included in this update and in total the review contains 75 included papers. Industry sponsored studies more often had favorable efficacy results, RR: 1.27 (95% CI: 1.17 to 1.37) (25 papers) (moderate quality evidence), similar harms results RR: 1.37 (95% CI: 0.64 to 2.93) (four papers) (very low quality evidence) and more often favorable conclusions RR: 1.34 (95% CI: 1.19 to 1.51) (29 papers) (low quality evidence) compared with non‐industry sponsored studies. Nineteen papers reported on sponsorship and efficacy effect size, but could not be pooled due to differences in their reporting of data and the results were heterogeneous. We did not find a difference between drug and device studies in the association between sponsorship and conclusions (test for interaction, P = 0.98) (four papers). Comparing industry and non‐industry sponsored studies, we did not find a difference in risk of bias from sequence generation, allocation concealment, follow‐up and selective outcome reporting. However, industry sponsored studies more often had low risk of bias from blinding, RR: 1.25 (95% CI: 1.05 to 1.50) (13 papers), compared with non‐industry sponsored studies. In industry sponsored studies, there was less agreement between the results and the conclusions than in non‐industry sponsored studies, RR: 0.83 (95% CI: 0.70 to 0.98) (six papers). </p> </section> <section id="MR000033-sec-0007"> <h3 class="title" id="MR000033-sec-0007">Authors' conclusions</h3> <p>Sponsorship of drug and device studies by the manufacturing company leads to more favorable efficacy results and conclusions than sponsorship by other sources. Our analyses suggest the existence of an industry bias that cannot be explained by standard 'Risk of bias' assessments. </p> </section> </div> </section> <section class="pls"> <div class="section-header section-collapse-header" id="MR000033-abs-0003" lang="en"> <h2 class="title section-collapse-title"> Plain language summary <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#MR000033-abs-0003">English</a> </li> <li class="section-language"> <a class="" href="full/de#MR000033-abs-0004">Deutsch</a> </li> <li class="section-language"> <a class="" href="full/es#MR000033-abs-0019">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#MR000033-abs-0012">فارسی</a> </li> <li class="section-language"> <a class="" href="full/fr#MR000033-abs-0009">Français</a> </li> <li class="section-language"> <a class="" href="full/hr#MR000033-abs-0007">Hrvatski</a> </li> <li class="section-language"> <a class="" href="full/ja#MR000033-abs-0006">日本語</a> </li> <li class="section-language"> <a class="" href="full/ko#MR000033-abs-0014">한국어</a> </li> <li class="section-language"> <a class="" href="full/ms#MR000033-abs-0017">Bahasa Malaysia</a> </li> <li class="section-language"> <a class="" href="full/pl#MR000033-abs-0008">Polski</a> </li> <li class="section-language"> <a class="" href="full/pt#MR000033-abs-0016">Português</a> </li> <li class="section-language"> <a class="" href="full/ru#MR000033-abs-0005">Русский</a> </li> <li class="section-language"> <a class="" href="full/zh_HANS#MR000033-abs-0021">简体中文</a> </li> <li class="section-language"> <a class="" href="full/zh_HANT#MR000033-abs-0010">繁體中文</a> </li> </nav> </div> </div> <div class="abstract abstract_plainLanguageSummary" id="MR000033-abs-0003" lang="en"> <h3>Industry sponsorship and research outcome</h3> <p>Results from clinical studies on drugs and medical devices affect how doctors practice medicine and thereby the treatments offered to patients. However, clinical research is increasingly sponsored by companies that make these products, either because the companies directly perform the studies, or fully or partially fund them. Previous research has found that pharmaceutical industry sponsored studies tend to favor the sponsors’ drugs more than studies with any other sources of sponsorship. This suggests that industry sponsored studies are biased in favor of the sponsor’s products. </p> <p>This review is an update of a previous review that looked at sponsorship of drug and device studies. The primary aim of the review was to find out whether the published results and overall conclusions of industry sponsored drug and device studies were more likely to favor the sponsors’ products, compared with studies with other sources of sponsorship. The secondary aim was to find out whether such industry sponsored studies used methods that increase the risk of bias, again compared with studies with other sources of sponsorship. In this update, we carried out a comprehensive search of all relevant papers of empirical studies published from 2010 to February 2015 and included 27 new papers, yielding a total of 75 papers included in our review. </p> <p>Industry sponsored drug and device studies more often had efficacy results that were favorable to the sponsors' products, (risk ratio (RR): 1.27, 95% confidence interval (CI): 1.17 to 1.37), similar harms results (RR: 1.37, 95% CI: 0.64 to 2.93) and favorable overall conclusions (RR: 1.34, 95% CI: 1.19 to 1.51), compared with non‐industry sponsored drug and device studies. We did not find a difference between industry and non‐industry sponsored studies with respect to standard methodological factors that may increase the risk of bias, except for blinding: industry sponsored studies reported satisfactory blinding more often than non‐industry sponsored studies. In industry sponsored studies, there was less agreement between the results and the conclusions than in non‐industry sponsored studies, RR: 0.83 (95% CI: 0.70 to 0.98).We did not find a difference between drug and device studies in the association between sponsorship and conclusions. Our analysis suggests that industry sponsored drug and device studies are more often favorable to the sponsor’s products than non‐industry sponsored drug and device studies due to biases that cannot be explained by standard 'Risk of bias' assessment tools. </p> </div> </section> <section id="vls" style="display: none"> <div class="section-header section-collapse-header"> <h2 class="title section-collapse-title">Visual summary<i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i></h2> </div> <a href="" target="_blank"><img alt="visual summary" src=""/></a> </section> <section class="conclusions"> <div class="section-header section-collapse-header" id="MR000033-sec-0092" lang="en"> <h2 class="title section-collapse-title"> Authors' conclusions <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="authorsConclusions" lang="en"> <div class="section-header" id="MR000033-sec-0092"></div> <h3 class="title" id="MR000033-sec-0093">Implication for methodological research</h3> <section id="MR000033-sec-0093"> <p>Currently, the <i>Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0</i> acknowledges problems in relation to sponsorship, but does not recommend assessing industry sponsorship as a separate domain in the 'Risk of bias' assessment (<a href="./references#MR000033-bbs2-0234" title="HigginsJPT , AltmanDG , SterneJAC . Chapter 8: Assessing risk of bias in included studies. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane‐handbook.org. ">Higgins 2011b</a>). The assumption is that the influence of the sponsor will be mediated through the mechanisms of bias that are currently assessed, such as selective reporting of favorable outcomes. A Cochrane review that examined the association of sponsorship and selective outcome reporting bias (<a href="./references#MR000033-bbs2-0223" title="DwanK , AltmanDG , CresswellL , BlundellM , GambleCL , WilliamsonPR . Comparison of protocols and registry entries to published reports for randomised controlled trials. Cochrane Database of Systematic Reviews2011, Issue 1. [DOI: 10.1002/14651858.MR000031.pub2] ">Dwan 2011</a>), found uncertain evidence for the association; however, assessment of selective outcome reporting is complex and bias may be difficult to detect (<a href="./references#MR000033-bbs2-0239" title="KirkhamJJ , DwanKM , AltmanDG , GambleC , DoddS , SmythR , et al. The impact of outcome reporting bias in randomised controlled trials on a cohort of systematic reviews. BMJ2010;340:c365. ">Kirkham 2010</a>). Some studies that have documented the extensive selective reporting of favorable outcomes have examined only industry sponsored studies (<a href="./references#MR000033-bbs2-0258" title="RisingK , BacchettiP , BeroL . Reporting bias in drug trials submitted to the Food and Drug Administration: review of publication and presentation. PLoS Medicine2008;5(11):e217. ">Rising 2008</a>; <a href="./references#MR000033-bbs2-0273" title="VedulaSS , BeroL , SchererRW , DickersinK . Outcome reporting in industry‐sponsored trials of gabapentin for off‐label use. New England Journal of Medicine2009;361(20):1963‐71. ">Vedula 2009</a>), thus making comparison with non‐industry sponsored studies impossible. </p> <p>Our data suggest that the more favorable outcomes in industry sponsored studies are mediated by factors other than those documented in the 'Risk of bias' assessment tool in Cochrane reviews. It has been suggested that industry bias should be regarded as a meta‐bias, as industry sponsorship in itself is not a bias‐producing process –  as for example lack of concealment of allocation is – but a risk factor for bias (<a href="./references#MR000033-bbs2-0230" title="GoodmanS , DickersinK . Metabias: a challenge for comparative effectiveness research. Annals of Internal Medicine2011; Vol. 155, issue 1:61‐2. ">Goodman 2011</a>). However, the characteristics currently assessed in the standard risk of bias approach in Cochrane reviews likely do not capture the additional risk of bias in industry sponsored studies. For example, the <i>Handbook</i> states that design issues, such as dosage of comparators are not issues of bias, but of generalizability. Yet, pharmacological interventions have dose‐response curves, and testing drugs that are not in comparable places on their dose‐response curves sets up a systematic, unfair and biased comparison (<a href="./references#MR000033-bbs2-0263" title="SaferDJ . Design and reporting modifications in industry‐sponsored comparative psychopharmacology trials. Journal of Nervous and Mental Disease2002;190(9):583‐92. ">Safer 2002</a>). </p> <p>Consequently, our data suggest that industry sponsorship should be treated as bias‐inducing and industry bias should be treated as a separate domain. There are many subtle mechanisms through which sponsorship may influence outcomes, and an assessment of sponsorship should therefore be used as a proxy for these mechanisms. Interestingly, the AMSTAR tool for methodological quality assessment of systematic reviews includes funding and conflicts of interest as a domain (<a href="./references#MR000033-bbs2-0265" title="SheaBJ , GrimshawJM , WellsGA , BoersM , AnderssonN , HamelC , et al. Development of AMSTAR: a measurement tool to assess the methodological quality of systematic reviews. BMC Medical Research Methodology2007;7:10. ">Shea 2007</a>). Adaptations of Cochrane tools for assessing risk of bias in studies assessing environmental risks have also included funding source and conflicts of interest as a domain (<a href="./references#MR000033-bbs2-0236" title="JohnsonPI , KoustasE , VesterinenHM , SuttonP , AtchleyDS , KimAN , et al. Application of the Navigation Guide systematic review methodology to the evidence for developmental and reproductive toxicity of triclosan. Environment International2016;92‐93:716‐28. ">Johnson 2016</a>). Methods for reporting, assessing and handling industry bias and other biases in future systematic reviews must be developed. Specifically, further methodological research should focus on how industry bias is handled in Cochrane reviews. </p> </section> </section> </section> <section class="summaryOfFindings"> <div class="section-header section-collapse-header" id="MR000033-sec-0043" lang="en"> <h2 class="title section-collapse-title"> Summary of findings <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="summaryOfFindings" lang="en"> <div class="section-header" id="MR000033-sec-0043"></div> <div class="table" id="MR000033-tbl-0001"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">Industry sponsored compared to non‐industry sponsored studies for research outcome</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Results and conclusions: Industry sponsored compared to non‐industry sponsored studies</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Patient or population:</b> industry sponsorship and study results<br/> <b>Intervention:</b> industry sponsored studies<br/> <b>Comparator:</b> non‐industry sponsored studies </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Risk ratio<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>No of Participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Assumed risk</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Corresponding risk</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b> Non‐industry sponsored studies</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b> Industry sponsored studies</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Number of studies with favorable efficacy results</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>502 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>638 per 1000<br/> (588 to 688) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1.27<br/> (1.17 to 1.37) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>25 papers including 2923 studies</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕ ⊕ ⊕ ○<br/> MODERATE </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Upgraded as control for confounders and analysis of low risk of bias papers gave similar results. </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Number of studies with favorable harms results</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>474 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>649 per 1000<br/> (303 to 1388) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1.37<br/> (0.64 to 2.93) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>4 papers including 826 studies</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕ ○ ○ ○<br/> VERY LOW </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Downgraded due to substantial heterogeneity (inconsistency) and wide confidence intervals (imprecision). </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Number of studies with favorable conclusions</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>644 per 1000</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>863 per 1000<br/> (766 to 972) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1.34<br/> (1.19 to 1.51) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>29 papers including 4583 studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕ ⊕ ○ ○<br/> LOW </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Downgraded due to substantial heterogeneity (inconsistency).</p> <p>Upgraded as control for confounders and analysis of low risk of bias papers gave similar results. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*The basis for the <b>assumed risk</b> (e.g. the median control group risk across studies) is provided in footnotes. The <b>corresponding risk</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <b>CI:</b> Confidence interval </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>GRADE Working Group grades of evidence<br/> <b>High quality:</b> Further research is very unlikely to change our confidence in the estimate of effect.<br/> <b>Moderate quality:</b> Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<br/> <b>Low quality:</b> Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<br/> <b>Very low quality:</b> We are very uncertain about the estimate. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p>The assumed risk of the control group (i.e. non‐industry group) was calculated as the mean risk (i.e. number of studies with favorable results divided by total number of studies). </p> </div> </td> </tr> </tfoot> </table> </div> </section> </section> <section class="background"> <div class="section-header section-collapse-header" id="MR000033-sec-0044" lang="en"> <h2 class="title section-collapse-title"> Background <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="background" lang="en"> <div class="section-header" id="MR000033-sec-0044"></div> <section id="MR000033-sec-0045"> <h3 class="title" id="MR000033-sec-0045">Description of the problem or issue</h3> <p>Clinical research sponsored by the pharmaceutical industry affects how doctors practice medicine (<a href="./references#MR000033-bbs2-0252" title="PhRMA . Pharmaceutical marketing in perspective: its value and role as one of many factors informing prescribing. http://www.phrma.org/issues/sales‐marketing (accessed 22 February 2012). ">PhRMA 2008</a>; <a href="./references#MR000033-bbs2-0274" title="WyattJ . Use and sources of medical knowledge. Lancet1991;338(8779):1368‐73. ">Wyatt 1991</a>). An increasing number of clinical trials at all stages in a product's life cycle are funded by the pharmaceutical industry, and the industry now spends more on medical research than do the National Institutes of Health in the USA (<a href="./references#MR000033-bbs2-0249" title="MosesH3rd , MathesonDH , Cairns‐SmithS , GeorgeBP , PalischC , DorseyER . The anatomy of medical research: US and international comparisons. JAMA2015;313(2):174‐89. ">Moses 2015</a>). Results and conclusions that are unfavorable to the sponsor (i.e. studies that find an expensive drug similarly or less effective or more harmful than drugs used to treat the same condition) can pose considerable financial risks to companies. </p> <p>Several systematic reviews have documented that pharmaceutical industry sponsorship of drug studies is associated with findings that are favorable to the sponsor’s product (<a href="./references#MR000033-bbs2-0210" title="BekelmanJE , LiY , GrossCP . Scope and impact of financial conflicts of interest in biomedical research: a systematic review. JAMA2003;289(4):454‐65. ">Bekelman 2003</a>; <a href="./references#MR000033-bbs2-0275" title="LexchinJ , BeroL , DjulbegovicB , ClarkO . Pharmaceutical industry sponsorship and research outcome and quality: a systematic review. BMJ2003;326(7400):1167‐70. ">Lexchin 2003</a>; <a href="./references#MR000033-bbs2-0188" title="SchottG , PachlH , LimbachU , Gundert‐RemyU , LudwigWD , LiebK . The financing of drug trials by pharmaceutical companies and its consequences. Part 1: a qualitative, systematic review of the literature on possible influences on the findings, protocols, and quality of drug trials. Deutsches Arzteblatt international2010;107(16):279‐85. ">Schott 2010a</a>; <a href="./references#MR000033-bbs2-0266" title="SismondoS . Pharmaceutical company funding and its consequences: a qualitative systematic review. Contemporay Clinical Trials2008;29(2):109‐13. ">Sismondo 2008a</a>). There are several ways that industry can sponsor a study, including single‐source sponsorship, shared sponsorship, and provision of free drugs or devices only. There are also several potential ways that industry sponsors can influence the outcome of a study, including the framing of the question, the design of the study, the conduct of the study, how data are analyzed, selective reporting of favorable results, and spin in reporting conclusions (<a href="./references#MR000033-bbs2-0211" title="BeroLA , RennieD . Influences on the quality of published drug studies. International Journal of Technology Assessment in Health Care1996;12(2):209‐37. ">Bero 1996</a>; <a href="./references#MR000033-bbs2-0243" title="LexchinJ . Those who have the gold make the evidence: how the pharmaceutical industry biases the outcomes of clinical trials of medications. Science and Engineering Ethics2012;18(2):247‐61. ">Lexchin 2012</a>; <a href="./references#MR000033-bbs2-0267" title="SismondoS . How pharmaceutical industry funding affects trial outcomes: causal structures and responses. Social Science &amp; Medicine2008;66(9):1909‐14. ">Sismondo 2008b</a>). Although some journals now require that the role of the sponsor in the design, conduct and publication of the study be described, this practice is not widespread (<a href="./references#MR000033-bbs2-0271" title="TuechJJ , MoutelG , PessauxP , ThomaV , SchraubS , HerveC . Disclosure of competing financial interests and role of sponsors in phase III cancer trials. European Journal of Cancer2005;41(15):2237‐40. ">Tuech 2005</a>). In addition, some have argued that because industry sponsored studies are often conducted for regulatory purposes, their methods must meet high standards (<a href="./references#MR000033-bbs2-0259" title="RosefskyJB . Results of clinical trials sponsored by for‐profit vs nonprofit entities. JAMA2003; Vol. 290, issue 23:3070‐1. ">Rosefsky 2003</a>). Therefore, it is important to examine differences not only in the outcomes of industry versus non‐industry sponsored studies, but also differences in the methods or risks of bias. </p> </section> <section id="MR000033-sec-0046"> <h3 class="title" id="MR000033-sec-0046">Why it is important to do this review</h3> <p>This systematic review is the update of an original systematic review by three of the authors (<a href="./references#MR000033-bbs2-0277" title="LundhA , SismondoS , LexchinJ , BusuiocOA , BeroL . Industry sponsorship and research outcome. Cochrane Database of Systematic Reviews2012, Issue 12. [DOI: 10.1002/14651858.MR000033.pub2] ">Lundh 2012</a>), which investigated whether sponsorship by industry is associated with the publication of outcomes favorable to the sponsor. That review is now out of date. Developments, such as the adoption of trial registration could lessen the bias associated with industry sponsorship, as publication bias can be more readily detected (<a href="./references#MR000033-bbs2-0215" title="DeAngelisCD , DrazenJM , FrizelleFA , HaugC , HoeyJ , HortonR , et al. Clinical trial registration: a statement from the International Committee of Medical Journal Editors. JAMA2004; Vol. 292, issue 11:1363‐4. ">DeAngelis 2004</a>). Furthermore, companies now publish results in trial registries suggesting a move toward increased transparency (<a href="./references#MR000033-bbs2-0254" title="PotthastR , VervolgyiV , McGauranN , KerekesMF , WieselerB , KaiserT . Impact of inclusion of industry trial results registries as an information source for systematic reviews. PLoS One2014;9(4):e92067. ">Potthast 2014</a>; <a href="./references#MR000033-bbs2-0264" title="SchwartzLM , WoloshinS , ZhengE , TseT , ZarinDA . ClinicalTrials.gov and Drugs@FDA: A comparison of results reporting for new drug approval trials. Annals of Internal Medicine2016;165(6):421‐30. ">Schwartz 2016</a>). However, this may not be the case as a recent study found that reporting bias is also prevalent in registered trials, particular in industry sponsored trials (<a href="./references#MR000033-bbs2-0145" title="JonesCW , HandlerL , CrowellKE , KeilLG , WeaverMA , Platts‐MillsTF . Non‐publication of large randomized clinical trials: cross sectional analysis. BMJ2013;347:f6104. ">Jones 2013</a>). In addition, the release of internal industry documents as a result of settlement agreements resulting from litigation against drug companies has revealed examples of industry manipulation of the conduct and publication of studies (<a href="./references#MR000033-bbs2-0225" title='Fugh‐BermanAJ . The haunting of medical journals: how ghostwriting sold "HRT". PLoS Medicine2010;7(9):e1000335. '>Fugh‐Berman 2010</a>; <a href="./references#MR000033-bbs2-0262" title="RossJS , HillKP , EgilmanDS , KrumholzHM . Guest authorship and ghostwriting in publications related to rofecoxib: a case study of industry documents from rofecoxib litigation. JAMA2008;299(15):1800‐12. ">Ross 2008</a>; <a href="./references#MR000033-bbs2-0268" title="SteinmanMA , BeroLA , ChrenM‐M , LandefeldS . The promotion of gabapentin: an analysis of internal industry documents. Annals of Internal Medicine2006;145(4):284‐93. ">Steinman 2006</a>; <a href="./references#MR000033-bbs2-0273" title="VedulaSS , BeroL , SchererRW , DickersinK . Outcome reporting in industry‐sponsored trials of gabapentin for off‐label use. New England Journal of Medicine2009;361(20):1963‐71. ">Vedula 2009</a>). </p> </section> </section> </section> <section class="objectives"> <div class="section-header section-collapse-header" id="MR000033-sec-0047" lang="en"> <h2 class="title section-collapse-title"> Objectives <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="objectives" lang="en"> <div class="section-header" id="MR000033-sec-0047"></div> <p>The objectives were to investigate whether:</p> <p> <ul id="MR000033-list-0001"> <li> <p>sponsorship of drug and device studies by the pharmaceutical and device industries is associated with outcomes, including conclusions, that are favorable to the sponsor; </p> </li> <li> <p>drug and device studies sponsored by the pharmaceutical and device industries differ in their risk of bias compared with studies with other sources of sponsorship. </p> </li> </ul> </p> </section> </section> <section class="methods"> <div class="section-header section-collapse-header" id="MR000033-sec-0048" lang="en"> <h2 class="title section-collapse-title"> Methods <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="methods" lang="en"> <div class="section-header" id="MR000033-sec-0048"></div> <section id="MR000033-sec-0049"> <h3 class="title">Criteria for considering studies for this review</h3> <section id="MR000033-sec-0050"> <h4 class="title">Types of studies</h4> <p>This review includes reports of empirical studies that investigate samples of primary research studies. To avoid confusion we will use the terms 'studies' for the primary research studies and 'papers' for the reports of empirical studies of primary research studies. We will use the term trials to describe studies of a randomized clinical trial design. </p> <p>We included papers of cross‐sectional studies, cohort studies, systematic reviews or meta‐analyses that quantitatively compared primary research of human drug or medical device studies sponsored by the pharmaceutical or device industries with studies that had other sources of sponsorship. These papers could report the results of methodological studies or systematic reviews that had a pre‐specified subgroup or sensitivity analysis by sponsorship source. We also included papers investigating sources of heterogeneity (e.g. using meta‐regression) if sponsorship was investigated. Drugs were defined as medications that require approval by a regulatory authority as a prescription drug, recognizing that these approval standards vary worldwide. Devices were defined based on the Food and Drug Administration (FDA) definition as instruments intended for use in the diagnosis, treatment or prevention of disease. </p> <p>We excluded papers without quantitative data related to our primary or secondary outcomes. We excluded papers of the effects of sponsorship by non‐pharmaceutical or non‐device (e.g. tobacco, food or chemical) industries, and papers that evaluated the effectiveness of herbal supplements or medical procedures. Papers examining mixed interventions (e.g. pharmaceuticals and educational interventions) were included if drug or device data were reported separately or could be obtained from the authors. </p> <p>We excluded papers that quantitatively compared the association of sponsorship and results of syntheses of research studies (i.e. systematic reviews or meta‐analyses) or pharmacoeconomic studies of drugs or devices. We also excluded analyses of pharmacokinetic studies and studies restricted to non humans (e.g. animal or cell cultures). </p> <p>Only papers published in full, including structured research letters, were included. We excluded unstructured letters to the editor and conference abstracts. This decision was based on the poor reporting quality of data in letters and conference abstracts encountered in a previous version of our review (<a href="./references#MR000033-bbs2-0275" title="LexchinJ , BeroL , DjulbegovicB , ClarkO . Pharmaceutical industry sponsorship and research outcome and quality: a systematic review. BMJ2003;326(7400):1167‐70. ">Lexchin 2003</a>). A comment to the previous version of our review (<a href="./references#MR000033-bbs2-0277" title="LundhA , SismondoS , LexchinJ , BusuiocOA , BeroL . Industry sponsorship and research outcome. Cochrane Database of Systematic Reviews2012, Issue 12. [DOI: 10.1002/14651858.MR000033.pub2] ">Lundh 2012</a>) suggested that the exclusion of conference abstracts and letters could have introduced publication bias. Therefore, we included conference abstracts and all types of letters in a sensitivity analysis (see below). We had no language restrictions. </p> </section> <section id="MR000033-sec-0051"> <h4 class="title">Types of data</h4> <p>Drug and device papers including human research studies comparing drug to placebo, device to sham, drug to drug, drug to device, device to device, or mixed comparisons where the effectiveness, efficacy or harms of the drug or device were evaluated. A few papers included data from both unpublished and published studies. If data were reported separately for the published studies or were available from the authors we used data from published studies only. The reason for this decision was that published studies represent what is available to users of the medical literature and our focus was on assessing biases in published studies. </p> </section> <section id="MR000033-sec-0052"> <h4 class="title">Types of methods</h4> <p>We defined sponsorship as funding or provision of free drug or devices. Drug or device studies with pharmaceutical or device industry funding versus those with other or undisclosed funding were included. We extracted the definition of industry funding verbatim from the included papers (see <a href="#MR000033-sec-0062">Data extraction and management</a>) and reported this in the '<a href="./references#MR000033-sec-0106" title="">Characteristics of included studies</a>' table. For analysis, we grouped the definitions into a variety of categories, including 100% pharmaceutical or device company funding, 100% non‐industry funding, mixed funding (e.g. non‐industry and industry collaboration), free provision of drug or device only, and undisclosed funding. </p> <p>We included papers that compared industry sponsored studies with non‐industry sponsored studies and also papers that compared studies of products by competing manufacturers (i.e. studies sponsored by the manufacturer of the test treatment with studies sponsored by the manufacturer of the control treatment); we analyzed the two types of papers separately. </p> </section> <section id="MR000033-sec-0053"> <h4 class="title">Types of outcome measures</h4> <section id="MR000033-sec-0054"> <h5 class="title">Primary outcomes</h5> <p>We included two primary outcomes.</p> <p> <ul id="MR000033-list-0002"> <li> <p>Whether the results were favorable to the sponsor.</p> </li> <li> <p>Whether the conclusions were favorable to the sponsor. </p> </li> </ul> </p> <p>We used the definition of favorable results as described in the methods of the included papers. For efficacy results, most papers considered favorable results to be those that were statistically significant (e.g. P &lt; 0.05 or a 95% confidence interval excluding the possibility of no difference) in favor of the sponsor's product. Based on the previous review (<a href="./references#MR000033-bbs2-0277" title="LundhA , SismondoS , LexchinJ , BusuiocOA , BeroL . Industry sponsorship and research outcome. Cochrane Database of Systematic Reviews2012, Issue 12. [DOI: 10.1002/14651858.MR000033.pub2] ">Lundh 2012</a>), which found very few studies that reported results unfavorable to the sponsor, unfavorable results were combined with studies that reported results that were neutral or not statistically significant. For harms results, most papers regarded favorable results to be those where harms results were not statistically significant (e.g. P &gt; 0.05 or a 95% confidence interval including the possibility of no difference) or results that had a statistically significant higher number of harms in the comparator group. </p> <p>Conclusions in which the sponsor’s product was preferred over the control treatment were considered favorable to the sponsor. For conclusions we did not distinguish between efficacy and harms, as conclusions are often overall qualitative judgements based on a benefit to harm balance. </p> </section> <section id="MR000033-sec-0055"> <h5 class="title">Secondary outcomes</h5> <p>We included three secondary outcomes.</p> <p> <ul id="MR000033-list-0003"> <li> <p>The size of the effect estimate in industry sponsored studies versus those with other sources of sponsorship. </p> </li> <li> <p>The risk of bias in industry sponsored studies versus those with other sources of sponsorship. </p> </li> <li> <p>The concordance between study results and conclusions, i.e. whether the conclusions agreed with the study results, in industry sponsored studies versus those with other sources of sponsorship.  </p> </li> </ul> </p> <p>We included papers that reported at least one of these secondary outcomes, even if it reported neither of the primary outcomes. </p> </section> </section> </section> <section id="MR000033-sec-0056"> <h3 class="title">Search methods for identification of studies</h3> <section id="MR000033-sec-0057"> <h4 class="title">Electronic searches</h4> <p>In this update, we searched Ovid MEDLINE (R) In‐Process and other non‐indexed citations and Ovid MEDLINE (R) (2010 to February 2015), Ovid Embase (2010 to February 2015) and the Cochrane Methodology Register (2015, Issue 2) (Wiley InterScience Online). We searched the Web of Science (June 2015) for papers that cited any of the papers included in our review. </p> <section id="MR000033-sec-0058"> <h5 class="title">Search strategy</h5> <p>We used the strategy shown in <a href="./appendices#MR000033-sec-0097">Appendix 1</a> for Ovid MEDLINE and adapted it for the other databases. </p> </section> </section> <section id="MR000033-sec-0059"> <h4 class="title">Searching other resources</h4> <p>Other sources of data included author files, searches of reference lists of included papers and previous systematic reviews. </p> </section> </section> <section id="MR000033-sec-0060"> <h3 class="title" id="MR000033-sec-0060">Data collection and analysis</h3> <section id="MR000033-sec-0061"> <h4 class="title">Selection of studies</h4> <p>Two pairs of assessors  (LB and JS or BM and JL) screened the titles and abstracts, when available, of all retrieved records for obvious exclusions, and assessed the remaining papers based on full text. Any disagreements were resolved by consensus and reasons for exclusions of potentially eligible papers are described in the '<a href="./references#MR000033-sec-0107" title="">Characteristics of excluded studies</a>' table. There was no need for translation of non‐English papers. </p> </section> <section id="MR000033-sec-0062"> <h4 class="title">Data extraction and management</h4> <p>Two pairs of assessors (AL and JS or BM and JL) independently extracted data from included papers; differences in data extraction were resolved by consensus.  </p> <p>We extracted data on the following.</p> <p> <ul id="MR000033-list-0004"> <li> <p>Year published.</p> </li> <li> <p>Country of corresponding author.</p> </li> <li> <p>Study objective.</p> </li> <li> <p>Study design used in the paper (cohort, cross‐sectional, systematic review or meta‐analysis, other). </p> </li> <li> <p>Study domain ‐ descriptive (e.g. oncology drug trials).</p> </li> <li> <p>Study domain ‐ category (drug/device class, specific disease, medical specialty/type of diseases, mixed). </p> </li> <li> <p>Type of studies (drug, device, drug and device, mixed).</p> </li> <li> <p>Type of comparisons (drug versus drug, drug versus placebo, device versus device, device versus sham, device versus drug, mixed, other). </p> </li> <li> <p>Sample strategy used to locate research studies (electronic search only, electronic plus other, sampling of journals, sampling by venue (e.g. conference abstracts)). </p> </li> <li> <p>Whether there were language restrictions on the search.</p> </li> <li> <p>Number of studies included in the sample.</p> </li> <li> <p>Time period covered by studies in the paper.</p> </li> <li> <p>Sponsorship categories coded in the paper. Categories were:</p> </li> </ul> <ul id="MR000033-list-0005"> <li> <ul id="MR000033-list-0006"> <li> <p>100% pharmaceutical/device company funded;</p> </li> <li> <p>100% non‐profit funded;</p> </li> <li> <p>mixed funding ‐ e.g. non‐industry and industry collaboration;</p> </li> <li> <p>provision of drug or device only; and</p> </li> <li> <p>undisclosed funding.</p> </li> </ul> </li> <li> <p>Sponsorship categories used in analysis in the paper (e.g. 100% industry funded grouped with mixed funding for industry category). </p> </li> <li> <p>Description of role of the sponsor (if any). For example, definition of the sponsor’s role in the design, implementation or reporting in the sample of studies. </p> </li> <li> <p>Criteria used to assess risk of bias of the studies included in the paper.</p> </li> <li> <p>Primary purpose of the study.</p> </li> <li> <p>Whether the paper commented on appropriateness of comparators.</p> </li> <li> <p>Data on sponsorship and results.</p> </li> <li> <p>Data on sponsorship and conclusions.</p> </li> <li> <p>Data on sponsorship and effect size.</p> </li> <li> <p>Data on sponsorship and risk of bias.</p> </li> <li> <p>Data on sponsorship and concordance between study results and conclusions.</p> </li> <li> <p>Additional relevant data.</p> </li> <li> <p>Funding source of included paper. As this item was not included in the previous version of the review we also extracted data from papers included in the previous version. </p> </li> </ul> </p> </section> <section id="MR000033-sec-0063"> <h4 class="title">Assessment of risk of bias in included studies</h4> <p>Since there are no validated criteria for assessing risk of bias in these types of papers, we developed our own criteria. We reviewed papers for high, low or unclear risk of bias for each of four criteria. If a criterion was met, it was regarded as having low risk of bias, and high risk of bias otherwise. If we could not determine whether a criterion was met, we coded it as unclear. We used the following criteria: </p> <p> <ul id="MR000033-list-0007"> <li> <p>whether explicit and well‐defined criteria that could be replicated by others were used to select studies for inclusion/exclusion; </p> </li> <li> <p>whether there was an adequate study inclusion method, with two or more assessors selecting studies; </p> </li> <li> <p>whether the search for studies was comprehensive; and</p> </li> <li> <p>whether methodological differences and other characteristics that could introduce bias were controlled for or explored. </p> </li> </ul> </p> </section> <section id="MR000033-sec-0064"> <h4 class="title">Measures of the effect of the methods</h4> <p>We performed a meta‐analysis of the papers that reported the association of sponsorship with favorable study outcomes in cases where a pooled risk ratio (RR) and its 95% confidence interval could be computed. </p> <p>The definition of a favorable outcome varied among papers. In some papers favorable outcomes were defined as those that were favorable to the sponsor's product and in others favorable to the test treatment. This difference in terminology did not matter when the comparison was between active treatment and placebo, since the sponsor's product was the active treatment and not placebo. For head‐to‐head comparisons, however, the sponsor could be either the manufacturer of the test treatment or the control treatment. In these cases, when data were available, we recoded outcomes as to whether they were favorable to the sponsor's product. </p> <p>We separately analyzed papers of industry sponsored head‐to‐head studies, comparing studies sponsored by the manufacturer of the test treatment with studies sponsored by the manufacturer of the comparator treatment. This was done by assigning the newest treatment (most recent FDA approval date) as the 'test' treatment and the older treatment as the 'comparator' treatment using similar methods as described by Bero and colleagues (<a href="./references#MR000033-bbs2-0008" title="BeroL , OostvogelF , BacchettiP , LeeK . Factors associated with findings of published trials of drug‐drug comparisons: why some statins appear more efficacious than others. PLoS Medicine2007;4(6):e184. ">Bero 2007</a>) and comparing the number of studies favorable to the test treatment in the two groups (i.e. sponsor produces test treatment or sponsor produces comparator treatment). </p> <p>At the time many of the papers were published, the approach was to assess the methodological quality of studies as opposed to an assessment of the risk of bias of studies. We therefore recoded the data on methodological quality into 'Risk of bias' categories. So, for example, a trial with adequate concealment of allocation was coded as low risk of bias and a trial with inadequate concealment of allocation as high risk of bias. Some papers assessed risk of bias by summarizing results for individual domains into an overall methodological quality score (i.e. a scale approach). There are substantial methodological problems related to quality scales (<a href="./references#MR000033-bbs2-0237" title="JuniP , WitschiA , BlochR , EggerM . The hazards of scoring the quality of clinical trials for meta‐analysis. JAMA1999;282(11):1054‐60. ">Jüni 1999</a>), and their use is not recommended. We therefore did not combine the results obtained with these scales, but report the results descriptively. The included papers assessed blinding using different approaches. Some papers rated blinding for the study overall, for example whether a study used matching placebo tablets (which could be considered blinded) and some papers assessed who was blinded, similar to the Cochrane 'Risk of bias' tool. The Cochrane 'Risk of bias' tool assesses blinding to protect against performance bias (e.g. clinicians or patients are blinded) and to protect against detection bias (e.g. outcome assessors are blinded). We therefore categorized each 'Risk of bias' assessment into the items blinding‐overall, blinding‐performance bias and blinding‐detection bias. </p> </section> <section id="MR000033-sec-0065"> <h4 class="title">Dealing with missing data</h4> <p>We contacted authors of the original papers in an attempt to obtain missing data. If papers included studies reporting conflicts of interest, but not the source of funding, we contacted the authors in order to obtain separate data for funding. In total, we contacted authors of eight papers included in this update and received additional data for five of these papers. </p> </section> <section id="MR000033-sec-0066"> <h4 class="title">Assessment of heterogeneity</h4> <p>We assessed heterogeneity using I<sup>2</sup>. We defined substantial statistical heterogeneity as an I<sup>2</sup> &gt; 50% (<a href="./references#MR000033-bbs2-0233" title="HigginsJPT , GreenS (editors) . Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane‐handbook.org. ">Higgins 2011a</a>). </p> </section> <section id="MR000033-sec-0067"> <h4 class="title">Data synthesis</h4> <p>We used Review Manager (<a href="./references#MR000033-bbs2-0257" title="The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan). Version 5.3.5. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2014. ">RevMan 2014</a>) to analyze data. For dichotomous data we used the Mantel‐Haenszel random‐effects model to create a pooled RR. In the previous version of this review (<a href="./references#MR000033-bbs2-0277" title="LundhA , SismondoS , LexchinJ , BusuiocOA , BeroL . Industry sponsorship and research outcome. Cochrane Database of Systematic Reviews2012, Issue 12. [DOI: 10.1002/14651858.MR000033.pub2] ">Lundh 2012</a>), we used a fixed‐effect model as default and a random‐effects model when substantial heterogeneity was observed. However, due to the large clinical heterogeneity between papers (e.g. study domains, study designs and definition of outcomes), we decided that a random‐effects model was more appropriate. </p> </section> <section id="MR000033-sec-0068"> <h4 class="title">Subgroup analysis and investigation of heterogeneity</h4> <p>We considered the following factors as potential explanations for heterogeneity and investigated them in separate subgroup analyses for our primary outcomes.     </p> <p> <ul id="MR000033-list-0008"> <li> <p>We hypothesized that the association of industry sponsorship and favorable outcomes may be larger in high risk of bias papers. We assessed overall risk of bias of the included papers using the criteria described in '<a href="#MR000033-sec-0063">Assessment of risk of bias in included studies</a>'. We regarded papers with adequate study inclusion, a comprehensive search and controlling for bias as having a low risk of bias; others as having a high risk. We compared low risk of bias papers with high risk of bias papers in a subgroup analysis. </p> </li> <li> <p>We compared papers of drug studies with device studies, as the mechanisms of influencing study outcomes may differ between the industries. For example, drug trials are more regulated than device trials, which could have an influence on biases in the design, conduct and reporting of the trials. We compared this in a subgroup analysis.    </p> </li> <li> <p>As the study domain might contribute to heterogeneity, we compared papers on specific treatments or diseases with papers of mixed domains in another subgroup analysis. </p> </li> </ul> </p> </section> <section id="MR000033-sec-0069"> <h4 class="title">Sensitivity analysis</h4> <p>We undertook the following sensitivity analyses to test the robustness of our findings for our primary outcomes. </p> <p> <ul id="MR000033-list-0009"> <li> <p>The primary analyses compared the number of favorable results and conclusions in papers with industry sponsorship to those with other sources of sponsorship; 'industry sponsorship' included 100% pharmaceutical/device company funding, mixed funding and provision of drug or device only. 'Non‐industry sponsorship' included 100% government funding, 100% non‐industry funding and undisclosed funding. In a sensitivity analysis, we excluded those studies with mixed funding sources and those with funding consisting solely of free product from the 'industry sponsorship' category, and excluded studies with undisclosed funding from the category of 'non‐industry sponsorship', to determine if these had an impact on the initial analysis. As noted under '<a href="#MR000033-sec-0062">Data extraction and management</a>', we were reliant on how the studies in our review defined 'funding'. </p> </li> <li> <p>A sensitivity analysis restricted to papers that adjusted for confounders (e.g. adjusted for sample size and concealment of allocation using logistic regression) using adjusted estimates. We used the generic inverse variance method to pool adjusted odds ratios in a random‐effects model. </p> </li> <li> <p>A sensitivity analysis where all analyses were based on a fixed‐effect model.</p> </li> <li> <p>One paper (<a href="./references#MR000033-bbs2-0028" title="FinucaneTE , BoultCE . Association of funding and findings of pharmaceutical research at a meeting of a medical professional society. American Journal of Medicine2004;117(11):842‐5. ">Finucane 2004</a>), included unpublished abstracts from conference proceedings. One paper (<a href="./references#MR000033-bbs2-0046" title="LynchJR , CunninghamMR , WarmeWJ , SchaadDC , WolfFM , LeopoldSS . Commercially funded and United States‐based research is more likely to be published; good‐quality studies with negative outcomes are not. Journal of Bone and Joint Surgery. American volume2007;89(5):1010‐8. ">Lynch 2007</a>), included manuscripts submitted to a medical journal of which the majority were never published. However, based on the reported data it was not possible to extract data from the published studies separately. As these two papers included unpublished data and we planned to analyze only published data, we conducted a sensitivity analysis that excluded these two papers. </p> </li> <li> <p>Many of the included papers investigated similar domains (e.g. antidepressants or oncology drugs) or included studies from similar journals in overlapping time‐periods. This is likely to lead to double counting if data from the same studies are included more than once and to an overestimate of the precision of effect estimates. Due to the way data were reported in the papers, it was not possible ensure that data was not double counted. Instead we performed a sensitivity analysis restricted to papers on specific treatments or diseases where none of the other included papers were related to the same domain. </p> </li> <li> <p>We included letters and conference abstracts reporting quantitative data in a sensitivity analysis. </p> </li> </ul> </p> <p><b>Quality of Evidence</b> </p> <p>We created a 'Summary of findings' table using the GRADE approach (<a href="./references#MR000033-bbs2-0233" title="HigginsJPT , GreenS (editors) . Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane‐handbook.org. ">Higgins 2011a</a>) and using the MAGICapp software (<a href="./references#MR000033-bbs2-0245" title="MAGIC authoring and publication platform (MAGICapp) for improving patient care through guidelines, evidence summaries and decision aids that we can all trust, use and share. Version Accessed May 24, 2016. ">MAGICapp</a>; <a href="./references#MR000033-bbs2-0272" title="VandvikPO , BrandtL , Alonso‐CoelloP , TreweekS , AklEA , KristiansenA , et al. Creating clinical practice guidelines we can trust, use, and share: a new era is imminent. Chest2013;144(2):381‐9. ">Vandvik 2013</a>). </p> </section> </section> </section> </section> <section class="results"> <div class="section-header section-collapse-header" id="MR000033-sec-0070" lang="en"> <h2 class="title section-collapse-title"> Results <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="results" lang="en"> <div class="section-header" id="MR000033-sec-0070"></div> <section id="MR000033-sec-0071"> <h3 class="title">Description of studies</h3> <p>See:<a href="./references#MR000033-sec-0106" title="">Characteristics of included studies</a>; <a href="./references#MR000033-sec-0107" title="">Characteristics of excluded studies</a>. </p> <section id="MR000033-sec-0072"> <h4 class="title">Results of the search</h4> <p>See: <a href="#MR000033-fig-0001">Figure 1</a>. </p> <div class="figure" id="MR000033-fig-0001"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 1</div> </div> <hr class="top"/><img alt="Study flow diagram." data-id="MR000033-fig-0001" src="/cdsr/doi/10.1002/14651858.MR000033.pub3/media/CDSR/MR000033/image_n/nMR000033-AFig-FIG01.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Study flow diagram.</p> </div> </div> </div> <p>After removal of duplicates, 3052 references were identified. From reading titles and abstracts, 2925 were eliminated as being not relevant to the review. Full‐text papers were obtained for 127 references. From these 127 papers, 104 papers were excluded (see <a href="./references#MR000033-sec-0107" title="">Characteristics of excluded studies</a>) and 23 included (see <a href="./references#MR000033-sec-0106" title="">Characteristics of included studies</a>). Four additional papers were included from searching additional sources and 48 were included from the previous version of the review (see <a href="./references#MR000033-sec-0106" title="">Characteristics of included studies</a>). In total, 75 papers were included. </p> </section> <section id="MR000033-sec-0073"> <h4 class="title">Included studies</h4> <p>See: <a href="./references#MR000033-sec-0106" title="">Characteristics of included studies</a>. </p> <p>The 75 papers were published between 1986 and 2015. Seventy‐two papers included mainly published studies, one included studies presented at a conference, one included studies submitted to a medical journal, and one included studies submitted to eight medical journals. Fifty‐seven papers included only drug studies, three only device studies, two drug and device studies and 13 included different types of interventions (e.g. drugs, devices, behavioral interventions). Thirty‐four papers included studies related to specific drug classes, 16 related to specific medical specialties or types of diseases (e.g. endocrinology), 10 related to a specific disease, three related to a specific type of device, 11 included all types of research studies, and one did not state the domain. Various aspects of medicine were covered, but 16 (21%) papers were restricted to psychiatric diseases or drugs and eight (11%) to cancer treatment. Fifty‐eight papers included only clinical trials, two only observational studies, and 15 both clinical trials and observational studies. Thirteen papers included only drug versus drug comparisons, eight only drug versus placebo, 49 mixed comparisons (e.g. drug versus drug, drug versus placebo) and five did not describe the kind of comparisons. The median number of included studies per paper was 105 (range: nine to 930). Of the 75 papers, 27 reported data on both favorable outcomes and risk of bias, 44 on favorable outcomes only, and four on risk of bias only. Twenty‐five papers were non‐industry funded, two were industry funded (<a href="./references#MR000033-bbs2-0030" title="FreemantleN , AndersonIM , YoungP . Predictive value of pharmacological activity for the relative efficacy of antidepressant drugs. Meta‐regression analysis. British Journal of Psychiatry2000;177:292‐302. ">Freemantle 2000</a>; <a href="./references#MR000033-bbs2-0072" title="vanLentM , OverbekeJ , OutHJ . Role of editorial and peer review processes in publication bias: analysis of drug trials submitted to eight medical journals. PLoS One2014;9(8):e104846. ">van Lent 2014</a>), one was funded by both industry and non‐industry sources (<a href="./references#MR000033-bbs2-0046" title="LynchJR , CunninghamMR , WarmeWJ , SchaadDC , WolfFM , LeopoldSS . Commercially funded and United States‐based research is more likely to be published; good‐quality studies with negative outcomes are not. Journal of Bone and Joint Surgery. American volume2007;89(5):1010‐8. ">Lynch 2007</a>), 17 reported that they did not receive funding and 30 did not reported on funding. </p> </section> </section> <section id="MR000033-sec-0074"> <h3 class="title">Risk of bias in included studies</h3> <p>See: <a href="#MR000033-fig-0002">Figure 2</a>; <a href="#MR000033-fig-0003">Figure 3</a>. </p> <div class="figure" id="MR000033-fig-0002"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 2</div> </div> <hr class="top"/><img alt="'Risk of bias' graph: review authors' judgements about each risk of bias item presented as percentages across all included papers." data-id="MR000033-fig-0002" src="/cdsr/doi/10.1002/14651858.MR000033.pub3/media/CDSR/MR000033/image_n/nMR000033-AFig-FIG02.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>'Risk of bias' graph: review authors' judgements about each risk of bias item presented as percentages across all included papers. </p> </div> </div> </div> <div class="figure" id="MR000033-fig-0003"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 3</div> </div> <hr class="top"/><img alt="'Risk of bias' summary: review authors' judgements about each risk of bias item for each included paper." data-id="MR000033-fig-0003" src="/cdsr/doi/10.1002/14651858.MR000033.pub3/media/CDSR/MR000033/image_n/nMR000033-AFig-FIG03.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>'Risk of bias' summary: review authors' judgements about each risk of bias item for each included paper. </p> </div> </div> </div> <p>Sixty‐eight papers had low risk of bias for the selection criteria for inclusion of studies, three were unclear and four had high risk. Twenty‐one papers had low risk of bias for the study inclusion process, 40 were unclear and 14 had high risk. Sixty‐six papers had low risk of bias from the search, one was unclear and eight had high risk. Thirty‐one papers had low risk of bias due to lack of control for bias in the studies, five were unclear and 39 had high risk. Fourteen papers were regarded as having an overall low risk of bias and 61 as a high risk of bias according to our criteria. </p> </section> <section id="MR000033-sec-0075"> <h3 class="title" id="MR000033-sec-0075">Effect of methods</h3> <p>See: <a href="./full#MR000033-tbl-0001"><b>Summary of findings for the main comparison</b> Industry sponsored compared to non‐industry sponsored studies for research outcome</a> </p> <section id="MR000033-sec-0076"> <h4 class="title">Favorable results: industry sponsored versus non‐industry sponsored studies</h4> <p>See: <a href="./full#MR000033-tbl-0001">summary of findings Table for the main comparison</a> </p> <p>Twenty‐six papers, including 3081 studies (3062 drug studies and 19 device studies), reported on sponsorship and efficacy results; 25 could be combined in a pooled analysis. An analysis based on these 25 papers, including 2923 studies, found that industry sponsored studies more often had favorable efficacy results (e.g. those with significant P values) compared with non‐industry sponsored studies, risk ratio (RR): 1.27 (95% confidence interval (CI): 1.17 to 1.37), I<sup>2</sup>: 28% (<a href="./references#MR000033-fig-0004" title="">Analysis 1.1</a>). The paper that could not be included in the pooled analysis (<a href="./references#MR000033-bbs2-0009" title="BhandariM , BusseJW , JackowskiD , MontoriVM , SchünemannH , SpragueS , et al. Association between industry funding and statistically significant pro‐industry findings in medical and surgical randomized trials. CMAJ: Canadian Medical Association Journal2004;170(4):477‐80. ">Bhandari 2004</a>), which had included 158 drug studies in general medicine, found similar results, odds ratio (OR): 1.6 (95% CI: 1.1 to 2.8). </p> <p>Four papers, including 826 studies, did not find a difference in favorable harms results in industry sponsored studies compared with non‐industry sponsored studies, RR: 1.37 (95% CI: 0.64 to 2.93), I<sup>2</sup>: 96%. (<a href="./references#MR000033-fig-0005" title="">Analysis 1.2</a>). The results of one paper (<a href="./references#MR000033-bbs2-0003" title="Als‐NielsenB , ChenW , GluudC , KjaergardLL . Association of funding and conclusions in randomized drug trials: a reflection of treatment effect or adverse events?. JAMA2003;290(7):921‐8. ">Als‐Nielsen 2003</a>), were opposite in direction to the other papers and resulted in the substantial heterogeneity. . </p> </section> <section id="MR000033-sec-0077"> <h4 class="title">Favorable results: industry sponsorship by test treatment company versus industry sponsorship by comparator treatment company </h4> <p>Three papers, including 151 studies (all drug trials), compared efficacy results of trials sponsored by the manufacturer of the test treatment with trials sponsored by the manufacturer of the comparator treatment; two could be combined in a pooled analysis. An analysis based on these two papers (<a href="./references#MR000033-bbs2-0008" title="BeroL , OostvogelF , BacchettiP , LeeK . Factors associated with findings of published trials of drug‐drug comparisons: why some statins appear more efficacious than others. PLoS Medicine2007;4(6):e184. ">Bero 2007</a>; <a href="./references#MR000033-bbs2-0060" title="RattingerG , BeroL . Factors associated with results and conclusions of trials of thiazolidinediones. PLoS One2009;4(6):e5826. ">Rattinger 2009</a>), which included 131 industry sponsored trials of statins and thiazolidinediones, found that trials were much more likely to favor the test treatment when they were sponsored by the manufacturer of the test treatment than when they were sponsored by the manufacturer of the comparator treatment, RR: 3.88 (95% CI: 1.26 to 11.94), I<sup>2</sup>: 50% (<a href="./references#MR000033-fig-0006" title="">Analysis 2.1</a>). The paper that could not be included in the pooled analysis, which had included 20 selective serotonin reuptake inhibitor head‐to‐head trials, found that two trials favored the sponsor's drug, 18 had similar efficacy and none favored the comparator drug (<a href="./references#MR000033-bbs2-0032" title="GartlehnerG , MorganL , ThiedaP , FlegA . The effect of study sponsorship on a systematically evaluated body of evidence of head‐to‐head trials was modest: secondary analysis of a systematic review. Journal of Clinical Epidemiology2010;63(2):117‐25. ">Gartlehner 2010</a>). </p> </section> <section id="MR000033-sec-0078"> <h4 class="title">Favorable conclusions: industry sponsored versus non‐industry sponsored studies</h4> <p>See: <a href="./full#MR000033-tbl-0001">summary of findings Table for the main comparison</a> </p> <p>Thirty‐two papers, including 5258 studies (4761 drug studies and 497 device studies), reported on sponsorship and conclusions, 29 of which could be combined in a pooled analysis. An analysis based on these 29 papers, including 4583 studies (4179 drug studies and 404 device studies), found that industry sponsored studies more often had favorable conclusions than non‐industry sponsored studies, RR: 1.34 (95% CI: 1.19 to 1.51), I<sup>2</sup>: 92% (<a href="./references#MR000033-fig-0007" title="">Analysis 3.1</a>). Three papers could not be included in the pooled analysis due to the reporting of data. Of these, one paper reporting on 301 psychiatric drug studies (<a href="./references#MR000033-bbs2-0038" title="KellyREJr , CohenLJ , SempleRJ , BialerP , LauA , BodenheimerA , et al. Relationship between drug company funding and outcomes of clinical psychiatric research. Psychological Medicine2006;36(11):1647‐56. ">Kelly 2006</a>) found that industry sponsored studies more often had favorable conclusions than non‐industry sponsored studies (P &lt; 0.001) and similar findings were reported in a paper of 59 trials of antipsychotics (P = 0.02) (<a href="./references#MR000033-bbs2-0050" title="MontgomeryJH , ByerlyM , CarmodyT , LiB , MillerDR , VargheseF , et al. An analysis of the effect of funding source in randomized clinical trials of second generation antipsychotics for the treatment of schizophrenia. Controlled Clinical Trials2004;25(6):598‐612. ">Montgomery 2004</a>). A paper on 315 gastroenterology trials (222 drug trials and 93 device trials) did not find a difference in conclusions between industry sponsored trials and non‐industry sponsored trials (industry: 86% favorable, non‐industry: 83% favorable; P = 0.57) (<a href="./references#MR000033-bbs2-0013" title="BrownA , KraftD , SchmitzSM , SharplessV , MartinC , ShahR , et al. Association of industry sponsorship to published outcomes in gastrointestinal clinical research. Clinical Gastroenterology and Hepatology2006;4(12):1445‐51. ">Brown 2006</a>). </p> </section> <section id="MR000033-sec-0079"> <h4 class="title">Favorable conclusions: industry sponsorship by test treatment company versus sponsorship by comparator treatment company </h4> <p>Five papers, including 348 drug trials, compared conclusions of studies sponsored by the manufacturer of the test treatment with studies sponsored by the manufacturer of the comparator treatment, and three could be combined in a pooled analysis. These three papers (<a href="./references#MR000033-bbs2-0008" title="BeroL , OostvogelF , BacchettiP , LeeK . Factors associated with findings of published trials of drug‐drug comparisons: why some statins appear more efficacious than others. PLoS Medicine2007;4(6):e184. ">Bero 2007</a>; <a href="./references#MR000033-bbs2-0034" title="HeresS , DavisJ , MainoK , JetzingerE , KisslingW , LeuchtS . Why olanzapine beats risperidone, risperidone beats quetiapine, and quetiapine beats olanzapine: An exploratory analysis of head‐to‐head comparison studies of second‐generation antipsychotics. American Journal of Psychiatry2006;163(2):185‐94. ">Heres 2006</a>; <a href="./references#MR000033-bbs2-0060" title="RattingerG , BeroL . Factors associated with results and conclusions of trials of thiazolidinediones. PLoS One2009;4(6):e5826. ">Rattinger 2009</a>) including 154 industry sponsored trials of statins, antipsychotics and thiazolidinediones, found that trials were much more likely to favor the test treatment when they were sponsored by the manufacturer of the test treatment than when they were sponsored by the manufacturer of the control treatment, RR: 5.92 (95% CI: 2.80 to 12.54). No heterogeneity was observed (<a href="./references#MR000033-fig-0008" title="">Analysis 4.1</a>). A paper including 138 psychiatric drug studies (<a href="./references#MR000033-bbs2-0038" title="KellyREJr , CohenLJ , SempleRJ , BialerP , LauA , BodenheimerA , et al. Relationship between drug company funding and outcomes of clinical psychiatric research. Psychological Medicine2006;36(11):1647‐56. ">Kelly 2006</a>) had similar findings, RR 2.80 (95% CI: 2.02 to 3.88), and a paper on 56 non‐steroidal anti‐inflammatory drug (NSAID) trials (<a href="./references#MR000033-bbs2-0063" title="RochonPA , GurwitzJH , SimmsRW , FortinPR , FelsonDT , MinakerKL , et al. A study of manufacturer‐supported trials of nonsteroidal anti‐inflammatory drugs in the treatment of arthritis. Archives of Internal Medicine1994;154(2):157‐63. ">Rochon 1994</a>), found that 16 trials favored the sponsor's drug, 40 concluded that the drugs had similar effect and none favored the comparator drug. </p> </section> <section id="MR000033-sec-0080"> <h4 class="title">Effect size: industry sponsored versus non‐industry sponsored studies</h4> <p>Twenty‐four papers, including 1517 studies (1476 drug studies and 41 device studies), reported on sponsorship and effect size, but could not be pooled due to differences in reporting of data. The results were heterogeneous and are described in Table 1 below. </p> <p><b>Table 1. Effect size in industry and non‐industry sponsored studies.</b> </p> <p> <div class="table" id="MR000033-tblf-0001"> <table> <div class="table-heading"><span class="table-title"></span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Paper ID</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Study domain</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Effect size of industry versus non‐industry studies</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="3" rowspan="1" valign=""> <p><i>Efficacy</i> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#MR000033-bbs2-0003" title="Als‐NielsenB , ChenW , GluudC , KjaergardLL . Association of funding and conclusions in randomized drug trials: a reflection of treatment effect or adverse events?. JAMA2003;290(7):921‐8. ">Als‐Nielsen 2003</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>370 drug RCTs in Cochrane reviews</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Primary outcome. Mean z‐scores: industry: ‐1.48 (95% CI: ‐1.77 to ‐1.19); mixed: ‐1.77 (95% CI: ‐2.28 to ‐1.26); non‐industry: ‐1.20 (95% CI: ‐1.81 to ‐0.59); not stated: ‐1.20 (95% CI: ‐1,49 to ‐0.91) (P &gt; 0.05). </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#MR000033-bbs2-0004" title="AvniT , Shiber‐OferS , LeiboviciL , PaulM . Assessment of bias in outcomes reported in trials on pneumonia: a systematic review. European Journal of Clinical Microbiology &amp; Infectious Diseases2014;33(6):969‐74. ">Avni 2014</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>36 RCTs of antibiotics for pneumonia</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No difference in mortality and clinical failure.</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#MR000033-bbs2-0005" title="BardenJ , DerryS , McQuayHJ , MooreRA . Bias from industry trial funding? A framework, a suggested approach, and a negative result. Pain2006;121(3):207‐18. ">Barden 2006</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>176 acute pain and migraine drug RCTs</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No difference in pain relief.</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#MR000033-bbs2-0017" title="ClarkO , AdamsJR , BennettCL , DjulbegovicB . Erythropoietin, uncertainty principle and cancer related anaemia. BMC Cancer2002;2:23. ">Clark 2002</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>19 RCTs of erythropoietin for cancer‐related anemia</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Number of transfusions: industry: OR: 0.43 (95% CI: 0.35 to 0.54); non‐industry OR: 0.22 (95% CI: 0.11 to 0.45). </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#MR000033-bbs2-0020" title="CoronaG , IsidoriAM , BuvatJ , AversaA , RastrelliG , HackettG , et al. Testosterone supplementation and sexual function: a meta‐analysis study. Journal of Sexual Medicine2014;11(6):1577‐92. ">Corona 2014a</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>25 RCTs of testosterone for male sexual dysfunction</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Erectile dysfunction. Standardized mean difference (SMD): industry: SMD: 1.36 (95% CI: 0.55 to 1.16); non‐industry: SMD: 0.33 (95% CI: 0.13 to 0.54) (P = 0.02). </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#MR000033-bbs2-0023" title="DavisJM , ChenN , GlickID . Issues that may determine the outcome of antipsychotic trials: industry sponsorship and extrapyramidal side effect. Neuropsychopharmacology2008;33(5):971‐5. ">Davis 2008</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>124 RCTs of 2nd generation versus 1st generation antipsychotics</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Effect on psychotic symptoms (P = 0.57).</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#MR000033-bbs2-0026" title="DjulbegovicB , KumarA , MiladinovicB , ReljicT , GalebS , MhaskarA , et al. Treatment success in cancer: industry compared to publicly sponsored randomized controlled trials. PLoS One2013;8(3):e58711. ">Djulbegovic 2013</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>126 oncology drug RCTs</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Primary outcome: industry: OR/hazard ratio (HR): 0.61 (99% CI: 0.47 to 0.78); non‐industry OR/HR: 0.86 (99% CI: 0.74 to 1.00) (P = 0.003). Overall survival (P = 1.00). </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#MR000033-bbs2-0027" title="EtterJF , BurriM , StapletonJ . The impact of pharmaceutical company funding on results of randomized trials of nicotine replacement therapy for smoking cessation: a meta‐analysis. Addiction2007;102(5):815‐22. ">Etter 2007</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>34 RCTs of nicotine replacement therapy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Effect: industry: OR: 1.90 (95% CI: 1.67 to 2.16); non‐industry: OR: 1.61 (95% CI: 1.43 to 1.80) (P = 0.06). </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#MR000033-bbs2-0030" title="FreemantleN , AndersonIM , YoungP . Predictive value of pharmacological activity for the relative efficacy of antidepressant drugs. Meta‐regression analysis. British Journal of Psychiatry2000;177:292‐302. ">Freemantle 2000</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>105 RCTs of selective serotonin reuptake inhibitors versus alternative antidepressants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No difference in effect.</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#MR000033-bbs2-0036" title="JinapriyaD , AnrakuA , AlasbaliT , TropeGE , BuysYM . Evaluation of investigator bias in industry‐funded clinical trials of latanoprost. Canadian Journal of Ophthalmology2011;46(6):531‐6. ">Jinapriya 2011</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>31 of prostaglandin analogues for open‐angle glaucoma</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Effect on intraocular pressure (P = 0.83).</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#MR000033-bbs2-0041" title="KillinLO , RussTC , StarrJM , AbrahamsS , Della SalaS . The effect of funding sources on donepezil randomised controlled trial outcome: a meta‐analysis. BMJ Open2014;4(4):e004083. ">Killin 2014</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>14 RCTs of donepezil for Alzheimer's disease</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Effect on cognitive scales: industry: SMD: 0.46 (95% CI: 0.38 to 0.54); non‐industry: SMD: 0.33 (95% CI: 0.18 to 0.48) (P = 0.13). </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#MR000033-bbs2-0045" title="LubowitzJH , ApplebyD , CentenoJM , WoolfSK , ReidJB3rd . The relationship between the outcome of studies of autologous chondrocyte implantation and the presence of commercial funding. American Journal of Sports Medicine2007;35(11):1809‐16. ">Lubowitz 2007</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>23 studies of chondrocyte implantation</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No difference in effect on various outcomes.</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#MR000033-bbs2-0049" title="MoncrieffJ . Clozapine v. conventional antipsychotic drugs for treatment‐resistant schizophrenia: A re‐examination. British Journal of Psychiatry2003;183:161‐6. ">Moncrieff 2003</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>9 RCTs of clozapine versus conventional antipsychotics</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Psychotic symptoms: industry: SMD: ‐0.83 (95% CI: ‐1.06 to ‐0.61); non‐industry: SMD: ‐0.21 (95% CI: ‐0.34 to ‐0.07) (P &lt; 0.001). </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#MR000033-bbs2-0051" title="NaciH , DiasS , AdesAE . Industry sponsorship bias in research findings: a network meta‐analysis of LDL cholesterol reduction in randomised trials of statins. BMJ2014;349:g5741. ">Naci 2014</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>183 statin RCTs</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No difference in effect on mean change in LDL levels, after controlling for statin dose. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#MR000033-bbs2-0057" title="PopelutA , ValetF , FromentinO , ThomasA , BouchardP . Relationship between sponsorship and failure rate of dental implants: a systematic approach. PLoS One2010;5(4):e10274. ">Popelut 2010</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>41 clinical studies of dental implants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Failure rates. Industry versus non‐industry: OR: 0.21 (95% CI: 0.12 to 0.38).</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#MR000033-bbs2-0065" title="RösnerS , Hackl‐HerrwerthA , LeuchtS , LehertP , VecchiS , SoykaM . Acamprosate for alcohol dependence. Cochrane Database of Systematic Reviews2010, Issue 9. [DOI: 10.1002/14651858.CD004332.pub2] ">Rösner 2010</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>24 RCTs of acamprosate for alcohol dependence</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Return to any drinking: industry: RR: 0.88 (95% CI: 0.80 to 0.97); mixed: RR: 0.84 (95% CI: 0.78 to 0.89); non‐industry: RR: 0.86 (95%: CI 0.81 to 0.91). </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#MR000033-bbs2-0066" title="RösnerS , Hackl‐HerrwerthA , LeuchtS , VecchiS , SrisurapanontM , SoykaM . Opioid antagonists for alcohol dependence. Cochrane Database of Systematic Reviews2010, Issue 12. [DOI: 10.1002/14651858.CD001867.pub3] ">Rösner 2010a</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>26 RCTs of opioid antagonists for alcohol dependence</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Return to any drinking: industry: RR: 0.90 (95% CI: 0.78 to 1.05); non‐industry: RR: 0.84 (95% CI: 0.77 to 0.91). </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#MR000033-bbs2-0073" title="VladSC , LaValleyMP , McAlindonTE , FelsonDT . Glucosamine for pain in osteoarthritis: why do trial results differ?. Arthritis and Rheumatism2007;56(7):2267‐77. ">Vlad 2007</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>15 RCTs of glucosamine for osteoarthritis</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Primary outcome: industry: SMD: 0.47 (95% CI: 0.24 to 0.70); non‐industry: SMD: 0.05 (95% CI: ‐0.32 to 0.41) (P = 0.05). </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#MR000033-bbs2-0075" title="ZhangJP , GallegoJA , RobinsonDG , MalhotraAK , KaneJM , CorrellCU . Efficacy and safety of individual second‐generation vs. first‐generation antipsychotics in first‐episode psychosis: a systematic review and meta‐analysis. International Journal of Neuropsychopharmacology2013;16(6):1205‐18. ">Zhang 2013</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12 RCTs of 2nd generation versus 1st generation antipsychotics</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Short‐term symptom reduction and response (P = 0.007 and P = 0.046).</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="3" rowspan="1" valign=""> <p><i>Harms</i> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#MR000033-bbs2-0019" title="CoronaG , MaseroliE , RastrelliG , IsidoriAM , SforzaA , MannucciE , et al. Cardiovascular risk associated with testosterone‐boosting medications: a systematic review and meta‐analysis. Expert Opinion on Drug Safety2014;13(10):1327‐51. ">Corona 2014</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>26 RCTs of testosterone therapy for men</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Cardiovascular events: industry: OR: 1.07 (95% CI: 0.54 to 2.24); non‐industry: OR: 0.94 (95% CI: 0.39 to 2.24). </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#MR000033-bbs2-0039" title="KemmerenJM , AlgraA , GrobbeeDE . Third generation oral contraceptives and risk of venous thrombosis: meta‐analysis. BMJ2001;323(7305):131‐4. ">Kemmeren 2001</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>9 observational studies of 3rd generation versus 2nd generation oral contraceptives</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Thrombosis: industry: OR: 1.3 (95% CI: 1.0 to 1.7); non‐industry: OR 2.3 (95% CI: 1.7 to 3.2). </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#MR000033-bbs2-0047" title="MaD , ZhangZ , ZhangX , LiL . Comparative efficacy, acceptability, and safety of medicinal, cognitive‐behavioral therapy, and placebo treatments for acute major depressive disorder in children and adolescents: a multiple‐treatments meta‐analysis. Current Medical Research and Opinion2014;30(6):971‐95. ">Ma 2014</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>4 RCTs of fluoxetine for major depressive disorder</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Harms: industry: OR: 2.34 (95% CI: 1.62 to 3.36); non‐industry: OR: 2.78 (95% CI:1.76 to 4.38). </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#MR000033-bbs2-0074" title="XuL , FreemanG , CowlingBJ , SchoolingCM . Testosterone therapy and cardiovascular events among men: a systematic review and meta‐analysis of placebo‐controlled randomized trials. BMC Medicine2013;11:108. ">Xu 2013</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>27 RCTs of testosterone therapy for men</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Cardiovascular events: industry: OR 0.89 (95%: CI 0.50 to 1.60); non‐industry: OR 2.06 (95% CI: 1.34 to 3.17) (P = 0.03). </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="3" rowspan="1" valign=""> <p><i>Efficacy and dosage</i> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#MR000033-bbs2-0067" title="SinyorM , SchafferA , SmartKA , LevittAJ , LanctotKL , GrysmanNH . Sponsorship, antidepressant dose, and outcome in major depressive disorder: meta‐analysis of randomized controlled trials. Journal of Clinical Psychiatry2012;73(2):e277‐87. ">Sinyor 2012</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>58 industry head‐to‐head RCTs of antidepressants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Remission: sponsor's drug at higher dose OR: 1.28 (95% CI: 1.11 to 1.47) versus sponsor's drug at comparable or lower dose OR: 1.06 (95% CI: 0.96 to 1.17) (P = 0.04). </p> </td> </tr> </tbody> </table> </div> </p> <p>Most papers (19 out of 24) compared effect sizes for efficacy results. Twelve of these papers, including 1131 drug studies, did not find a difference in effect sizes for efficacy estimates between industry sponsored studies and non‐industry sponsored studies. In contrast, seven papers, including 262 studies (221 drug studies and 41 device studies) found higher effect sizes of efficacy estimates in industry sponsored studies. Two papers, including 30 drug studies, did not find a difference in effect size of harms between industry sponsored studies and non‐industry sponsored studies. In contrast, two papers, including 36 drug studies, found lower effect size of harms in industry sponsored studies. Lastly, a paper on 58 industry‐sponsored head‐to‐head trials of antidepressants (<a href="./references#MR000033-bbs2-0067" title="SinyorM , SchafferA , SmartKA , LevittAJ , LanctotKL , GrysmanNH . Sponsorship, antidepressant dose, and outcome in major depressive disorder: meta‐analysis of randomized controlled trials. Journal of Clinical Psychiatry2012;73(2):e277‐87. ">Sinyor 2012</a>), found that the sponsor's antidepressants were often given at a higher dose than the comparator. Effects on remission were higher when the sponsor's drug was given at a higher dose, as compared to trials in which the sponsor's drug was given in comparable or lower dose OR: 1.28 (95% CI: 1.11 to 1.47) versus OR: 1.06 (95% CI: 0.96 to 1.17) (P = 0.04). </p> </section> <section id="MR000033-sec-0081"> <h4 class="title">Risk of bias: industry sponsored versus non‐industry sponsored studies</h4> <p>Twelve papers, including 1660 studies (1482 drug studies and 178 device studies), compared risk of bias in industry versus non‐industry studies using six different composite quality scales (Brown, Cho, Cochrane, Jadad, PEDro or Sackett) and the results were heterogeneous. Seven papers did not find a difference in risk of bias between industry sponsored and non‐industry sponsored studies (<a href="./references#MR000033-bbs2-0016" title="ChoMK , BeroLA . The quality of drug studies published in symposium proceedings. Annals of Internal Medicine1996;124(5):485‐9. ">Cho 1996</a>; <a href="./references#MR000033-bbs2-0017" title="ClarkO , AdamsJR , BennettCL , DjulbegovicB . Erythropoietin, uncertainty principle and cancer related anaemia. BMC Cancer2002;2:23. ">Clark 2002</a>; <a href="./references#MR000033-bbs2-0019" title="CoronaG , MaseroliE , RastrelliG , IsidoriAM , SforzaA , MannucciE , et al. Cardiovascular risk associated with testosterone‐boosting medications: a systematic review and meta‐analysis. Expert Opinion on Drug Safety2014;13(10):1327‐51. ">Corona 2014</a>; <a href="./references#MR000033-bbs2-0035" title="JeffersonT , DiPietrantonjC , DebaliniMG , RivettiA , DemicheliV . Relation of study quality, concordance, take home message, funding, and impact in studies of influenza vaccines: systematic review. BMJ2009;338:b354. ">Jefferson 2009</a>; <a href="./references#MR000033-bbs2-0046" title="LynchJR , CunninghamMR , WarmeWJ , SchaadDC , WolfFM , LeopoldSS . Commercially funded and United States‐based research is more likely to be published; good‐quality studies with negative outcomes are not. Journal of Bone and Joint Surgery. American volume2007;89(5):1010‐8. ">Lynch 2007</a>; <a href="./references#MR000033-bbs2-0069" title="SungKH , ChungCY , LeeKM , LeeYK , LeeSY , LeeJ , et al. Conflict of interest in the assessment of botulinum toxin A injections in patients with cerebral palsy: a systematic review. Journal of Pediatric Orthopedics2013;33(5):494‐500. ">Sung 2013</a>; <a href="./references#MR000033-bbs2-0073" title="VladSC , LaValleyMP , McAlindonTE , FelsonDT . Glucosamine for pain in osteoarthritis: why do trial results differ?. Arthritis and Rheumatism2007;56(7):2267‐77. ">Vlad 2007</a>), whereas five papers found lower risk of bias (i.e. higher methodological quality scores) in industry sponsored studies (<a href="./references#MR000033-bbs2-0013" title="BrownA , KraftD , SchmitzSM , SharplessV , MartinC , ShahR , et al. Association of industry sponsorship to published outcomes in gastrointestinal clinical research. Clinical Gastroenterology and Hepatology2006;4(12):1445‐51. ">Brown 2006</a>; <a href="./references#MR000033-bbs2-0025" title="DjulbegovicB , LacevicM , CantorA , FieldsKK , BennettCL , AdamsJR , et al. The uncertainty principle and industry‐sponsored research. Lancet2000;356(9230):635‐8. ">Djulbegovic 2000</a>; <a href="./references#MR000033-bbs2-0050" title="MontgomeryJH , ByerlyM , CarmodyT , LiB , MillerDR , VargheseF , et al. An analysis of the effect of funding source in randomized clinical trials of second generation antipsychotics for the treatment of schizophrenia. Controlled Clinical Trials2004;25(6):598‐612. ">Montgomery 2004</a>; <a href="./references#MR000033-bbs2-0053" title="PengelLH , BarcenaL , MorrisPJ . The quality of reporting of randomized controlled trials in solid organ transplantation. Transplant International2009;22(4):377‐84. ">Pengel 2009</a>; <a href="./references#MR000033-bbs2-0055" title="PerlisCS , HarwoodM , PerlisRH . Extent and impact of industry sponsorship conflicts of interest in dermatology research. Journal of the American Academy of Dermatology2005;52(6):967‐71. ">Perlis 2005a</a>).    </p> <p>Nine papers, including 913 drug trials, did not find a difference in risk of bias from sequence generation in industry sponsored trials compared with non‐industry sponsored trials, RR: 0.99 (95% CI: 0.78 to 1.27), I<sup>2</sup>: 73% (<a href="./references#MR000033-fig-0009" title="">Analysis 5.1</a>). Sixteen papers, including 1886 trials (1867 drug trials and 19 device trials), did not find a difference in risk of bias from concealment of allocation in industry sponsored trials compared with non‐industry sponsored trials, RR: 1.06 (95% CI: 0.85 to 1.31), I<sup>2</sup>: 71% (<a href="./references#MR000033-fig-0010" title="">Analysis 5.2</a>). Thirteen papers, including 1578 trials (1559 drug trials and 19 device trials), found that industry sponsored trials more often had low risk of bias from overall blinding compared with non‐industry sponsored trials, RR: 1.25 (95% CI: 1.05 to 1.50), I<sup>2</sup>: 72% (<a href="./references#MR000033-fig-0011" title="">Analysis 5.3</a>). Three papers, including 128 drug trials, did not find a difference in risk of performance bias (e.g. blinding of clinicians or patients) in industry sponsored trials compared with non‐industry sponsored trials, RR: 1.26 (95% CI: 0.60 to 2.62), I<sup>2</sup>: 66% (<a href="./references#MR000033-fig-0012" title="">Analysis 5.4</a>). Four papers, including 307 drug trials, found that industry sponsored trials more often had low risk of detection bias (e.g. blinding of outcome assessors) compared with non‐industry sponsored trials, RR: 1.47 (95% CI: 1.02 to 2.12). No heterogeneity was observed (<a href="./references#MR000033-fig-0013" title="">Analysis 5.5</a>). Six papers, including 416 drug trials, did not find a difference in risk of bias from loss to follow‐up in industry sponsored trials compared with non‐industry sponsored trials, RR: 1.05 (95% CI: 0.92 to 1.18), I<sup>2</sup>: 2% (<a href="./references#MR000033-fig-0014" title="">Analysis 5.6</a>). Two papers, including 193 drug trials, did not find a difference in risk of reporting bias in industry sponsored trials compared with non‐industry sponsored trials, RR: 1.49 (95% CI: 0.61 to 3.60), I<sup>2</sup>: 79% (<a href="./references#MR000033-fig-0015" title="">Analysis 5.7</a>). </p> </section> <section id="MR000033-sec-0082"> <h4 class="title">Concordance between study results and conclusions: industry sponsored versus non‐industry sponsored studies </h4> <p>Six papers, including 751 drug studies, reported on concordance between study efficacy results (e.g. as judged by their P values) and conclusions. Industry sponsored studies were less concordant than non‐industry sponsored studies, RR: 0.83 (95% CI: 0.70 to 0.98), I<sup>2</sup>: 63% (<a href="./references#MR000033-fig-0016" title="">Analysis 6.1</a>). One paper (<a href="./references#MR000033-bbs2-0002" title="AlasbaliT , SmithM , GeffenN , TropeGE , FlanaganJG , JinY , et al. Discrepancy between results and abstract conclusions in industry‐ vs nonindustry‐funded studies comparing topical prostaglandins. American Journal of Ophthalmology2009;147(1):33‐8.e2. ">Alasbali 2009</a>), including 39 drug studies, found markedly higher lack of concordance in industry studies than the other four papers, and this was the reason for the high heterogeneity between papers. </p> <p>One paper, of 211 corticosteroid studies with statistically significant harms results, found that industry sponsored studies more often concluded that the drug was safe than non‐industry sponsored studies, RR: 3.68 (95% CI: 2.14 to 6.33) (<a href="./references#MR000033-bbs2-0052" title="NietoA , MazonA , PamiesR , LinanaJJ , LanuzaA , JiménezFO , et al. Adverse effects of inhaled corticosteroids in funded and nonfunded studies. Archives of Internal Medicine2007;167(19):2047‐53. ">Nieto 2007</a>). </p> <section id="MR000033-sec-0083"> <h5 class="title">Subgroup analysis and investigation of heterogeneity</h5> <p>For efficacy results, the association between industry sponsorship and favorable results was stronger in papers with a low risk of bias than in those with a high risk of bias, RR: 1.46 (95% CI: 1.25 to 1.71) versus RR: 1.20 (95% CI: 1.11 to 1.30) (test for subgroup differences P = 0.03) (<a href="./references#MR000033-fig-0017" title="">Analysis 7.1</a>). For harms results, the association between industry sponsorship and favorable harms results differed in papers with a low risk of bias compared with those with a high risk of bias, RR: 0.82 (95%: 0.72 to 0.93) versus RR: 1.87 (95% CI: 1.54 to 2.27) (test for subgroup differences P &lt; 0.0001) (<a href="./references#MR000033-fig-0018" title="">Analysis 7.2</a>). For conclusions, the differences between the groups went in the same direction as for efficacy results, RR: 1.42 (95% CI: 1.12 to 1.79) versus RR: 1.32 (95% CI: 1.15 to 1.50) (test for subgroup differences P = 0.60) (<a href="./references#MR000033-fig-0019" title="">Analysis 7.3</a>). </p> <p>For efficacy results, the association between industry sponsorship and favorable results were opposite in direction in drug studies compared with device studies, RR: 1.27 (95% CI: 1.17 to 1.38) versus RR: 0.50 (95% CI: 0.26 to 0.97) (test for subgroup differences P = 0.006) (<a href="./references#MR000033-fig-0020" title="">Analysis 7.4</a>). However, the analysis only included 19 device studies, of which only three were non‐industry. We did not find a difference in the association between sponsorship and conclusions in drug studies compared with device studies (test for subgroup differences P = 0.98) (<a href="./references#MR000033-fig-0021" title="">Analysis 7.5</a>) or between sponsorship and efficacy results or conclusion in studies limited to specific treatments or diseases compared with studies of mixed domains (test for subgroup differences P = 0.67 and P = 0.49 ) (<a href="./references#MR000033-fig-0022" title="">Analysis 7.6</a>; <a href="./references#MR000033-fig-0024" title="">Analysis 7.8</a>). However, for harms results the association between industry sponsorship and favorable harms results differed in papers with mixed study domain compared with those of specific treatments or diseases, RR: 0.82 (95%: 0.72 to 0.93) versus RR: 1.87 (95% CI: 1.54 to 2.27) (test for subgroup differences P &lt; 0.0001) (<a href="./references#MR000033-fig-0023" title="">Analysis 7.7</a>). </p> </section> <section id="MR000033-sec-0084"> <h5 class="title">Sensitivity analysis</h5> <p>Our re‐analyses of the outcomes using variations in definition of sponsorship categories gave similar results as our main analyses for efficacy results, harms results and conclusions (<a href="./references#MR000033-fig-0025" title="">Analysis 8.1</a>; <a href="./references#MR000033-fig-0026" title="">Analysis 8.2</a>; <a href="./references#MR000033-fig-0027" title="">Analysis 8.3</a>). Our analyses, taking into account papers that adjusted for confounding, based on pooling adjusted odds ratios, confirmed our findings that industry sponsored trials compared with non‐industry sponsored trials more often had favorable results, OR: 3.15 (95% CI: 2.07 to 4.80), I<sup>2</sup>: 0% and favorable conclusions, OR: 3.13 (95% CI: 1.66 to 5.93), I<sup>2</sup>: 38% (<a href="./references#MR000033-fig-0028" title="">Analysis 8.4</a>; <a href="./references#MR000033-fig-0029" title="">Analysis 8.5</a>). Similarly, sensitivity analyses using a fixed‐effect model rather than a random‐effects model did not affect our results (<a href="./references#MR000033-fig-0030" title="">Analysis 8.6</a>; <a href="./references#MR000033-fig-0032" title="">Analysis 8.8</a>; <a href="./references#MR000033-fig-0033" title="">Analysis 8.9</a>; <a href="./references#MR000033-fig-0034" title="">Analysis 8.10</a>), except for harms results where they changed from RR: 1.37 (95% CI: 0.64 to 2.93) to RR: 1.29 (95% CI: 1.15 to 1.46) (<a href="./references#MR000033-fig-0031" title="">Analysis 8.7</a>). When we excluded papers sampling unpublished studies, it did not affect our analysis on favorable conclusions (<a href="./references#MR000033-fig-0035" title="">Analysis 8.11</a>). The same was found when we limited our analyses to papers from specific domains (i.e. papers on specific treatments or diseases where none of the other included papers were related to the same domain) (<a href="./references#MR000033-fig-0036" title="">Analysis 8.12</a>; ; <a href="./references#MR000033-fig-0038" title="">Analysis 8.14</a>; <a href="./references#MR000033-fig-0039" title="">Analysis 8.15</a>; <a href="./references#MR000033-fig-0040" title="">Analysis 8.16</a>), except for harms results where they changed from RR: 1.37 (95% CI: 0.64 to 2.93) to RR: 1.87 (95% CI: 1.54 to 2.27) (<a href="./references#MR000033-fig-0037" title="">Analysis 8.13</a>). Lastly, if we included the two additional papers that were only published as letters (<a href="./references#MR000033-bbs2-0246" title="MandelkernM . Manufacturer support and outcome. Journal of Clinical Psychiatry1999; Vol. 60, issue 2:122‐3. ">Mandelkern 1999</a>; <a href="./references#MR000033-bbs2-0270" title="ThomasPS , TanKS , YatesDH . Sponsorship, authorship, and accountability. Lancet2002; Vol. 359, issue 9303:351. ">Thomas 2002</a>) our analysis on the association between sponsorship and favorable conclusions gave similar results RR: 1.35 (95% CI: 1.20 to 1.52), I<sup>2</sup>: 91%. </p> </section> </section> </section> </section> </section> <section class="discussion"> <div class="section-header section-collapse-header" id="MR000033-sec-0085" lang="en"> <h2 class="title section-collapse-title"> Discussion <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="discussion" lang="en"> <div class="section-header" id="MR000033-sec-0085"></div> <section id="MR000033-sec-0086"> <h3 class="title" id="MR000033-sec-0086">Summary of main results</h3> <p>We found that drug and device studies sponsored by the manufacturing company more often had favorable efficacy results (e.g. those with statistically significant results, usually defined using P values) and conclusions than those that were sponsored by other sources. The findings were consistent across a wide range of diseases and treatments. We did not find any differences in harms results and risk of bias of drug and device trials sponsored by industry compared with non‐industry sponsored trials, except in relation to blinding, where industry sponsored trials seemed to have lower risk of bias. Industry sponsored studies also had less concordance between results and conclusions than non‐industry sponsored studies. The evidence from device studies was limited due to fewer data, but the association between sponsorship and favorable conclusions was similar to drug studies. </p> <section id="MR000033-sec-0087"> <h4 class="title">Reasons for observed heterogeneity</h4> <p>For the association between sponsorship and favorable efficacy results of drug and device studies the data had acceptable heterogeneity, but heterogeneity for the association between sponsorship and harms results and study conclusions was substantial with an I<sup>2</sup> of 96% and 92%, respectively. </p> <p>The reason for the large heterogeneity related to harms results is attributed to the results of the Als‐Nielsen paper (<a href="./references#MR000033-bbs2-0003" title="Als‐NielsenB , ChenW , GluudC , KjaergardLL . Association of funding and conclusions in randomized drug trials: a reflection of treatment effect or adverse events?. JAMA2003;290(7):921‐8. ">Als‐Nielsen 2003</a>), that was opposite in direction to the other papers (i.e. industry had less favorable harms results as opposed to more favorable harms results) (<a href="./references#MR000033-bbs2-0033" title="HalpernSD , BartonTD , GrossR , HennessyS , BerlinJA , StromBL . Epidemiologic studies of adverse effects of anti‐retroviral drugs: how well is statistical power reported. Pharmacoepidemiology and Drug Safety2005;14(3):155‐61. ">Halpern 2005</a>; <a href="./references#MR000033-bbs2-0039" title="KemmerenJM , AlgraA , GrobbeeDE . Third generation oral contraceptives and risk of venous thrombosis: meta‐analysis. BMJ2001;323(7305):131‐4. ">Kemmeren 2001</a>; <a href="./references#MR000033-bbs2-0052" title="NietoA , MazonA , PamiesR , LinanaJJ , LanuzaA , JiménezFO , et al. Adverse effects of inhaled corticosteroids in funded and nonfunded studies. Archives of Internal Medicine2007;167(19):2047‐53. ">Nieto 2007</a>), and the interaction tests in the subgroup analyses were statistically significant. The Als‐Nielsen paper differs in some aspects from the three other included papers. First, it samples trials from various therapeutic areas, whereas the other papers each deal with harms results of single‐drug classes (HIV drugs, oral contraceptives and inhaled corticosteroids). Second, the three papers related to single‐drug classes had harms results as their primary outcome and only included studies with quantitative data, but Als‐Nielsen had harms as a secondary outcome and also included trials without quantitative harms data. The number of trials without harms data was high, particularly in the non‐industry group, 28% and 52%, respectively. Third, Als‐Nielsen only included trials, whereas <a href="./references#MR000033-bbs2-0033" title="HalpernSD , BartonTD , GrossR , HennessyS , BerlinJA , StromBL . Epidemiologic studies of adverse effects of anti‐retroviral drugs: how well is statistical power reported. Pharmacoepidemiology and Drug Safety2005;14(3):155‐61. ">Halpern 2005</a> included both trials and observational studies and <a href="./references#MR000033-bbs2-0039" title="KemmerenJM , AlgraA , GrobbeeDE . Third generation oral contraceptives and risk of venous thrombosis: meta‐analysis. BMJ2001;323(7305):131‐4. ">Kemmeren 2001</a> and <a href="./references#MR000033-bbs2-0052" title="NietoA , MazonA , PamiesR , LinanaJJ , LanuzaA , JiménezFO , et al. Adverse effects of inhaled corticosteroids in funded and nonfunded studies. Archives of Internal Medicine2007;167(19):2047‐53. ">Nieto 2007</a> only included observational studies. Finally, we assessed <a href="./references#MR000033-bbs2-0003" title="Als‐NielsenB , ChenW , GluudC , KjaergardLL . Association of funding and conclusions in randomized drug trials: a reflection of treatment effect or adverse events?. JAMA2003;290(7):921‐8. ">Als‐Nielsen 2003</a> as having an overall low risk of bias, compared to high risk of bias in the other three papers. </p> <p>In relation to the substantial heterogeneity for study conclusions, one reason was likely that the coding of favorable results was similar across the different papers, using statistical significance as the cut‐off, but coding varied for favorable conclusions. Some papers did not describe what they considered a favorable conclusion and this would involve some judgement. Others used scales, but for similar scales the cut‐off varied between papers. For example, on the same six‐point scale one paper used four as the cut‐off (<a href="./references#MR000033-bbs2-0025" title="DjulbegovicB , LacevicM , CantorA , FieldsKK , BennettCL , AdamsJR , et al. The uncertainty principle and industry‐sponsored research. Lancet2000;356(9230):635‐8. ">Djulbegovic 2000</a>) and another used six as the cut‐off (<a href="./references#MR000033-bbs2-0003" title="Als‐NielsenB , ChenW , GluudC , KjaergardLL . Association of funding and conclusions in randomized drug trials: a reflection of treatment effect or adverse events?. JAMA2003;290(7):921‐8. ">Als‐Nielsen 2003</a>). </p> <p>Also, the proportion of studies with favorable conclusions in the non‐industry sponsored group might have contributed to the size of the association and thereby the heterogeneity. For example, while the Chard and Liss papers (<a href="./references#MR000033-bbs2-0015" title="ChardJA , TallonD , DieppePA . Epidemiology of research into interventions for the treatment of osteoarthritis of the knee joint. Annals of the Rheumatic Diseases2000;59(6):414‐8. ">Chard 2000</a>; <a href="./references#MR000033-bbs2-0044" title="LissH . Publication bias in the pulmonary/allergy literature: effect of pharmaceutical company sponsorship. Israel Medical Association Journal2006;8(7):451‐4. ">Liss 2006</a>) had a similar proportion of favorable industry sponsored studies (both 98%), they reported very different proportions of favorable non‐industry sponsored studies (32% and 97%) and this explains why the risk ratios reported in the two studies were not the same: RR: 3.03 in Liss and RR: 1.01 in Chard. Variations in the definition of favorable conclusions might explain why the risk ratios reported in the two papers were not similar. For example, in the Chard paper, a conclusion was coded as favorable if the study authors supported the use of the treatment, even in the absence of a statistically significant result. </p> <p>Our subgroup analyses stratifying papers in relation to risk of bias (low versus high), type of intervention (drug versus device) or study domain (mixed versus specific treatments or diseases) did not explain the observed heterogeneity, though this was a simplistic comparison and other factors might also contribute to heterogeneity. </p> <p>We found mixed results on the relationship between sponsorship and effect size, with most papers not finding a difference. All but one of these papers were restricted to specific treatments, which may explain the different findings. A recent study of systematic reviews of nine different drugs found that the influence of reporting biases on effect sizes varied considerably between drugs (<a href="./references#MR000033-bbs2-0232" title="HartB , LundhA , BeroL . Effect of reporting bias on meta‐analyses of drug trials: reanalysis of meta‐analyses. BMJ2012;344:d7202. ">Hart 2012</a>). Furthermore, one paper found that even when adjusting for effect size, industry sponsored studies more often had favorable conclusions, compared with non‐industry sponsored studies (<a href="./references#MR000033-bbs2-0003" title="Als‐NielsenB , ChenW , GluudC , KjaergardLL . Association of funding and conclusions in randomized drug trials: a reflection of treatment effect or adverse events?. JAMA2003;290(7):921‐8. ">Als‐Nielsen 2003</a>). Therefore, while the direction of the relationship between sponsorship and favorable outcomes was consistent, the size of the effect likely varies depending on the type of treatment or treated condition. </p> </section> <section id="MR000033-sec-0088"> <h4 class="title">Reasons for favorable outcomes in industry sponsored studies</h4> <p>The pharmaceutical and medical device industries have strong interests in scientific publications that present their products positively, as publications are the basis of regulatory, purchasing, and medical decisions. These interests can influence the design, conduct and publication of studies in ways that make the sponsor’s product appear better than the comparator product (<a href="./references#MR000033-bbs2-0211" title="BeroLA , RennieD . Influences on the quality of published drug studies. International Journal of Technology Assessment in Health Care1996;12(2):209‐37. ">Bero 1996</a>). </p> <p>Several possible factors can explain the relationship between industry sponsorship and favorable outcomes. It has been argued that since many industry sponsored studies are undertaken to fulfill regulatory requirements, industry sponsored studies could have a lower risk of bias than non‐industry sponsored studies (<a href="./references#MR000033-bbs2-0259" title="RosefskyJB . Results of clinical trials sponsored by for‐profit vs nonprofit entities. JAMA2003; Vol. 290, issue 23:3070‐1. ">Rosefsky 2003</a>). Even if this were true, it would not explain the association of industry sponsorship and favorable efficacy results and conclusions. In addition, we did not find evidence for differences in risk of bias except in relation to blinding, where industry sponsored trials tended to have a lower risk of bias, even when restricted to head‐to‐head trials (<a href="./references#MR000033-bbs2-0008" title="BeroL , OostvogelF , BacchettiP , LeeK . Factors associated with findings of published trials of drug‐drug comparisons: why some statins appear more efficacious than others. PLoS Medicine2007;4(6):e184. ">Bero 2007</a>). The papers comparing blinding between trials with different sponsorship often used a description of double blinding as an indicator for low risk of bias. Double blinding is an inconsistent term and does not ensure that, for example, outcome assessors are blinded (<a href="./references#MR000033-bbs2-0217" title="DevereauxPJ , MannsBJ , GhaliWA , QuanH , LacchettiC , MontoriVM , et al. Physician interpretations and textbook definitions of blinding terminology in randomized controlled trials. JAMA2001;285(15):2000‐3. ">Devereaux 2001</a>). The more frequent use of double blinding may therefore be a reporting issue, with industry trials being better reported. This is further substantiated by the fact that nearly all the papers finding a higher methodological quality score in industry studies used the Jadad scale, a scale which has been criticized for having more focus on the quality of reporting than on methodological quality (<a href="./references#MR000033-bbs2-0244" title="LundhA , GøtzschePC . Recommendations by Cochrane Review Groups for assessment of the risk of bias in studies. BMC Medical Research Methodology2008;8:22. ">Lundh 2008</a>).    </p> <p>A few papers assessing a more specific definition of blinding related to performance bias and detection bias also found that industry sponsored studies had lower risk of bias. Evidence also suggests that for non‐industry trials, companies may prevent proper blinding by restricting access to placebo drugs (<a href="./references#MR000033-bbs2-0214" title="ChristensenM , KnopFK . The unobtainable placebo: control of independent clinical research by industry?. Lancet2012; Vol. 379, issue 9810:30. ">Christensen 2012</a>), and therefore differences in adequate blinding may be real. In addition, double blinding can be used as a proxy for low risk of bias and trials without double blinding are on average more likely to have favorable results (<a href="./references#MR000033-bbs2-0253" title="PildalJ , HróbjartssonA , JørgensenKJ , HildenJ , AltmanDG , GøtzschePC . Impact of allocation concealment on conclusions drawn from meta‐analyses of randomized trials. International Journal of Epidemiology2007;36(4):847‐57. ">Pildal 2007</a>). The effect of this bias is in the opposite direction of our findings, as it would lead to industry sponsored studies having less favorable results and conclusions, and our findings can therefore, not be explained by differences in risk of bias related to blinding between industry and non‐industry sponsored studies. </p> <p>Another possible explanation for our findings could be that industry studies have larger sample sizes, and would have a higher chance of achieving statistically significant results. Although industry trials seem in general to be of larger size (<a href="./references#MR000033-bbs2-0003" title="Als‐NielsenB , ChenW , GluudC , KjaergardLL . Association of funding and conclusions in randomized drug trials: a reflection of treatment effect or adverse events?. JAMA2003;290(7):921‐8. ">Als‐Nielsen 2003</a>; <a href="./references#MR000033-bbs2-0011" title="BoothCM , CesconDW , WangL , TannockIF , KrzyzanowskaMK . Evolution of the randomized controlled trial in oncology over three decades. Journal of Clinical Oncology2008;26(33):5458‐64. ">Booth 2008</a>; <a href="./references#MR000033-bbs2-0012" title="BourgeoisFT , MurthyS , MandlKD . Outcome reporting among drug trials registered in ClinicalTrials.gov. Annals of Internal Medicine2010;153(3):158‐66. ">Bourgeois 2010</a>; <a href="./references#MR000033-bbs2-0026" title="DjulbegovicB , KumarA , MiladinovicB , ReljicT , GalebS , MhaskarA , et al. Treatment success in cancer: industry compared to publicly sponsored randomized controlled trials. PLoS One2013;8(3):e58711. ">Djulbegovic 2013</a>; <a href="./references#MR000033-bbs2-0027" title="EtterJF , BurriM , StapletonJ . The impact of pharmaceutical company funding on results of randomized trials of nicotine replacement therapy for smoking cessation: a meta‐analysis. Addiction2007;102(5):815‐22. ">Etter 2007</a>; <a href="./references#MR000033-bbs2-0029" title="FlaccoME , ManzoliL , BocciaS , CapassoL , AleksovskaK , RossoA , et al. Head‐to‐head randomized trials are mostly industry sponsored and almost always favor the industry sponsor. Journal of Clinical Epidemiology2015;68(7):811‐20. ">Flacco 2015</a>; <a href="./references#MR000033-bbs2-0055" title="PerlisCS , HarwoodM , PerlisRH . Extent and impact of industry sponsorship conflicts of interest in dermatology research. Journal of the American Academy of Dermatology2005;52(6):967‐71. ">Perlis 2005a</a>), when we restricted our analysis to studies controlling for sample size and other confounders, the relationship between industry sponsorship and favorable results or conclusions was still present. </p> <p>Industry representatives argues that the trials they sponsor are more likely to have favorable outcomes because they fund research that has a high chance of achieving success (<a href="./references#MR000033-bbs2-0251" title="PalmerRH . Results of clinical trials sponsored by for‐profit vs nonprofit entities. JAMA2003; Vol. 290, issue 23:3070. ">Palmer 2003</a>). However, when independent investigators conduct non‐industry sponsored trials, they in most cases test treatments that have been approved based on favorable industry trial results. Non‐industry sponsored trials would therefore also be expected to achieve successful results, unless they are designed to answer different questions than industry sponsored trials. For example, non‐industry sponsored studies may test a new treatment against a well‐established treatment, while industry sponsored studies might test the new treatment against placebo or against an outdated, inferior treatment. </p> <p>Accordingly, it seems most plausible that industry achieves overly positive results through a variety of biasing choices in the design, conduct and reporting of their studies. For example, industry protocols might include inferior comparators that will increase the chance of their product’s success. Djulbegovic and colleagues (<a href="./references#MR000033-bbs2-0218" title="DjulbegovicB , CantorA , ClarkeM . The importance of preservation of the ethical principle of equipoise in the design of clinical trials: relative impact of the methodological quality domains on the treatment effect in randomized controlled trials. Accountability in Research2003;10(4):301‐15. ">Djulbegovic 2003</a>) have argued that industry sponsored studies violate equipoise by choosing inferior competing treatment alternatives. Previous studies have found that industry sponsored trials more often use placebo control (<a href="http://archie.cochrane.org/sections/documents/view?version=71717599855005491979120831102044%26format=REVMAN#STD-Als_x002d_Nielsen-2003" target="_blank">Als‐Nielsen 2003</a>; <a href="http://archie.cochrane.org/sections/documents/view?version=71717599855005491979120831102044%26format=REVMAN#STD-Djulbegovic-2000" target="_blank">Djulbegovic 2000</a>; <a href="./references#MR000033-bbs2-0221" title="DunnAG , MandlKD , CoieraE , BourgeoisFT . The effects of industry sponsorship on comparator selection in trial registrations for neuropsychiatric conditions in children. PLoS One2013;8(12):e84951. ">Dunn 2013</a>; <a href="./references#MR000033-bbs2-0224" title="EstellatC , RavaudP . Lack of head‐to‐head trials and fair control arms: randomized controlled trials of biologic treatment for rheumatoid arthritis. Archives of Internal Medicine2012;172(3):237‐44. ">Estellat 2012</a>; <a href="./references#MR000033-bbs2-0238" title="KatzKA , KarlawishJH , ChiangDS , BognetRA , PropertKJ , MargolisDJ . Prevalence and factors associated with use of placebo control groups in randomized controlled trials in psoriasis: a cross‐sectional study. Journal of the American Academy of Dermatology2006;55(5):814‐22. ">Katz 2006</a>; <a href="./references#MR000033-bbs2-0241" title="LathyrisDN , PatsopoulosNA , SalantiG , IoannidisJP . Industry sponsorship and selection of comparators in randomized clinical trials. European Journal of Clinical Investigation2010;40(2):172‐82. ">Lathyris 2010</a>), active comparators in inferior doses (<a href="http://archie.cochrane.org/sections/documents/view?version=71717599855005491979120831102044%26format=REVMAN#STD-Rochon-1994" target="_blank">Rochon 1994</a>; <a href="http://archie.cochrane.org/sections/documents/view?version=71717599855005491979120831102044%26format=REVMAN#REF-Safer-2002" target="_blank">Safer 2002</a>; <a href="./references#MR000033-bbs2-0067" title="SinyorM , SchafferA , SmartKA , LevittAJ , LanctotKL , GrysmanNH . Sponsorship, antidepressant dose, and outcome in major depressive disorder: meta‐analysis of randomized controlled trials. Journal of Clinical Psychiatry2012;73(2):e277‐87. ">Sinyor 2012</a>), or inappropriate administration of the drugs (<a href="./references#MR000033-bbs2-0235" title="JohansenHK , GøtzschePC . Problems in the design and reporting of trials of antifungal agents encountered during meta‐analysis. JAMA1999;282(18):1752‐9. ">Johansen 1999</a>). Industry may also selectively choose less clinical relevant outcomes as their primary outcome in order to get a higher chance of achieving an effect. For example, in the paper by Djulbegovic (<a href="./references#MR000033-bbs2-0026" title="DjulbegovicB , KumarA , MiladinovicB , ReljicT , GalebS , MhaskarA , et al. Treatment success in cancer: industry compared to publicly sponsored randomized controlled trials. PLoS One2013;8(3):e58711. ">Djulbegovic 2013</a>) industry sponsored trials had higher effect size than non‐industry sponsored trials on primary outcomes, but not overall survival. This could also be one of the possible explanations as to why industry sponsored trials more often have favorable results and conclusions while the effect sizes are often similar when comparing similar outcomes. </p> <p>Industry sponsored studies may also be biased in the coding of events and their data analysis (<a href="./references#MR000033-bbs2-0226" title="FurukawaTA . All clinical trials must be reported in detail and made publicly available. BMJ2004; Vol. 329, issue 7466:626. ">Furukawa 2004</a>; <a href="./references#MR000033-bbs2-0255" title="PsatyBM , KronmalRA . Reporting mortality findings in trials of rofecoxib for Alzheimer disease or cognitive impairment: a case study based on documents from rofecoxib litigation. JAMA2008;299(15):1813‐7. ">Psaty 2008</a>; <a href="./references#MR000033-bbs2-0256" title="PsatyBM , PrenticeRL . Minimizing bias in randomized trials: the importance of blinding. JAMA2010;304(7):793‐4. ">Psaty 2010</a>). Industry and its sponsored investigators also may selectively report favorable outcomes, fail to publish whole studies with unfavorable results, or publish studies with favorable results multiple times (<a href="./references#MR000033-bbs2-0213" title="ChanAW , HróbjartssonA , HaahrMT , GøtzschePC , AltmanDG . Empirical evidence for selective reporting of outcomes in randomized trials: comparison of protocols to published articles. JAMA2004;291(20):2457‐65. ">Chan 2004</a>; <a href="./references#MR000033-bbs2-0222" title="DwanK , AltmanDG , ArnaizJA , BloomJ , ChanAW , CroninE , et al. Systematic review of the empirical evidence of study publication bias and outcome reporting bias. PLoS One2008;3(8):e3081. ">Dwan 2008</a>; <a href="http://archie.cochrane.org/sections/documents/view?version=71717599855005491979120831102044%26format=REVMAN#REF-G_x00f8_tzsche-2011" target="_blank">Gøtzsche 2011</a>; <a href="./references#MR000033-bbs2-0247" title="McGauranN , WieselerB , KreisJ , SchulerYB , KolschH , KaiserT . Reporting bias in medical research ‐ a narrative review. Trials2010;11:37. ">McGauran 2010</a>; <a href="./references#MR000033-bbs2-0248" title="MelanderH , Ahlqvist‐RastadJ , MeijerG , BeermannB . Evidence b(i)ased medicine‐‐selective reporting from studies sponsored by pharmaceutical industry: review of studies in new drug applications. BMJ2003;326(7400):1171‐3. ">Melander 2003</a>; <a href="http://archie.cochrane.org/sections/documents/view?version=71717599855005491979120831102044%26format=REVMAN#REF-Rising-2008" target="_blank">Rising 2008</a>; <a href="http://archie.cochrane.org/sections/documents/view?version=71717599855005491979120831102044%26format=REVMAN#REF-Vedula-2009" target="_blank">Vedula 2009</a>). While such biases in analyses and reporting have been documented in a number of cases, the papers included in this review focused on comparisons of published studies. Only two papers (<a href="./references#MR000033-bbs2-0041" title="KillinLO , RussTC , StarrJM , AbrahamsS , Della SalaS . The effect of funding sources on donepezil randomised controlled trial outcome: a meta‐analysis. BMJ Open2014;4(4):e004083. ">Killin 2014</a>; <a href="./references#MR000033-bbs2-0051" title="NaciH , DiasS , AdesAE . Industry sponsorship bias in research findings: a network meta‐analysis of LDL cholesterol reduction in randomised trials of statins. BMJ2014;349:g5741. ">Naci 2014</a>) included in our review compared risk of selective reporting between industry sponsored trials and non‐industry sponsored trials and found no difference. However, confidence intervals were wide and the analysis was limited to two types of drugs (donepezil for Alzheimer's disease and statins). Therefore, we are unable to determine the extent to which selective analysis or reporting contribute to our findings. Similarly, we found no difference in harms results between industry sponsored and non‐industry sponsored studies. Under‐reporting of harms seems to be a major problem in both industry and non‐industry sponsored studies with 28% of trials included in <a href="./references#MR000033-bbs2-0003" title="Als‐NielsenB , ChenW , GluudC , KjaergardLL . Association of funding and conclusions in randomized drug trials: a reflection of treatment effect or adverse events?. JAMA2003;290(7):921‐8. ">Als‐Nielsen 2003</a> not reporting any harms data, which is in line with a recent systematic review that found that a median of 54% studies do not report harms data (<a href="./references#MR000033-bbs2-0229" title="GolderS , LokeYK , WrightK , NormanG . Reporting of adverse events in published and unpublished studies of health care interventions: a systematic review. PLoS Medicine2016;13(9):e1002127. ">Golder 2016</a>). </p> <p>Favorable conclusions in industry‐sponsored trials may also be reached by over‐interpreting results and use of spin in conclusions (<a href="./references#MR000033-bbs2-0212" title="BoutronI , DuttonS , RavaudP , AltmanDG . Reporting and interpretation of randomized controlled trials with statistically nonsignificant results for primary outcomes. JAMA2010;303(20):2058‐64. ">Boutron 2010</a>). We found that industry sponsored studies had less concordance between results and conclusions compared with non‐industry sponsored studies, suggesting that conclusions of industry sponsored studies are less reliable. </p> <p>It should also be noted that some studies in the non‐industry group likely had authors with conflicts of interest related to the pharmaceutical or device industry, which may have influenced their interpretation of study results (<a href="./references#MR000033-bbs2-0269" title="StelfoxHT , ChuaG , O'RourkeK , DetskyAS . Conflict of interest in the debate over calcium‐channel antagonists. New England Journal of Medicine1998;338(2):101‐6. ">Stelfox 1998</a>; <a href="./references#MR000033-bbs2-0202" title="WangAT , McCoyCP , MuradMH , MontoriVM . Association between industry affiliation and position on cardiovascular risk with rosiglitazone: cross sectional systematic review. BMJ2010;340:c1344. ">Wang 2010</a>), thereby diluting the measured effect of industry bias on study conclusions. Also, we coded studies as non‐industry sponsored if they did not state who sponsored the study. As some of these studies were likely industry sponsored, this misclassification will have led to similar bias towards the null. However, in our sensitivity analyses, we excluded studies without sponsorship statements and did not see a change in results. </p> <p>Further evidence for industry bias stems from our comparison of studies sponsored by the manufacturer of the test treatment with those sponsored by the manufacturer of the control treatment. These studies had the advantage of comparing like with like, as they are restricted to specific drug classes or types of devices and have similar methodologies. Though limited to only three papers on drug trials, the findings show associations that are stronger than the comparison between industry and non‐industry sponsored studies. These comparisons are restricted to drugs competing for the same market, which may put pressure on companies to influence outcomes to a greater degree than what is needed in placebo‐controlled trials to present the drug in a good light. </p> <p>In sum, the industry bias associated with favorable efficacy results and conclusions may be mediated by factors other than traditional measures of the risk of bias (e.g. lack of concealment of allocation, blinding and dropout) and sample size. This industry bias may be partially mediated by such factors as the choice of comparators, dosing and timing of comparisons, choice of outcomes, selective analysis, and selective reporting. </p> </section> </section> <section id="MR000033-sec-0089"> <h3 class="title" id="MR000033-sec-0089">Quality of the evidence</h3> <p>The majority of included papers were regarded as having a high risk of bias. Many lacked information on study conduct and did not control for confounders that could influence the relationship. Nevertheless, we did identify 14 papers with low risk of bias and analyses restricted to these papers actually strengthened the relationship between industry sponsorship and conclusions. In general, there is convincing and consistent evidence for the existence of an industry bias in studies; however, the body of evidence for device studies is not as strong as for drug studies. While many papers, including studies of devices and other interventions, have been published in the surgical field (<a href="./references#MR000033-bbs2-0080" title="AmiriAR , KanesalingamK , CroS , CaseyAT . Does source of funding and conflict of interest influence the outcome and quality of spinal research?. Spine Journal2014;14(2):308‐14. ">Amiri 2014</a>; <a href="./references#MR000033-bbs2-0105" title="CunninghamMR , WarmeWJ , SchaadDC , WolfFM , LeopoldSS . Industry‐funded positive studies not associated with better design or larger size. Clinical Orthopaedics and Related Research2007;457:235‐41. ">Cunningham 2007</a>; <a href="./references#MR000033-bbs2-0147" title="KhanSN , MermerMJ , MyersE , SandhuHS . The roles of funding source, clinical trial outcome, and quality of reporting in orthopedic surgery literature. American Journal of Orthopedics2008;37(12):E205‐12. ">Khan 2008</a>; <a href="./references#MR000033-bbs2-0156" title="LeopoldSS , WarmeWJ , Fritz BraunlichE , ShottS . Association between funding source and study outcome in orthopaedic research. Clinical Orthopaedics and Related Research2003;415:293‐301. ">Leopold 2003</a>; <a href="./references#MR000033-bbs2-0184" title="RoachJW , SkaggsDL , SponsellerPD , MacleodLM . Is research presented at the scoliosis research society annual meeting influenced by industry funding?. Spine2008;33(20):2208‐12. ">Roach 2008</a>; <a href="./references#MR000033-bbs2-0190" title="ShahRV , AlbertTJ , Bruegel‐SanchezV , VaccaroAR , HilibrandAS , GrauerJN . Industry support and correlation to study outcome for papers published in spine. Spine2005;30(9):1099‐104. ">Shah 2005</a>; <a href="./references#MR000033-bbs2-0196" title="SunGH , HoultonJJ , MacEachernMP , BradfordCR , HaywardRA . Influence of study sponsorship on head and neck cancer randomized trial results. Head &amp; Neck2013;35(10):1515‐20. ">Sun 2013</a>; <a href="./references#MR000033-bbs2-0204" title="YaoF , SingerM , RosenfeldRM . Randomized controlled trials in otolaryngology journals. Otolaryngology‐Head and Neck Surgery2007;137(4):539‐44. ">Yao 2007</a>), the papers do not report separate data for device studies. </p> </section> <section id="MR000033-sec-0090"> <h3 class="title" id="MR000033-sec-0090">Potential biases in the review process</h3> <p>We did a comprehensive search, our methods were based on pre‐specified criteria in a protocol as outlined in <i>Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0</i> (<a href="./references#MR000033-bbs2-0233" title="HigginsJPT , GreenS (editors) . Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane‐handbook.org. ">Higgins 2011a</a>), and this updated review has substantially increased the number of included papers from our previous review (<a href="./references#MR000033-bbs2-0277" title="LundhA , SismondoS , LexchinJ , BusuiocOA , BeroL . Industry sponsorship and research outcome. Cochrane Database of Systematic Reviews2012, Issue 12. [DOI: 10.1002/14651858.MR000033.pub2] ">Lundh 2012</a>). Nevertheless, there are some limitations. First, we decided only to include published papers. In our first version of the review (<a href="./references#MR000033-bbs2-0275" title="LexchinJ , BeroL , DjulbegovicB , ClarkO . Pharmaceutical industry sponsorship and research outcome and quality: a systematic review. BMJ2003;326(7400):1167‐70. ">Lexchin 2003</a>), we found problems with the completeness and quality of the data in conference abstracts and unstructured letters and therefore decided not to include them in this review. A comment to the previous version of this review (<a href="./references#MR000033-bbs2-0277" title="LundhA , SismondoS , LexchinJ , BusuiocOA , BeroL . Industry sponsorship and research outcome. Cochrane Database of Systematic Reviews2012, Issue 12. [DOI: 10.1002/14651858.MR000033.pub2] ">Lundh 2012</a>), suggested that the exclusion of conference abstracts and letters could have introduced publication bias. In this update, we decided to include these papers in a sensitivity analysis, which gave similar results. However, we could only include quantitative data from two papers and we might have missed relevant papers. We expect that due to the high number of included papers such unidentified papers would not have major impact on our results. Due to the heterogeneity of included papers we decided not to assess publication bias using a funnel plot as it would be difficult to interpret. </p> <p>Second, our assessment of risk of bias in the included papers was not based on validated criteria similar to 'Risk of bias' assessment for clinical trials (<a href="./references#MR000033-bbs2-0234" title="HigginsJPT , AltmanDG , SterneJAC . Chapter 8: Assessing risk of bias in included studies. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane‐handbook.org. ">Higgins 2011b</a>). As no validated assessment tools exist for these type of papers, we developed our own criteria and included items similar to assessment tools for systematic reviews (<a href="./references#MR000033-bbs2-0250" title="OxmanAD , GuyattGH , SingerJ , GoldsmithCH , HutchisonBG , MilnerRA , et al. Agreement among reviewers of review articles. Journal of Clinical Epidemiology1991;44(1):91‐8. ">Oxman 1991</a>; <a href="./references#MR000033-bbs2-0265" title="SheaBJ , GrimshawJM , WellsGA , BoersM , AnderssonN , HamelC , et al. Development of AMSTAR: a measurement tool to assess the methodological quality of systematic reviews. BMC Medical Research Methodology2007;7:10. ">Shea 2007</a>). </p> <p>Third, one item not included in our assessment of risk of bias in the papers was whether coders of outcomes were blinded to the sponsorship status of the studies. If these types of papers were undertaken by authors with a particular view on the drug industry, knowledge of sponsorship status could introduce bias in the assessment of whether outcomes were favorable, particularly for conclusions, as this is an outcome that is qualitative in nature. Some of the included papers were written by authors who had published multiple times in the area, and as such could be at increased risk of bias. These papers used coders who were both blinded and unblinded to the sponsorship status of the studies. The agreement in coding was high, suggesting a lack of bias (<a href="./references#MR000033-bbs2-0003" title="Als‐NielsenB , ChenW , GluudC , KjaergardLL . Association of funding and conclusions in randomized drug trials: a reflection of treatment effect or adverse events?. JAMA2003;290(7):921‐8. ">Als‐Nielsen 2003</a>; <a href="./references#MR000033-bbs2-0008" title="BeroL , OostvogelF , BacchettiP , LeeK . Factors associated with findings of published trials of drug‐drug comparisons: why some statins appear more efficacious than others. PLoS Medicine2007;4(6):e184. ">Bero 2007</a>; <a href="./references#MR000033-bbs2-0042" title="KjaergardLL , Als‐NielsenB . Association between competing interests and authors' conclusions: Epidemiological study of randomised clinical trials published in the BMJ. BMJ2002;325(7358):249‐52. ">Kjaergard 2002</a>). Likewise, all review authors (AL, BM, JL, JS, LB) have published several times in the field and one review author (LB) is the author of four of the included papers (<a href="./references#MR000033-bbs2-0008" title="BeroL , OostvogelF , BacchettiP , LeeK . Factors associated with findings of published trials of drug‐drug comparisons: why some statins appear more efficacious than others. PLoS Medicine2007;4(6):e184. ">Bero 2007</a>; <a href="./references#MR000033-bbs2-0016" title="ChoMK , BeroLA . The quality of drug studies published in symposium proceedings. Annals of Internal Medicine1996;124(5):485‐9. ">Cho 1996</a>; <a href="./references#MR000033-bbs2-0059" title="RasmussenN , LeeK , BeroL . Association of trial registration with the results and conclusions of published trials of new oncology drugs. Trials2009;10:116. ">Rasmussen 2009</a>; <a href="./references#MR000033-bbs2-0060" title="RattingerG , BeroL . Factors associated with results and conclusions of trials of thiazolidinediones. PLoS One2009;4(6):e5826. ">Rattinger 2009</a>), which could have introduced bias. Because of the way data were presented in the papers, it was not possible to blind our data extraction process. None of the data extractors were co‐authors of the included papers. Furthermore, our data extraction of outcomes did not involve any qualitative interpretation as we extracted actual numbers. </p> <p>Fourth, if the papers included in this review included some of the same studies, their findings would not be independent. Furthermore, some papers included some of the same studies (<a href="./references#MR000033-bbs2-0019" title="CoronaG , MaseroliE , RastrelliG , IsidoriAM , SforzaA , MannucciE , et al. Cardiovascular risk associated with testosterone‐boosting medications: a systematic review and meta‐analysis. Expert Opinion on Drug Safety2014;13(10):1327‐51. ">Corona 2014</a>; <a href="./references#MR000033-bbs2-0074" title="XuL , FreemanG , CowlingBJ , SchoolingCM . Testosterone therapy and cardiovascular events among men: a systematic review and meta‐analysis of placebo‐controlled randomized trials. BMC Medicine2013;11:108. ">Xu 2013</a>), but had different results, which could be explained by differences in inclusion criteria and data extraction. In the majority of cases, it was not possible to assess the potential overlap of studies as most papers did not provide a reference list of included studies and we rarely had access to raw data. Instead we undertook sensitivity analyses restricted to papers on specific treatments or diseases where none of the other included papers were related to that domain. The analyses gave similar results, however with wider confidence intervals. </p> </section> <section id="MR000033-sec-0091"> <h3 class="title" id="MR000033-sec-0091">Agreements and disagreements with other studies or reviews</h3> <p>Our results are in agreement with previous systematic reviews (<a href="./references#MR000033-bbs2-0210" title="BekelmanJE , LiY , GrossCP . Scope and impact of financial conflicts of interest in biomedical research: a systematic review. JAMA2003;289(4):454‐65. ">Bekelman 2003</a>; <a href="./references#MR000033-bbs2-0275" title="LexchinJ , BeroL , DjulbegovicB , ClarkO . Pharmaceutical industry sponsorship and research outcome and quality: a systematic review. BMJ2003;326(7400):1167‐70. ">Lexchin 2003</a>; <a href="./references#MR000033-bbs2-0188" title="SchottG , PachlH , LimbachU , Gundert‐RemyU , LudwigWD , LiebK . The financing of drug trials by pharmaceutical companies and its consequences. Part 1: a qualitative, systematic review of the literature on possible influences on the findings, protocols, and quality of drug trials. Deutsches Arzteblatt international2010;107(16):279‐85. ">Schott 2010a</a>; <a href="./references#MR000033-bbs2-0266" title="SismondoS . Pharmaceutical company funding and its consequences: a qualitative systematic review. Contemporay Clinical Trials2008;29(2):109‐13. ">Sismondo 2008a</a>), though the risk ratios for the associations are less than previous quantitative estimates, but similar to our previous estimates (<a href="./references#MR000033-bbs2-0277" title="LundhA , SismondoS , LexchinJ , BusuiocOA , BeroL . Industry sponsorship and research outcome. Cochrane Database of Systematic Reviews2012, Issue 12. [DOI: 10.1002/14651858.MR000033.pub2] ">Lundh 2012</a>). Previous reviews did not distinguish between favorable efficacy results or conclusions, but looked at the association between sponsorship and outcomes. <a href="./references#MR000033-bbs2-0210" title="BekelmanJE , LiY , GrossCP . Scope and impact of financial conflicts of interest in biomedical research: a systematic review. JAMA2003;289(4):454‐65. ">Bekelman 2003</a> found OR 3.60 (95% CI: 2.63 to 4.91) and <a href="./references#MR000033-bbs2-0275" title="LexchinJ , BeroL , DjulbegovicB , ClarkO . Pharmaceutical industry sponsorship and research outcome and quality: a systematic review. BMJ2003;326(7400):1167‐70. ">Lexchin 2003</a> OR 4.05 (95% CI: 2.98 to 5.51). Translated to odds ratios, we found 2.05 (95% CI: 1.66 to 2.52) for results and 2.69 (95% CI 2.04 to 3.54) for conclusions in our review. This difference could be due to chance or it could be because the earlier reviews also included pharmacoeconomic analyses, non‐drug studies, unstructured letters and conference abstracts. It is also possible that the degree of industry bias has diminished over time, for example with a decrease in reporting bias due to trial registration. One paper on oncology drug trials (<a href="./references#MR000033-bbs2-0026" title="DjulbegovicB , KumarA , MiladinovicB , ReljicT , GalebS , MhaskarA , et al. Treatment success in cancer: industry compared to publicly sponsored randomized controlled trials. PLoS One2013;8(3):e58711. ">Djulbegovic 2013</a>), suggested that the treatment effect size between industry sponsored and non‐industry trials became more similar over time. However, the analysis included both published and unpublished trials and did not investigate the association between sponsorship and results or conclusions over time. In contrast, a recent paper found that reporting bias is also prevalent in registered trials, particular in industry sponsored trials (<a href="./references#MR000033-bbs2-0145" title="JonesCW , HandlerL , CrowellKE , KeilLG , WeaverMA , Platts‐MillsTF . Non‐publication of large randomized clinical trials: cross sectional analysis. BMJ2013;347:f6104. ">Jones 2013</a>). Second, one of the most recent papers (<a href="./references#MR000033-bbs2-0029" title="FlaccoME , ManzoliL , BocciaS , CapassoL , AleksovskaK , RossoA , et al. Head‐to‐head randomized trials are mostly industry sponsored and almost always favor the industry sponsor. Journal of Clinical Epidemiology2015;68(7):811‐20. ">Flacco 2015</a>) sampled drug trials published in 2011 and found OR: 2.8 (95% CI: 1.6 to 4.7) for results, suggesting that industry bias has not changed over time.  </p> <p>For harms results one other systematic review (<a href="./references#MR000033-bbs2-0228" title="GolderS , LokeYK . Is there evidence for biased reporting of published adverse effects data in pharmaceutical industry‐funded studies?. British Journal of Clinical Pharmacology2008;66(6):767‐73. ">Golder 2008</a>) has been published. Due to the anticipated heterogeneity of the data, the authors decided not to perform a meta‐analysis. The results of the review are in line with our findings of no differences in harms results between industry sponsored and non‐industry sponsored studies, but there are large variation in findings among individual papers. </p> </section> </section> </section> <div class="figures-list"> <div class="figure" id="MR000033-fig-0001"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000033.pub3/media/CDSR/MR000033/urn:x-wiley:14651858:media:MR000033:MR000033-AFig-FIG01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000033.pub3/media/CDSR/MR000033/image_t/tMR000033-AFig-FIG01.png" target="_blank"><b></b></a></p> </div><img alt="Study flow diagram." data-id="MR000033-fig-0001" src="/cdsr/doi/10.1002/14651858.MR000033.pub3/media/CDSR/MR000033/image_n/nMR000033-AFig-FIG01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 1</div> <div class="figure-caption"> <p>Study flow diagram.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.MR000033.pub3/full#MR000033-fig-0001">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.MR000033.pub3/media/CDSR/MR000033/image_n/nMR000033-AFig-FIG01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="MR000033-fig-0002"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000033.pub3/media/CDSR/MR000033/urn:x-wiley:14651858:media:MR000033:MR000033-AFig-FIG02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000033.pub3/media/CDSR/MR000033/image_t/tMR000033-AFig-FIG02.png" target="_blank"><b></b></a></p> </div><img alt="'Risk of bias' graph: review authors' judgements about each risk of bias item presented as percentages across all included papers." data-id="MR000033-fig-0002" src="/cdsr/doi/10.1002/14651858.MR000033.pub3/media/CDSR/MR000033/image_n/nMR000033-AFig-FIG02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 2</div> <div class="figure-caption"> <p>'Risk of bias' graph: review authors' judgements about each risk of bias item presented as percentages across all included papers. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.MR000033.pub3/full#MR000033-fig-0002">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.MR000033.pub3/media/CDSR/MR000033/image_n/nMR000033-AFig-FIG02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="MR000033-fig-0003"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000033.pub3/media/CDSR/MR000033/urn:x-wiley:14651858:media:MR000033:MR000033-AFig-FIG03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000033.pub3/media/CDSR/MR000033/image_t/tMR000033-AFig-FIG03.png" target="_blank"><b></b></a></p> </div><img alt="'Risk of bias' summary: review authors' judgements about each risk of bias item for each included paper." data-id="MR000033-fig-0003" src="/cdsr/doi/10.1002/14651858.MR000033.pub3/media/CDSR/MR000033/image_n/nMR000033-AFig-FIG03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 3</div> <div class="figure-caption"> <p>'Risk of bias' summary: review authors' judgements about each risk of bias item for each included paper. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.MR000033.pub3/full#MR000033-fig-0003">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.MR000033.pub3/media/CDSR/MR000033/image_n/nMR000033-AFig-FIG03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="MR000033-fig-0004"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000033.pub3/media/CDSR/MR000033/urn:x-wiley:14651858:media:MR000033:MR000033-CMP-001-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000033.pub3/media/CDSR/MR000033/image_t/tMR000033-CMP-001-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Results: Industry sponsored versus non‐industry sponsored studies, Outcome 1 Number of studies with favorable efficacy results." data-id="MR000033-fig-0004" src="/cdsr/doi/10.1002/14651858.MR000033.pub3/media/CDSR/MR000033/image_n/nMR000033-CMP-001-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.1</div> <div class="figure-caption"> <p>Comparison 1 Results: Industry sponsored versus non‐industry sponsored studies, Outcome 1 Number of studies with favorable efficacy results. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.MR000033.pub3/references#MR000033-fig-0004">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.MR000033.pub3/media/CDSR/MR000033/image_n/nMR000033-CMP-001-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="MR000033-fig-0005"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000033.pub3/media/CDSR/MR000033/urn:x-wiley:14651858:media:MR000033:MR000033-CMP-001-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000033.pub3/media/CDSR/MR000033/image_t/tMR000033-CMP-001-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Results: Industry sponsored versus non‐industry sponsored studies, Outcome 2 Number of studies with favorable harms results." data-id="MR000033-fig-0005" src="/cdsr/doi/10.1002/14651858.MR000033.pub3/media/CDSR/MR000033/image_n/nMR000033-CMP-001-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.2</div> <div class="figure-caption"> <p>Comparison 1 Results: Industry sponsored versus non‐industry sponsored studies, Outcome 2 Number of studies with favorable harms results. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.MR000033.pub3/references#MR000033-fig-0005">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.MR000033.pub3/media/CDSR/MR000033/image_n/nMR000033-CMP-001-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="MR000033-fig-0006"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000033.pub3/media/CDSR/MR000033/urn:x-wiley:14651858:media:MR000033:MR000033-CMP-002-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000033.pub3/media/CDSR/MR000033/image_t/tMR000033-CMP-002-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Results: Industry sponsorship by test treatment company versus sponsorship by comparator treatment company, Outcome 1 Number of studies with favorable test treatment efficacy results." data-id="MR000033-fig-0006" src="/cdsr/doi/10.1002/14651858.MR000033.pub3/media/CDSR/MR000033/image_n/nMR000033-CMP-002-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.1</div> <div class="figure-caption"> <p>Comparison 2 Results: Industry sponsorship by test treatment company versus sponsorship by comparator treatment company, Outcome 1 Number of studies with favorable test treatment efficacy results. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.MR000033.pub3/references#MR000033-fig-0006">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.MR000033.pub3/media/CDSR/MR000033/image_n/nMR000033-CMP-002-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="MR000033-fig-0007"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000033.pub3/media/CDSR/MR000033/urn:x-wiley:14651858:media:MR000033:MR000033-CMP-003-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000033.pub3/media/CDSR/MR000033/image_t/tMR000033-CMP-003-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Conclusions: industry sponsored versus non‐industry sponsored studies, Outcome 1 Number of studies with favorable conclusions." data-id="MR000033-fig-0007" src="/cdsr/doi/10.1002/14651858.MR000033.pub3/media/CDSR/MR000033/image_n/nMR000033-CMP-003-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.1</div> <div class="figure-caption"> <p>Comparison 3 Conclusions: industry sponsored versus non‐industry sponsored studies, Outcome 1 Number of studies with favorable conclusions. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.MR000033.pub3/references#MR000033-fig-0007">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.MR000033.pub3/media/CDSR/MR000033/image_n/nMR000033-CMP-003-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="MR000033-fig-0008"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000033.pub3/media/CDSR/MR000033/urn:x-wiley:14651858:media:MR000033:MR000033-CMP-004-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000033.pub3/media/CDSR/MR000033/image_t/tMR000033-CMP-004-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 Conclusions: Industry sponsorship by test treatment company versus sponsorship by comparator treatment company, Outcome 1 Number of studies with favorable test treatment conclusions." data-id="MR000033-fig-0008" src="/cdsr/doi/10.1002/14651858.MR000033.pub3/media/CDSR/MR000033/image_n/nMR000033-CMP-004-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.1</div> <div class="figure-caption"> <p>Comparison 4 Conclusions: Industry sponsorship by test treatment company versus sponsorship by comparator treatment company, Outcome 1 Number of studies with favorable test treatment conclusions. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.MR000033.pub3/references#MR000033-fig-0008">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.MR000033.pub3/media/CDSR/MR000033/image_n/nMR000033-CMP-004-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="MR000033-fig-0009"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000033.pub3/media/CDSR/MR000033/urn:x-wiley:14651858:media:MR000033:MR000033-CMP-005-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000033.pub3/media/CDSR/MR000033/image_t/tMR000033-CMP-005-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 Risk of bias: industry sponsored versus non‐industry sponsored studies, Outcome 1 Number of studies with low risk of bias from sequence generation." data-id="MR000033-fig-0009" src="/cdsr/doi/10.1002/14651858.MR000033.pub3/media/CDSR/MR000033/image_n/nMR000033-CMP-005-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.1</div> <div class="figure-caption"> <p>Comparison 5 Risk of bias: industry sponsored versus non‐industry sponsored studies, Outcome 1 Number of studies with low risk of bias from sequence generation. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.MR000033.pub3/references#MR000033-fig-0009">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.MR000033.pub3/media/CDSR/MR000033/image_n/nMR000033-CMP-005-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="MR000033-fig-0010"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000033.pub3/media/CDSR/MR000033/urn:x-wiley:14651858:media:MR000033:MR000033-CMP-005-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000033.pub3/media/CDSR/MR000033/image_t/tMR000033-CMP-005-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 Risk of bias: industry sponsored versus non‐industry sponsored studies, Outcome 2 Number of studies with low risk of bias from concealment of allocation." data-id="MR000033-fig-0010" src="/cdsr/doi/10.1002/14651858.MR000033.pub3/media/CDSR/MR000033/image_n/nMR000033-CMP-005-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.2</div> <div class="figure-caption"> <p>Comparison 5 Risk of bias: industry sponsored versus non‐industry sponsored studies, Outcome 2 Number of studies with low risk of bias from concealment of allocation. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.MR000033.pub3/references#MR000033-fig-0010">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.MR000033.pub3/media/CDSR/MR000033/image_n/nMR000033-CMP-005-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="MR000033-fig-0011"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000033.pub3/media/CDSR/MR000033/urn:x-wiley:14651858:media:MR000033:MR000033-CMP-005-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000033.pub3/media/CDSR/MR000033/image_t/tMR000033-CMP-005-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 Risk of bias: industry sponsored versus non‐industry sponsored studies, Outcome 3 Number of studies with low risk of bias from blinding‐overall." data-id="MR000033-fig-0011" src="/cdsr/doi/10.1002/14651858.MR000033.pub3/media/CDSR/MR000033/image_n/nMR000033-CMP-005-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.3</div> <div class="figure-caption"> <p>Comparison 5 Risk of bias: industry sponsored versus non‐industry sponsored studies, Outcome 3 Number of studies with low risk of bias from blinding‐overall. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.MR000033.pub3/references#MR000033-fig-0011">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.MR000033.pub3/media/CDSR/MR000033/image_n/nMR000033-CMP-005-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="MR000033-fig-0012"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000033.pub3/media/CDSR/MR000033/urn:x-wiley:14651858:media:MR000033:MR000033-CMP-005-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000033.pub3/media/CDSR/MR000033/image_t/tMR000033-CMP-005-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 Risk of bias: industry sponsored versus non‐industry sponsored studies, Outcome 4 Number of studies with low risk from blinding‐performance bias." data-id="MR000033-fig-0012" src="/cdsr/doi/10.1002/14651858.MR000033.pub3/media/CDSR/MR000033/image_n/nMR000033-CMP-005-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.4</div> <div class="figure-caption"> <p>Comparison 5 Risk of bias: industry sponsored versus non‐industry sponsored studies, Outcome 4 Number of studies with low risk from blinding‐performance bias. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.MR000033.pub3/references#MR000033-fig-0012">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.MR000033.pub3/media/CDSR/MR000033/image_n/nMR000033-CMP-005-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="MR000033-fig-0013"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000033.pub3/media/CDSR/MR000033/urn:x-wiley:14651858:media:MR000033:MR000033-CMP-005-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000033.pub3/media/CDSR/MR000033/image_t/tMR000033-CMP-005-05.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 Risk of bias: industry sponsored versus non‐industry sponsored studies, Outcome 5 Number of studies with low risk from blinding‐detection bias." data-id="MR000033-fig-0013" src="/cdsr/doi/10.1002/14651858.MR000033.pub3/media/CDSR/MR000033/image_n/nMR000033-CMP-005-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.5</div> <div class="figure-caption"> <p>Comparison 5 Risk of bias: industry sponsored versus non‐industry sponsored studies, Outcome 5 Number of studies with low risk from blinding‐detection bias. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.MR000033.pub3/references#MR000033-fig-0013">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.MR000033.pub3/media/CDSR/MR000033/image_n/nMR000033-CMP-005-05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="MR000033-fig-0014"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000033.pub3/media/CDSR/MR000033/urn:x-wiley:14651858:media:MR000033:MR000033-CMP-005-06" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000033.pub3/media/CDSR/MR000033/image_t/tMR000033-CMP-005-06.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 Risk of bias: industry sponsored versus non‐industry sponsored studies, Outcome 6 Number of studies with low risk of bias from loss to follow‐up." data-id="MR000033-fig-0014" src="/cdsr/doi/10.1002/14651858.MR000033.pub3/media/CDSR/MR000033/image_n/nMR000033-CMP-005-06.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.6</div> <div class="figure-caption"> <p>Comparison 5 Risk of bias: industry sponsored versus non‐industry sponsored studies, Outcome 6 Number of studies with low risk of bias from loss to follow‐up. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.MR000033.pub3/references#MR000033-fig-0014">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.MR000033.pub3/media/CDSR/MR000033/image_n/nMR000033-CMP-005-06.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="MR000033-fig-0015"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000033.pub3/media/CDSR/MR000033/urn:x-wiley:14651858:media:MR000033:MR000033-CMP-005-07" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000033.pub3/media/CDSR/MR000033/image_t/tMR000033-CMP-005-07.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 Risk of bias: industry sponsored versus non‐industry sponsored studies, Outcome 7 Number of studies with low risk of bias from selective outcome reporting." data-id="MR000033-fig-0015" src="/cdsr/doi/10.1002/14651858.MR000033.pub3/media/CDSR/MR000033/image_n/nMR000033-CMP-005-07.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.7</div> <div class="figure-caption"> <p>Comparison 5 Risk of bias: industry sponsored versus non‐industry sponsored studies, Outcome 7 Number of studies with low risk of bias from selective outcome reporting. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.MR000033.pub3/references#MR000033-fig-0015">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.MR000033.pub3/media/CDSR/MR000033/image_n/nMR000033-CMP-005-07.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="MR000033-fig-0016"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000033.pub3/media/CDSR/MR000033/urn:x-wiley:14651858:media:MR000033:MR000033-CMP-006-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000033.pub3/media/CDSR/MR000033/image_t/tMR000033-CMP-006-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 6 Concordance between study results and conclusions: industry sponsored versus non‐industry sponsored studies, Outcome 1 Number of studies with concordant study results and conclusions." data-id="MR000033-fig-0016" src="/cdsr/doi/10.1002/14651858.MR000033.pub3/media/CDSR/MR000033/image_n/nMR000033-CMP-006-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 6.1</div> <div class="figure-caption"> <p>Comparison 6 Concordance between study results and conclusions: industry sponsored versus non‐industry sponsored studies, Outcome 1 Number of studies with concordant study results and conclusions. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.MR000033.pub3/references#MR000033-fig-0016">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.MR000033.pub3/media/CDSR/MR000033/image_n/nMR000033-CMP-006-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="MR000033-fig-0017"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000033.pub3/media/CDSR/MR000033/urn:x-wiley:14651858:media:MR000033:MR000033-CMP-007-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000033.pub3/media/CDSR/MR000033/image_t/tMR000033-CMP-007-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 7 Subgroup analysis, Outcome 1 Number of studies with favorable efficacy results, stratified by risk of bias." data-id="MR000033-fig-0017" src="/cdsr/doi/10.1002/14651858.MR000033.pub3/media/CDSR/MR000033/image_n/nMR000033-CMP-007-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 7.1</div> <div class="figure-caption"> <p>Comparison 7 Subgroup analysis, Outcome 1 Number of studies with favorable efficacy results, stratified by risk of bias. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.MR000033.pub3/references#MR000033-fig-0017">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.MR000033.pub3/media/CDSR/MR000033/image_n/nMR000033-CMP-007-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="MR000033-fig-0018"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000033.pub3/media/CDSR/MR000033/urn:x-wiley:14651858:media:MR000033:MR000033-CMP-007-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000033.pub3/media/CDSR/MR000033/image_t/tMR000033-CMP-007-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 7 Subgroup analysis, Outcome 2 Number of studies with favorable harms results, stratified by risk of bias." data-id="MR000033-fig-0018" src="/cdsr/doi/10.1002/14651858.MR000033.pub3/media/CDSR/MR000033/image_n/nMR000033-CMP-007-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 7.2</div> <div class="figure-caption"> <p>Comparison 7 Subgroup analysis, Outcome 2 Number of studies with favorable harms results, stratified by risk of bias. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.MR000033.pub3/references#MR000033-fig-0018">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.MR000033.pub3/media/CDSR/MR000033/image_n/nMR000033-CMP-007-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="MR000033-fig-0019"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000033.pub3/media/CDSR/MR000033/urn:x-wiley:14651858:media:MR000033:MR000033-CMP-007-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000033.pub3/media/CDSR/MR000033/image_t/tMR000033-CMP-007-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 7 Subgroup analysis, Outcome 3 Number of studies with favorable conclusions, stratified by risk of bias." data-id="MR000033-fig-0019" src="/cdsr/doi/10.1002/14651858.MR000033.pub3/media/CDSR/MR000033/image_n/nMR000033-CMP-007-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 7.3</div> <div class="figure-caption"> <p>Comparison 7 Subgroup analysis, Outcome 3 Number of studies with favorable conclusions, stratified by risk of bias. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.MR000033.pub3/references#MR000033-fig-0019">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.MR000033.pub3/media/CDSR/MR000033/image_n/nMR000033-CMP-007-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="MR000033-fig-0020"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000033.pub3/media/CDSR/MR000033/urn:x-wiley:14651858:media:MR000033:MR000033-CMP-007-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000033.pub3/media/CDSR/MR000033/image_t/tMR000033-CMP-007-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 7 Subgroup analysis, Outcome 4 Number of studies with favorable efficacy results, stratified by type of intervention." data-id="MR000033-fig-0020" src="/cdsr/doi/10.1002/14651858.MR000033.pub3/media/CDSR/MR000033/image_n/nMR000033-CMP-007-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 7.4</div> <div class="figure-caption"> <p>Comparison 7 Subgroup analysis, Outcome 4 Number of studies with favorable efficacy results, stratified by type of intervention. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.MR000033.pub3/references#MR000033-fig-0020">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.MR000033.pub3/media/CDSR/MR000033/image_n/nMR000033-CMP-007-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="MR000033-fig-0021"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000033.pub3/media/CDSR/MR000033/urn:x-wiley:14651858:media:MR000033:MR000033-CMP-007-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000033.pub3/media/CDSR/MR000033/image_t/tMR000033-CMP-007-05.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 7 Subgroup analysis, Outcome 5 Number of studies with favorable conclusions, stratified by type of intervention." data-id="MR000033-fig-0021" src="/cdsr/doi/10.1002/14651858.MR000033.pub3/media/CDSR/MR000033/image_n/nMR000033-CMP-007-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 7.5</div> <div class="figure-caption"> <p>Comparison 7 Subgroup analysis, Outcome 5 Number of studies with favorable conclusions, stratified by type of intervention. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.MR000033.pub3/references#MR000033-fig-0021">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.MR000033.pub3/media/CDSR/MR000033/image_n/nMR000033-CMP-007-05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="MR000033-fig-0022"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000033.pub3/media/CDSR/MR000033/urn:x-wiley:14651858:media:MR000033:MR000033-CMP-007-06" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000033.pub3/media/CDSR/MR000033/image_t/tMR000033-CMP-007-06.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 7 Subgroup analysis, Outcome 6 Number of studies with favorable efficacy results, stratified by type of domain." data-id="MR000033-fig-0022" src="/cdsr/doi/10.1002/14651858.MR000033.pub3/media/CDSR/MR000033/image_n/nMR000033-CMP-007-06.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 7.6</div> <div class="figure-caption"> <p>Comparison 7 Subgroup analysis, Outcome 6 Number of studies with favorable efficacy results, stratified by type of domain. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.MR000033.pub3/references#MR000033-fig-0022">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.MR000033.pub3/media/CDSR/MR000033/image_n/nMR000033-CMP-007-06.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="MR000033-fig-0023"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000033.pub3/media/CDSR/MR000033/urn:x-wiley:14651858:media:MR000033:MR000033-CMP-007-07" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000033.pub3/media/CDSR/MR000033/image_t/tMR000033-CMP-007-07.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 7 Subgroup analysis, Outcome 7 Number of studies with favorable harms results, stratified by type of domain." data-id="MR000033-fig-0023" src="/cdsr/doi/10.1002/14651858.MR000033.pub3/media/CDSR/MR000033/image_n/nMR000033-CMP-007-07.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 7.7</div> <div class="figure-caption"> <p>Comparison 7 Subgroup analysis, Outcome 7 Number of studies with favorable harms results, stratified by type of domain. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.MR000033.pub3/references#MR000033-fig-0023">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.MR000033.pub3/media/CDSR/MR000033/image_n/nMR000033-CMP-007-07.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="MR000033-fig-0024"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000033.pub3/media/CDSR/MR000033/urn:x-wiley:14651858:media:MR000033:MR000033-CMP-007-08" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000033.pub3/media/CDSR/MR000033/image_t/tMR000033-CMP-007-08.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 7 Subgroup analysis, Outcome 8 Number of studies with favorable conclusions, stratified by type of domain." data-id="MR000033-fig-0024" src="/cdsr/doi/10.1002/14651858.MR000033.pub3/media/CDSR/MR000033/image_n/nMR000033-CMP-007-08.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 7.8</div> <div class="figure-caption"> <p>Comparison 7 Subgroup analysis, Outcome 8 Number of studies with favorable conclusions, stratified by type of domain. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.MR000033.pub3/references#MR000033-fig-0024">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.MR000033.pub3/media/CDSR/MR000033/image_n/nMR000033-CMP-007-08.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="MR000033-fig-0025"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000033.pub3/media/CDSR/MR000033/urn:x-wiley:14651858:media:MR000033:MR000033-CMP-008-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000033.pub3/media/CDSR/MR000033/image_t/tMR000033-CMP-008-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 8 Sensitivity analysis, Outcome 1 Number of studies with favorable efficacy results, sponsorship recoded." data-id="MR000033-fig-0025" src="/cdsr/doi/10.1002/14651858.MR000033.pub3/media/CDSR/MR000033/image_n/nMR000033-CMP-008-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 8.1</div> <div class="figure-caption"> <p>Comparison 8 Sensitivity analysis, Outcome 1 Number of studies with favorable efficacy results, sponsorship recoded. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.MR000033.pub3/references#MR000033-fig-0025">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.MR000033.pub3/media/CDSR/MR000033/image_n/nMR000033-CMP-008-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="MR000033-fig-0026"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000033.pub3/media/CDSR/MR000033/urn:x-wiley:14651858:media:MR000033:MR000033-CMP-008-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000033.pub3/media/CDSR/MR000033/image_t/tMR000033-CMP-008-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 8 Sensitivity analysis, Outcome 2 Number of studies with favorable harms results, sponsorship recoded." data-id="MR000033-fig-0026" src="/cdsr/doi/10.1002/14651858.MR000033.pub3/media/CDSR/MR000033/image_n/nMR000033-CMP-008-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 8.2</div> <div class="figure-caption"> <p>Comparison 8 Sensitivity analysis, Outcome 2 Number of studies with favorable harms results, sponsorship recoded. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.MR000033.pub3/references#MR000033-fig-0026">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.MR000033.pub3/media/CDSR/MR000033/image_n/nMR000033-CMP-008-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="MR000033-fig-0027"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000033.pub3/media/CDSR/MR000033/urn:x-wiley:14651858:media:MR000033:MR000033-CMP-008-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000033.pub3/media/CDSR/MR000033/image_t/tMR000033-CMP-008-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 8 Sensitivity analysis, Outcome 3 Number of studies with favorable conclusions, sponsorship recoded." data-id="MR000033-fig-0027" src="/cdsr/doi/10.1002/14651858.MR000033.pub3/media/CDSR/MR000033/image_n/nMR000033-CMP-008-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 8.3</div> <div class="figure-caption"> <p>Comparison 8 Sensitivity analysis, Outcome 3 Number of studies with favorable conclusions, sponsorship recoded. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.MR000033.pub3/references#MR000033-fig-0027">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.MR000033.pub3/media/CDSR/MR000033/image_n/nMR000033-CMP-008-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="MR000033-fig-0028"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000033.pub3/media/CDSR/MR000033/urn:x-wiley:14651858:media:MR000033:MR000033-CMP-008-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000033.pub3/media/CDSR/MR000033/image_t/tMR000033-CMP-008-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 8 Sensitivity analysis, Outcome 4 Number of studies with favorable efficacy results, analysis adjusted for confounders." data-id="MR000033-fig-0028" src="/cdsr/doi/10.1002/14651858.MR000033.pub3/media/CDSR/MR000033/image_n/nMR000033-CMP-008-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 8.4</div> <div class="figure-caption"> <p>Comparison 8 Sensitivity analysis, Outcome 4 Number of studies with favorable efficacy results, analysis adjusted for confounders. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.MR000033.pub3/references#MR000033-fig-0028">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.MR000033.pub3/media/CDSR/MR000033/image_n/nMR000033-CMP-008-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="MR000033-fig-0029"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000033.pub3/media/CDSR/MR000033/urn:x-wiley:14651858:media:MR000033:MR000033-CMP-008-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000033.pub3/media/CDSR/MR000033/image_t/tMR000033-CMP-008-05.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 8 Sensitivity analysis, Outcome 5 Number of studies with favorable conclusions, analysis adjusted for confounders." data-id="MR000033-fig-0029" src="/cdsr/doi/10.1002/14651858.MR000033.pub3/media/CDSR/MR000033/image_n/nMR000033-CMP-008-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 8.5</div> <div class="figure-caption"> <p>Comparison 8 Sensitivity analysis, Outcome 5 Number of studies with favorable conclusions, analysis adjusted for confounders. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.MR000033.pub3/references#MR000033-fig-0029">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.MR000033.pub3/media/CDSR/MR000033/image_n/nMR000033-CMP-008-05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="MR000033-fig-0030"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000033.pub3/media/CDSR/MR000033/urn:x-wiley:14651858:media:MR000033:MR000033-CMP-008-06" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000033.pub3/media/CDSR/MR000033/image_t/tMR000033-CMP-008-06.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 8 Sensitivity analysis, Outcome 6 Number of studies with favorable efficacy results, fixed‐effect model." data-id="MR000033-fig-0030" src="/cdsr/doi/10.1002/14651858.MR000033.pub3/media/CDSR/MR000033/image_n/nMR000033-CMP-008-06.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 8.6</div> <div class="figure-caption"> <p>Comparison 8 Sensitivity analysis, Outcome 6 Number of studies with favorable efficacy results, fixed‐effect model. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.MR000033.pub3/references#MR000033-fig-0030">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.MR000033.pub3/media/CDSR/MR000033/image_n/nMR000033-CMP-008-06.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="MR000033-fig-0031"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000033.pub3/media/CDSR/MR000033/urn:x-wiley:14651858:media:MR000033:MR000033-CMP-008-07" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000033.pub3/media/CDSR/MR000033/image_t/tMR000033-CMP-008-07.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 8 Sensitivity analysis, Outcome 7 Number of studies with favorable harms results, fixed‐effect model." data-id="MR000033-fig-0031" src="/cdsr/doi/10.1002/14651858.MR000033.pub3/media/CDSR/MR000033/image_n/nMR000033-CMP-008-07.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 8.7</div> <div class="figure-caption"> <p>Comparison 8 Sensitivity analysis, Outcome 7 Number of studies with favorable harms results, fixed‐effect model. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.MR000033.pub3/references#MR000033-fig-0031">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.MR000033.pub3/media/CDSR/MR000033/image_n/nMR000033-CMP-008-07.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="MR000033-fig-0032"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000033.pub3/media/CDSR/MR000033/urn:x-wiley:14651858:media:MR000033:MR000033-CMP-008-08" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000033.pub3/media/CDSR/MR000033/image_t/tMR000033-CMP-008-08.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 8 Sensitivity analysis, Outcome 8 Number of studies with favorable test treatment efficacy results, fixed‐effect model." data-id="MR000033-fig-0032" src="/cdsr/doi/10.1002/14651858.MR000033.pub3/media/CDSR/MR000033/image_n/nMR000033-CMP-008-08.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 8.8</div> <div class="figure-caption"> <p>Comparison 8 Sensitivity analysis, Outcome 8 Number of studies with favorable test treatment efficacy results, fixed‐effect model. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.MR000033.pub3/references#MR000033-fig-0032">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.MR000033.pub3/media/CDSR/MR000033/image_n/nMR000033-CMP-008-08.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="MR000033-fig-0033"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000033.pub3/media/CDSR/MR000033/urn:x-wiley:14651858:media:MR000033:MR000033-CMP-008-09" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000033.pub3/media/CDSR/MR000033/image_t/tMR000033-CMP-008-09.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 8 Sensitivity analysis, Outcome 9 Number of studies with favorable conclusions, fixed‐effect model." data-id="MR000033-fig-0033" src="/cdsr/doi/10.1002/14651858.MR000033.pub3/media/CDSR/MR000033/image_n/nMR000033-CMP-008-09.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 8.9</div> <div class="figure-caption"> <p>Comparison 8 Sensitivity analysis, Outcome 9 Number of studies with favorable conclusions, fixed‐effect model. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.MR000033.pub3/references#MR000033-fig-0033">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.MR000033.pub3/media/CDSR/MR000033/image_n/nMR000033-CMP-008-09.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="MR000033-fig-0034"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000033.pub3/media/CDSR/MR000033/urn:x-wiley:14651858:media:MR000033:MR000033-CMP-008-10" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000033.pub3/media/CDSR/MR000033/image_t/tMR000033-CMP-008-10.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 8 Sensitivity analysis, Outcome 10 Number of studies with favorable test treatment conclusions, fixed‐effect model." data-id="MR000033-fig-0034" src="/cdsr/doi/10.1002/14651858.MR000033.pub3/media/CDSR/MR000033/image_n/nMR000033-CMP-008-10.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 8.10</div> <div class="figure-caption"> <p>Comparison 8 Sensitivity analysis, Outcome 10 Number of studies with favorable test treatment conclusions, fixed‐effect model. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.MR000033.pub3/references#MR000033-fig-0034">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.MR000033.pub3/media/CDSR/MR000033/image_n/nMR000033-CMP-008-10.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="MR000033-fig-0035"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000033.pub3/media/CDSR/MR000033/urn:x-wiley:14651858:media:MR000033:MR000033-CMP-008-11" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000033.pub3/media/CDSR/MR000033/image_t/tMR000033-CMP-008-11.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 8 Sensitivity analysis, Outcome 11 Number of studies with favorable conclusions, papers with unpublished studies excluded." data-id="MR000033-fig-0035" src="/cdsr/doi/10.1002/14651858.MR000033.pub3/media/CDSR/MR000033/image_n/nMR000033-CMP-008-11.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 8.11</div> <div class="figure-caption"> <p>Comparison 8 Sensitivity analysis, Outcome 11 Number of studies with favorable conclusions, papers with unpublished studies excluded. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.MR000033.pub3/references#MR000033-fig-0035">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.MR000033.pub3/media/CDSR/MR000033/image_n/nMR000033-CMP-008-11.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="MR000033-fig-0036"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000033.pub3/media/CDSR/MR000033/urn:x-wiley:14651858:media:MR000033:MR000033-CMP-008-12" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000033.pub3/media/CDSR/MR000033/image_t/tMR000033-CMP-008-12.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 8 Sensitivity analysis, Outcome 12 Number of studies with favorable efficacy results, restricted to specific domains." data-id="MR000033-fig-0036" src="/cdsr/doi/10.1002/14651858.MR000033.pub3/media/CDSR/MR000033/image_n/nMR000033-CMP-008-12.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 8.12</div> <div class="figure-caption"> <p>Comparison 8 Sensitivity analysis, Outcome 12 Number of studies with favorable efficacy results, restricted to specific domains. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.MR000033.pub3/references#MR000033-fig-0036">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.MR000033.pub3/media/CDSR/MR000033/image_n/nMR000033-CMP-008-12.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="MR000033-fig-0037"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000033.pub3/media/CDSR/MR000033/urn:x-wiley:14651858:media:MR000033:MR000033-CMP-008-13" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000033.pub3/media/CDSR/MR000033/image_t/tMR000033-CMP-008-13.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 8 Sensitivity analysis, Outcome 13 Number of studies with favorable harms results, restricted to specific domains." data-id="MR000033-fig-0037" src="/cdsr/doi/10.1002/14651858.MR000033.pub3/media/CDSR/MR000033/image_n/nMR000033-CMP-008-13.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 8.13</div> <div class="figure-caption"> <p>Comparison 8 Sensitivity analysis, Outcome 13 Number of studies with favorable harms results, restricted to specific domains. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.MR000033.pub3/references#MR000033-fig-0037">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.MR000033.pub3/media/CDSR/MR000033/image_n/nMR000033-CMP-008-13.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="MR000033-fig-0038"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000033.pub3/media/CDSR/MR000033/urn:x-wiley:14651858:media:MR000033:MR000033-CMP-008-14" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000033.pub3/media/CDSR/MR000033/image_t/tMR000033-CMP-008-14.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 8 Sensitivity analysis, Outcome 14 Number of studies with favorable test treatment efficacy results, restricted to specific domains." data-id="MR000033-fig-0038" src="/cdsr/doi/10.1002/14651858.MR000033.pub3/media/CDSR/MR000033/image_n/nMR000033-CMP-008-14.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 8.14</div> <div class="figure-caption"> <p>Comparison 8 Sensitivity analysis, Outcome 14 Number of studies with favorable test treatment efficacy results, restricted to specific domains. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.MR000033.pub3/references#MR000033-fig-0038">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.MR000033.pub3/media/CDSR/MR000033/image_n/nMR000033-CMP-008-14.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="MR000033-fig-0039"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000033.pub3/media/CDSR/MR000033/urn:x-wiley:14651858:media:MR000033:MR000033-CMP-008-15" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000033.pub3/media/CDSR/MR000033/image_t/tMR000033-CMP-008-15.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 8 Sensitivity analysis, Outcome 15 Number of studies with favorable conclusions, restricted to specific domains." data-id="MR000033-fig-0039" src="/cdsr/doi/10.1002/14651858.MR000033.pub3/media/CDSR/MR000033/image_n/nMR000033-CMP-008-15.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 8.15</div> <div class="figure-caption"> <p>Comparison 8 Sensitivity analysis, Outcome 15 Number of studies with favorable conclusions, restricted to specific domains. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.MR000033.pub3/references#MR000033-fig-0039">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.MR000033.pub3/media/CDSR/MR000033/image_n/nMR000033-CMP-008-15.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="MR000033-fig-0040"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000033.pub3/media/CDSR/MR000033/urn:x-wiley:14651858:media:MR000033:MR000033-CMP-008-16" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000033.pub3/media/CDSR/MR000033/image_t/tMR000033-CMP-008-16.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 8 Sensitivity analysis, Outcome 16 Number of studies with favorable test treatment conclusions, restricted to specific domains." data-id="MR000033-fig-0040" src="/cdsr/doi/10.1002/14651858.MR000033.pub3/media/CDSR/MR000033/image_n/nMR000033-CMP-008-16.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 8.16</div> <div class="figure-caption"> <p>Comparison 8 Sensitivity analysis, Outcome 16 Number of studies with favorable test treatment conclusions, restricted to specific domains. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.MR000033.pub3/references#MR000033-fig-0040">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.MR000033.pub3/media/CDSR/MR000033/image_n/nMR000033-CMP-008-16.png" target="_blank">Open in new tab</a></div> </div> </div> <div class="tables-list"> <div class="table"> <table class="summary-of-findings framed" data-id="MR000033-tbl-0001"> <div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">Industry sponsored compared to non‐industry sponsored studies for research outcome</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Results and conclusions: Industry sponsored compared to non‐industry sponsored studies</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Patient or population:</b> industry sponsorship and study results<br/> <b>Intervention:</b> industry sponsored studies<br/> <b>Comparator:</b> non‐industry sponsored studies </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Risk ratio<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>No of Participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Assumed risk</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Corresponding risk</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b> Non‐industry sponsored studies</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b> Industry sponsored studies</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Number of studies with favorable efficacy results</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>502 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>638 per 1000<br/> (588 to 688) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1.27<br/> (1.17 to 1.37) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>25 papers including 2923 studies</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕ ⊕ ⊕ ○<br/> MODERATE </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Upgraded as control for confounders and analysis of low risk of bias papers gave similar results. </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Number of studies with favorable harms results</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>474 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>649 per 1000<br/> (303 to 1388) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1.37<br/> (0.64 to 2.93) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>4 papers including 826 studies</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕ ○ ○ ○<br/> VERY LOW </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Downgraded due to substantial heterogeneity (inconsistency) and wide confidence intervals (imprecision). </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Number of studies with favorable conclusions</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>644 per 1000</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>863 per 1000<br/> (766 to 972) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1.34<br/> (1.19 to 1.51) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>29 papers including 4583 studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕ ⊕ ○ ○<br/> LOW </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Downgraded due to substantial heterogeneity (inconsistency).</p> <p>Upgraded as control for confounders and analysis of low risk of bias papers gave similar results. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*The basis for the <b>assumed risk</b> (e.g. the median control group risk across studies) is provided in footnotes. The <b>corresponding risk</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <b>CI:</b> Confidence interval </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>GRADE Working Group grades of evidence<br/> <b>High quality:</b> Further research is very unlikely to change our confidence in the estimate of effect.<br/> <b>Moderate quality:</b> Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<br/> <b>Low quality:</b> Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<br/> <b>Very low quality:</b> We are very uncertain about the estimate. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p>The assumed risk of the control group (i.e. non‐industry group) was calculated as the mean risk (i.e. number of studies with favorable results divided by total number of studies). </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">Industry sponsored compared to non‐industry sponsored studies for research outcome</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.MR000033.pub3/full#MR000033-tbl-0001">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="MR000033-tbl-0002"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">Results: Industry sponsored versus non‐industry sponsored studies</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Number of studies with favorable efficacy results <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>25</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>2923</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.27 [1.17, 1.37]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Number of studies with favorable harms results <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>826</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.37 [0.64, 2.93]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">Results: Industry sponsored versus non‐industry sponsored studies</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.MR000033.pub3/references#MR000033-tbl-0002">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="MR000033-tbl-0003"> <div class="table-heading"><span class="table-label">Comparison 2.</span> <span class="table-title">Results: Industry sponsorship by test treatment company versus sponsorship by comparator treatment company</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Number of studies with favorable test treatment efficacy results <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>131</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>3.88 [1.26, 11.94]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 2.</span> <span class="table-title">Results: Industry sponsorship by test treatment company versus sponsorship by comparator treatment company</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.MR000033.pub3/references#MR000033-tbl-0003">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="MR000033-tbl-0004"> <div class="table-heading"><span class="table-label">Comparison 3.</span> <span class="table-title">Conclusions: industry sponsored versus non‐industry sponsored studies</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Number of studies with favorable conclusions <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>29</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>4583</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.34 [1.19, 1.51]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 3.</span> <span class="table-title">Conclusions: industry sponsored versus non‐industry sponsored studies</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.MR000033.pub3/references#MR000033-tbl-0004">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="MR000033-tbl-0005"> <div class="table-heading"><span class="table-label">Comparison 4.</span> <span class="table-title">Conclusions: Industry sponsorship by test treatment company versus sponsorship by comparator treatment company</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Number of studies with favorable test treatment conclusions <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>154</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>5.92 [2.80, 12.54]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 4.</span> <span class="table-title">Conclusions: Industry sponsorship by test treatment company versus sponsorship by comparator treatment company</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.MR000033.pub3/references#MR000033-tbl-0005">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="MR000033-tbl-0006"> <div class="table-heading"><span class="table-label">Comparison 5.</span> <span class="table-title">Risk of bias: industry sponsored versus non‐industry sponsored studies</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Number of studies with low risk of bias from sequence generation <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>913</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.99 [0.78, 1.27]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Number of studies with low risk of bias from concealment of allocation <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>16</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1886</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.06 [0.85, 1.31]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Number of studies with low risk of bias from blinding‐overall <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>13</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1578</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.25 [1.05, 1.50]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Number of studies with low risk from blinding‐performance bias <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>128</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.26 [0.60, 2.62]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 Number of studies with low risk from blinding‐detection bias <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>307</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.47 [1.02, 2.12]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6 Number of studies with low risk of bias from loss to follow‐up <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>416</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.05 [0.92, 1.18]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">7 Number of studies with low risk of bias from selective outcome reporting <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>193</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.49 [0.61, 3.60]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 5.</span> <span class="table-title">Risk of bias: industry sponsored versus non‐industry sponsored studies</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.MR000033.pub3/references#MR000033-tbl-0006">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="MR000033-tbl-0007"> <div class="table-heading"><span class="table-label">Comparison 6.</span> <span class="table-title">Concordance between study results and conclusions: industry sponsored versus non‐industry sponsored studies</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Number of studies with concordant study results and conclusions <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>751</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.83 [0.70, 0.98]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 6.</span> <span class="table-title">Concordance between study results and conclusions: industry sponsored versus non‐industry sponsored studies</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.MR000033.pub3/references#MR000033-tbl-0007">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="MR000033-tbl-0008"> <div class="table-heading"><span class="table-label">Comparison 7.</span> <span class="table-title">Subgroup analysis</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Number of studies with favorable efficacy results, stratified by risk of bias <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>25</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>2923</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.27 [1.17, 1.37]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1 High risk of bias</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>20</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>2107</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.20 [1.11, 1.30]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.2 Low risk of bias</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>816</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.46 [1.25, 1.71]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Number of studies with favorable harms results, stratified by risk of bias <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>826</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.37 [0.64, 2.93]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.1 High risk of bias</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>561</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.87 [1.54, 2.27]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.2 Low risk of bias</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>265</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.82 [0.72, 0.93]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Number of studies with favorable conclusions, stratified by risk of bias <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>29</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>4583</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.34 [1.19, 1.51]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.1 High risk of bias</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>23</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>3515</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.32 [1.15, 1.50]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.2 Low risk of bias</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1068</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.42 [1.12, 1.79]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Number of studies with favorable efficacy results, stratified by type of intervention <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>25</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>2923</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.26 [1.15, 1.38]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.1 Drug studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>25</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>2904</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.27 [1.17, 1.38]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.2 Device studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>19</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.50 [0.26, 0.97]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 Number of studies with favorable conclusions, stratified by type of intervention <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>29</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>4583</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.33 [1.18, 1.49]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.1 Drug studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>27</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>4179</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.33 [1.17, 1.52]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.2 Device studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>404</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.33 [1.13, 1.57]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6 Number of studies with favorable efficacy results, stratified by type of domain <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>25</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>2923</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.27 [1.17, 1.37]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.1 Specific treatments or diseases</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>20</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1845</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.27 [1.13, 1.42]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.2 Mixed domain</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1078</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.31 [1.18, 1.46]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">7 Number of studies with favorable harms results, stratified by type of domain <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>826</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.37 [0.64, 2.93]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>7.1 Specific treatments or diseases</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>561</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.87 [1.54, 2.27]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>7.2 Mixed study domain</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>265</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.82 [0.72, 0.93]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">8 Number of studies with favorable conclusions, stratified by type of domain <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>29</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>4583</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.34 [1.19, 1.51]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>8.1 Specific treatments or diseases</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>24</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>3416</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.37 [1.17, 1.61]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>8.2 Mixed study domain</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1167</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.26 [1.07, 1.49]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 7.</span> <span class="table-title">Subgroup analysis</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.MR000033.pub3/references#MR000033-tbl-0008">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="MR000033-tbl-0009"> <div class="table-heading"><span class="table-label">Comparison 8.</span> <span class="table-title">Sensitivity analysis</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Number of studies with favorable efficacy results, sponsorship recoded <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>726</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.35 [1.18, 1.55]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Number of studies with favorable harms results, sponsorship recoded <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>501</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.42 [0.31, 6.50]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Number of studies with favorable conclusions, sponsorship recoded <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1029</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.24 [1.04, 1.47]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Number of studies with favorable efficacy results, analysis adjusted for confounders <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>3.15 [2.07, 4.80]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 Number of studies with favorable conclusions, analysis adjusted for confounders <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>3.13 [1.66, 5.93]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6 Number of studies with favorable efficacy results, fixed‐effect model <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>25</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>2923</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.31 [1.23, 1.40]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">7 Number of studies with favorable harms results, fixed‐effect model <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>826</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.29 [1.15, 1.46]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">8 Number of studies with favorable test treatment efficacy results, fixed‐effect model <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>131</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>4.64 [2.08, 10.32]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">9 Number of studies with favorable conclusions, fixed‐effect model <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>29</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>4583</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.29 [1.24, 1.35]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">10 Number of studies with favorable test treatment conclusions, fixed‐effect model <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>154</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>5.90 [2.79, 12.49]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">11 Number of studies with favorable conclusions, papers with unpublished studies excluded <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>27</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>4436</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.35 [1.19, 1.54]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">12 Number of studies with favorable efficacy results, restricted to specific domains <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>13</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>797</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.28 [1.07, 1.51]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">13 Number of studies with favorable harms results, restricted to specific domains <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>561</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.87 [1.54, 2.27]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">14 Number of studies with favorable test treatment efficacy results, restricted to specific domains <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>131</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>3.88 [1.26, 11.94]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">15 Number of studies with favorable conclusions, restricted to specific domains <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>15</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1803</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.42 [1.25, 1.61]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">16 Number of studies with favorable test treatment conclusions, restricted to specific domains <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>154</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>5.92 [2.80, 12.54]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 8.</span> <span class="table-title">Sensitivity analysis</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.MR000033.pub3/references#MR000033-tbl-0009">Navigate to table in review</a></div> </div> </div> <noscript> <img height="1" src="/scolaris-auth/report/nonjs/fulltexthtmlreg?doi=10.1002%2F14651858.MR000033.pub3&amp;rf=&amp;articleType=CDSR" style="display:none" width="1"> </img></noscript> <section class="translation-notes-modal" data-modal-class="translation-notes" data-modal-title="Translation notes" data-ok-btn-selector=".ok-btn" style="display: none"> <div class="translation-notes"> <div class="section-language-toggles"> <nav class="section-languages"> <ul> <li class="section-languages-legend">Available in</li> <li class="section-language"> <a class="" href="de#MR000033-note-0001">Deutsch</a> </li> <li class="section-language"> <a class="" href="es#MR000033-note-0012">Español</a> </li> <li class="section-language"> <a class="" href="fa#MR000033-note-0008">فارسی</a> </li> <li class="section-language"> <a class="" href="fr#MR000033-note-0006">Français</a> </li> <li class="section-language"> <a class="" href="hr#MR000033-note-0004">Hrvatski</a> </li> <li class="section-language"> <a class="" href="ja#MR000033-note-0003">日本語</a> </li> <li class="section-language"> <a class="" href="ko#MR000033-note-0009">한국어</a> </li> <li class="section-language"> <a class="" href="ms#MR000033-note-0011">Bahasa Malaysia</a> </li> <li class="section-language"> <a class="" href="pl#MR000033-note-0005">Polski</a> </li> <li class="section-language"> <a class="" href="pt#MR000033-note-0010">Português</a> </li> <li class="section-language"> <a class="" href="ru#MR000033-note-0002">Русский</a> </li> <li class="section-language"> <a class="" href="zh_HANS#MR000033-note-0015">简体中文</a> </li> <li class="section-language"> <a class="" href="zh_HANT#MR000033-note-0007">繁體中文</a> </li> </ul> </nav> </div> <section class="translation-notes-content"> </section> <button class="btn primary ok-btn pull-right" type="button">Close</button> </div> </section></article> </div> <div class="citation-modal" style="display: none"> <div class="export-citation-header"> <p class="inset-message" data-load-error="Unable to load citation data" id="citeProcText"></p> </div> <div class="export-citation-body row-fluid"> <div class="span12"> <div class="addthis_toolbox addthis_default_style addthis_16x16_style"> <nav class="inline-nav-list is-bordered"> <li> <h4 class="heading">Save citation to:</h4> </li> <li><a class="citation-btn-refworks at300b btn btn-link" href="#" id="refWorksCitationBtn"><span class="citation-icon refworks"></span>RefWorks</a></li> <li><a class="citation-btn-sciwheel at300b btn btn-link disabled" href="#" id="sciWheelCitationBtn" target="_blank"><span class="citation-icon sciwheel"></span>SciWheel</a></li> </nav> </div> </div> </div> <div class="row-fluid"> <div class="span12"> <div class="citation-format"> <h4>Copy or download citation</h4> <a href="/en/help/exporting-search-results" rel="noopener noreferrer" target="_blank">Export help</a> </div> <nav class="inline-nav-list has-dividers"> <li class="citation-option" data-option="plain"><button class="btn btn-link" type="button">Plain text</button></li> <li class="citation-option" data-option="endnote"><button class="btn btn-link" type="button">EndNote</button></li> <li class="citation-option" data-option="refmanager"><button class="btn btn-link" type="button">Reference Manager</button></li> <li class="citation-option" data-option="procite"><button class="btn btn-link" type="button">ProCite</button></li> <li class="citation-option" data-option="bibtex"><button class="btn btn-link" type="button">BibteX</button></li> <li class="citation-option" data-option="csv"><button class="btn btn-link" type="button">CSV (Excel)</button></li> </nav> <div class="citation-content"> <pre data-load-error="Unable to load citation data" id="citationContent" tabindex="0"></pre> </div> <div class="clearfix"> <form class="download-citation-form" data-citation-citeproc-url="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=citation-citeproc&amp;p_p_cacheability=cacheLevelPage&amp;p_p_col_id=column-1&amp;p_p_col_count=1" method="GET" target="citation-download-iframe"> <input id="siteId" name="siteId" type="hidden" value=""> <input id="downloadType" name="downloadType" type="hidden" value=""> <input id="style" name="style" type="hidden" value=""> <input id="articleId" name="articleId" type="hidden" value=""> <input name="p_p_id" type="hidden" value="scolariscontentdisplay_WAR_scolariscontentdisplay"><input name="p_p_lifecycle" type="hidden" value="2"><input name="p_p_state" type="hidden" value="normal"><input name="p_p_mode" type="hidden" value="view"/><input name="p_p_resource_id" type="hidden" value="citation-download"/><input name="p_p_cacheability" type="hidden" value="cacheLevelPage"/><input name="p_p_col_id" type="hidden" value="column-1"/><input name="p_p_col_count" type="hidden" value="1"/> <button class="btn primary wide pull-right" type="submit">Download</button> <div class="inline-checkbox pull-right"> <label title=" for=" withabstract"=""> <input checked="" class="checkbox" name="withAbstract" type="checkbox"/> <span class="checkbox-label">Include abstract</span> </label> </div> </input></input></input></input></input></input></input></form> <iframe aria-hidden="true" name="citation-download-iframe" src="" style="display: none; visibility: hidden" title="Citation download frame"></iframe> </div> </div> </div> </div> <div class="print-modal" data-modal-title="Print this review" style="display: none;"> <div class="print-options-wrapper"> <p><strong>All sections are selected by default</strong>, please select the sections you do not wish to print or use the select or deselect all button to add or remove sections.</p> <div class="print-options-controls"> <input checked="checked" class="print-options-select-all" title="Select/deselect all" type="checkbox"/> <span class="checkbox-label">Select/deselect all</span> </div> <ul class="print-options checkbox-list"> </ul> <button class="btn primary print-article pull-right"><i aria-hidden="true" class="fa fa-print"></i> Print</button> </div> </div> <div class="download-stats-data-modal" data-modal-title="Download data package" style="display: none;"> <div> <p> The data available are protected by copyright and may only be used in accordance with the <a class="external" href="/about/data-download" target="_blank">Terms and Conditions.</a> </p> <div class="hide-for-zip"> <p> <a class="external" href="https://revman.cochrane.org/#/rm5Converter" target="_blank">RevMan 5 files</a> can be converted to a <a class="external" href="https://links.cochrane.org/review-datapack-userguide" target="_blank">data package.</a> </p> </div> <p> Files in the data package can be imported to <a class="external" href="https://revman.cochrane.org/info" target="_blank">Review Manager software</a> or opened in other tools that support CSV and RIS. </p> <form class="download-stats-data-form" method="GET" target="_blank"> <input name="content-disposition" type="hidden" value="attachment"/> <input name="mime-type" type="hidden" value="application/octet-stream"/> <p class="print-options-controls"> <input aria-label="I agree to these terms and conditions" class="download-stats-data-toc-check-box" type="checkbox"/> <span aria-hidden="true" class="checkbox-label">I agree to these terms and conditions</span> <button class="btn primary download-stats-data pull-right" disabled=""><i aria-hidden="true" class="fa fa-download"></i> Download data</button> </p> </form> </div> </div> <div class="share-modal" data-modal-title="Share this review" style="display:none;"> </div> <div class="viewer-thumbnail-pane-html" style="display:none;"> <div class="figure-viewer-options"> <nav class="inline-nav-list"> <li class="figure-options-btn-container"><button class="btn btn-link" id="figureOptionBtn" type="button">Figures</button></li> <li class="table-options-btn-container"><button class="btn btn-link" id="tableOptionBtn" type="button">Tables</button></li> </nav> </div> <div class="figure-viewer-thumbnails"> <div class="figure-thumbnails is-visible" id="figureThumbnails"></div> <div class="table-thumbnails" id="tableThumbnails"></div> </div> </div> <div class="utilities-html" style="display:none;"> <div class="figure-viewer-utilities"> <a class="figure-viewer-menu-toggle" href="#"> <i class="fa fa-chevron-left"></i><span class="toggle-label" data-figure-hide-text="Hide thumbnails" data-figure-show-text="Show thumbnails" data-table-hide-text="Hide table list" data-table-show-text="Show table list">Hide thumbnails</span> </a> <a class="figure-viewer-navigateback" href="#"> <i class="fa fa-chevron-left"></i> </a> <a class="figure-viewer-rotate" href="#"> <i class="fa fa-undo"></i> </a> <a class="figure-viewer-download" href="#"> <i class="fa fa-download"></i> </a> <a class="figure-viewer-share" href="#"> <i class="fa fa-share-alt"></i> </a> <a class="figure-viewer-zoomin" href="#"> <i class="fa fa-plus"></i><span>zoom in</span> </a> <a class="figure-viewer-zoomout" href="#"> <i class="fa fa-minus"></i><span>zoom out</span> </a> </div> </div> <div class="controls-html" style="display:none;"> <div class="figure-viewer-navigation"> <a class="figure-viewer-nav previous" href="#"> <i class="fa fa-chevron-left"></i><span>left</span> </a> <a class="figure-viewer-nav next" href="#"> <i class="fa fa-chevron-right"></i><span>right</span> </a> </div> </div> <div class="mobile-thumbnail-selector-html" style="display:none;"> <div class="figure-viewer-mobile-thumbnails"> <select class="figure-selection"> <option>Figures</option> </select> <select class="table-selection"> <option>Tables</option> </select> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div>
<div class="portlet-boundary portlet-boundary_1_WAR_kaleodesignerportlet_ portlet-static portlet-static-end kaleo-designer-portlet" id="p_p_id_1_WAR_kaleodesignerportlet_">
<span id="p_1_WAR_kaleodesignerportlet"></span>
</div>
<form action="#" id="hrefFm" method="post" name="hrefFm">
<span></span>
</form>
</div>
<footer class="footer">
<div class="main-footer">
<div class="main-footer-wrapper container">
<div class="brand">
<p class="brand-name">Cochrane</p>
<a href="http://www.cochrane.org/" title="Cochrane logo">
<img alt="Cochrane logo" class="footer-logo logo-part-1" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-1.png"> <img alt="" class="footer-logo logo-part-2" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-2.png"> </img></img></a> </div> </div> </div> <div class="aux-footer"> <div class="aux-footer-nav-container container"> <nav class="aux-footer-nav"> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse Publications</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse by Subject</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/advertisers">Advertisers &amp; Agents</a></li> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Contact Us</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Help &amp; Support</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/terms-and-conditions">Terms &amp; Conditions</a></li> </ul> </nav> </div> <div class="brand"> <div class="brand-container container"> <p class="copyright"> Copyright © 2000 - 2025 by <a class="" href="http://www.wiley.com">John Wiley &amp; Sons, Inc.</a> All Rights Reserved <br> Review our <a href="https://www.wiley.com/privacy"><strong>Privacy Policy</strong></a> <a href="https://www.wiley.com/cookies"><strong>Cookie Policy</strong></a> <a href="#" onclick="Osano.cm.showDrawer('osano-cm-dom-info-dialog-open')"><strong>Cookie Preferences</strong></a> </br></p> <a href="http://eu.wiley.com/"><img alt="Wiley logo" class="logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_wiley-footer-logo.png"/></a> </div> </div> <span class="wiley-semi-circle"></span> </div> <!--BEGIN QUALTRICS WEBSITE FEEDBACK SNIPPET--> <script type="text/javascript"> (function(){var g=function(e,h,f,g){ this.get=function(a){for(var a=a+"=",c=document.cookie.split(";"),b=0,e=c.length;b<e;b++){for(var d=c[b];" "==d.charAt(0);)d=d.substring(1,d.length);if(0==d.indexOf(a))return d.substring(a.length,d.length)}return null}; this.set=function(a,c){var b="",b=new Date;b.setTime(b.getTime()+6048E5);b="; expires="+b.toGMTString();document.cookie=a+"="+c+b+"; path=/; "}; this.check=function(){var a=this.get(f);if(a)a=a.split(":");else if(100!=e)"v"==h&&(e=Math.random()>=e/100?0:100),a=[h,e,0],this.set(f,a.join(":"));else return!0;var c=a[1];if(100==c)return!0;switch(a[0]){case "v":return!1;case "r":return c=a[2]%Math.floor(100/c),a[2]++,this.set(f,a.join(":")),!c}return!0}; this.go=function(){if(this.check()){var a=document.createElement("script");a.type="text/javascript";a.src=g;document.body&&document.body.appendChild(a)}}; this.start=function(){var t=this;"complete"!==document.readyState?window.addEventListener?window.addEventListener("load",function(){t.go()},!1):window.attachEvent&&window.attachEvent("onload",function(){t.go()}):t.go()};}; try{(new g(100,"r","QSI_S_ZN_cGCHHvWNpnJb1zf","https://zncgchhvwnpnjb1zf-wiley.siteintercept.qualtrics.com/SIE/?Q_ZID=ZN_cGCHHvWNpnJb1zf")).start()}catch(i){}})(); </script><div id="ZN_cGCHHvWNpnJb1zf"><!--DO NOT REMOVE-CONTENTS PLACED HERE--></div> <!--END WEBSITE FEEDBACK SNIPPET--> </footer> <div class="scolaris-modal-overlay"></div> <div class="scolaris-modal"> <div class="scolaris-modal-titlebar clearfix"> <p class="scolaris-modal-title"></p> <a class="scolaris-modal-close" href="#"><span>close</span><span class="icon fa fa-times"></span></a> <div class="scolaris-modal-ui"></div> </div> <!-- Static injection of addtoAny as dynamic injection not working properly--> <div class="scolaris-share-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"> <div class="a2a_kit a2a_kit_size_32 a2a_default_style"> <a class="a2a_button_facebook share-button">  Facebook</a> <a class="a2a_button_x share-button">  X(Twitter)</a> <a class="a2a_button_whatsapp share-button">  WhatsApp</a> <a class="a2a_dd share-button">  View more</a> </div> </div> </div> <div class="scolaris-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="english-only-modal-wrapper" data-modal-class="english-only-modal" data-modal-title="Feature in English only" style="display: none"> <div class="english-only-modal"> <p class="message"></p> <button class="btn primary ok-btn pull-right" type="button">OK</button> <button class="btn primary border-only cancel-btn pull-right" type="button">Cancel</button> </div> </div> <!--[if gte IE 9]><!--> <script src="/cochrane-theme/vendor/ie9.js?t=1738734064000" type="text/javascript"></script> <!--<![endif]--> <script src="https://www.cochranelibrary.com/cochrane-theme/js/theme.js?t=1738734064000" type="text/javascript"></script> <script src="https://content.readcube.com/cochrane/checkout.js"></script> <script src="https://content.readcube.com/cochrane/epdf_linker.js" type="text/javascript"></script> <script src="https://crossmark-cdn.crossref.org/widget/v2.0/widget.js" type="text/javascript"></script> <script src="https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/hit-highlighting.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/topics-lookup.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/institution.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/api-manager.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/pico.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/reference-linking.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/rightsLink.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.submit.failed.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.comment.form.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/safety-alerts.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.translation-notes-modal.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/notifications-portlet/notifications/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772751000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-search/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772894000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-topics/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772894000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-language-portlet/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772746000" type="text/javascript"></script> <script type="text/javascript">Liferay.Util.addInputFocus();</script> <script type="text/javascript">Liferay.Portlet.register("scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_",portletId:"scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eMR000033\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eMR000033\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eMR000033\x2epub3\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eMR000033\x2epub3"});Liferay.Portlet.register("scolariscontentdisplay_WAR_scolariscontentdisplay");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_",portletId:"scolariscontentdisplay_WAR_scolariscontentdisplay",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentdisplay_WAR_scolariscontentdisplay\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dcolumn-1\x26p_p_col_pos\x3d0\x26p_p_col_count\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eMR000033\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eMR000033\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D"});Liferay.provide(Liferay.Util,"openKaleoDesignerPortlet",function(c){var b=AUI();var e=Liferay.PortletURL.createURL("https://www.cochranelibrary.com/en/content?p_p_id=2_WAR_kaleodesignerportlet&p_p_lifecycle=0");e.setParameter("mvcPath","/designer/edit_kaleo_draft_definition.jsp");e.setParameter("availableFields",c.availableFields);e.setParameter("availablePropertyModels",c.availablePropertyModels);e.setParameter("ddmStructureId",c.ddmStructureId);e.setParameter("draftVersion",c.draftVersion);e.setParameter("kaleoProcessId",c.kaleoProcessId);e.setParameter("name",c.name);e.setParameter("openerWindowName",c.openerWindowName);e.setParameter("portletResourceNamespace",c.portletResourceNamespace);e.setParameter("propertiesSaveCallback",c.propertiesSaveCallback);e.setParameter("refreshOpenerOnClose",c.refreshOpenerOnClose);e.setParameter("saveCallback",c.saveCallback);e.setParameter("version",c.version);e.setWindowState("pop_up");c.uri=e.toString();var d=c.dialog;if(!d){var f=b.one(Liferay.Util.getOpener()).get("region");d={destroyOnHide:true};c.dialog=d}if(!("align" in d)){d.align=Liferay.Util.Window.ALIGN_CENTER}var a=c.dialogIframe;if(!a){a={closeOnEscape:false};c.dialogIframe=a}Liferay.Util.openWindow(c)},["liferay-portlet-url"]);Liferay.Portlet.register("1_WAR_kaleodesignerportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_1_WAR_kaleodesignerportlet_",portletId:"1_WAR_kaleodesignerportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3d1_WAR_kaleodesignerportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eMR000033\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eMR000033\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eMR000033\x2epub3\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eMR000033\x2epub3"});Liferay.Portlet.register("scolarissearchportlet_WAR_scolarissearch");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarissearchportlet_WAR_scolarissearch_",portletId:"scolarissearchportlet_WAR_scolarissearch",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarissearchportlet_WAR_scolarissearch\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eMR000033\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eMR000033\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eMR000033\x2epub3\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eMR000033\x2epub3"});Liferay.Portlet.register("scolariscontentlanguagebanner_WAR_scolarislanguageportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_",portletId:"scolariscontentlanguagebanner_WAR_scolarislanguageportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentlanguagebanner_WAR_scolarislanguageportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eMR000033\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eMR000033\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eMR000033\x2epub3\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eMR000033\x2epub3"});AUI().use("aui-base","liferay-menu","liferay-notice","liferay-poller","liferay-session",function(a){(function(){Liferay.Util.addInputType();Liferay.Portlet.ready(function(b,c){Liferay.Util.addInputType(c)});if(a.UA.mobile){Liferay.Util.addInputCancel()}})();(function(){new Liferay.Menu();var b=Liferay.Data.notices;for(var c=1;c<b.length;c++){new Liferay.Notice(b[c])}})();(function(){Liferay.Session=new Liferay.SessionBase({autoExtend:true,sessionLength:1800,redirectOnExpire:false,redirectUrl:"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane",warningLength:0})})()});</script> <script src="https://www.cochranelibrary.com/cochrane-theme/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" type="text/javascript"></script> <script type="text/javascript"></script> <div class="mobile-righthand-nav"> <a class="rh-nav-close-btn" href="#"> <span>Close</span> <span class="fa fa-chevron-down"></span> </a> <div class="wrapper"> </div> <a class="rh-nav-open-btn" href="#"> <span>Review tools &amp; navigation</span> </a> </div> <iframe aria-hidden="true" id="printframe" name="printframe" style="position: absolute; left: -2000px; top: 0;" title="Print frame"></iframe> <iframe aria-hidden="true" id="citationExportFrame" name="citationExportFrame" style="position: absolute; left: -2000px; top: 0;" title="scolaris.citation.export.frame"></iframe> <nav> <div class="mobile-navigation"> <div class="close-container"> <a aria-label="Navigate back" class="main-nav-back-btn" href="#"><i class="fa fa-chevron-left"></i></a> <a class="main-nav-close-btn" href="#" title="Close menu">Close menu <i class="fa fa-times"></i></a> </div> <div class="mobile-search basic-search-container"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="ymag__null__null" src="/scolaris-search/icon.png"> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </img></span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=8ranHhTh&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"> <input name="facetDisplayName" type="hidden" value=""> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</input></input></form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.MR000033.pub3&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.MR000033.pub3';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<a class="btn secondary" href="/en/browse-by-topic">Browse </a>
<a class="btn secondary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
<div class="menu-items parent">
<div>
<div class="nav-root-item parent">
<a class="language-selection-title-link" href="#" title="Select language">
<span class="mobile-nav-language-title">Select your preferred language </span></a> <span class="icon fa fa-caret-down"></span>
<div class="mob-child">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="fdkn__null__null" src="/scolaris-language-portlet/icon.png"> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </img></span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> English </a> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> English </a> </div> <div class="form-content language-selector-modal child"> <div class="row-fluid"> <h3><i class="fa fa-file-text"></i> Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> <div class="dropdown-trigger" id="active-content-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="content-language-selector" data-languagecode="de" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=de">Deutsch</a> <a class="content-language-selector is-active" data-languagecode="en" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=en">English</a> <a class="content-language-selector" data-languagecode="es" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=es">Español</a> <a class="content-language-selector" data-languagecode="fa" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fa">فارسی</a> <a class="content-language-selector" data-languagecode="fr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fr">Français</a> <a class="content-language-selector" data-languagecode="hi" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hi">हिन्दी</a> <a class="content-language-selector" data-languagecode="hr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hr">Hrvatski</a> <a class="content-language-selector" data-languagecode="id" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=id">Bahasa Indonesia</a> <a class="content-language-selector" data-languagecode="ja" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ja">日本語</a> <a class="content-language-selector" data-languagecode="ko" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ko">한국어</a> <a class="content-language-selector" data-languagecode="hu" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hu">Magyar</a> <a class="content-language-selector" data-languagecode="ms" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ms">Bahasa Malaysia</a> <a class="content-language-selector" data-languagecode="nl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=nl">Nederlands</a> <a class="content-language-selector" data-languagecode="pl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pl">Polski</a> <a class="content-language-selector" data-languagecode="pt" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pt">Português</a> <a class="content-language-selector" data-languagecode="ru" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ru">Русский</a> <a class="content-language-selector" data-languagecode="ro" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ro">Română</a> <a class="content-language-selector" data-languagecode="ta" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ta">தமிழ்</a> <a class="content-language-selector" data-languagecode="th" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=th">ภาษาไทย</a> <a class="content-language-selector" data-languagecode="zh_HANT" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANT">繁體中文</a> <a class="content-language-selector" data-languagecode="zh_HANS" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANS">简体中文</a> </div> </div> <div class="row-fluid"> <h3 class="portal-language-header"><i class="fa fa-globe"></i> Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> <div class="dropdown-trigger" id="active-portal-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="portal-language-selector is-active" data-portallanguage="en" href="/en/cdsr/doi/10.1002/14651858.MR000033.pub3/full/en">English</a> <a class="portal-language-selector" data-portallanguage="es" href="/es/cdsr/doi/10.1002/14651858.MR000033.pub3/full/es">Español</a> </div> </div> <a class="btn secondary ok-btn pull-right" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
<div class="parent">
<a class="mobile-link signin" data-redirect="false" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.MR000033.pub3%2Ffull" rel="nofollow">
                        Sign In
                    </a>
</div>
</div>
<div class="menu-items-footer">
<div class="utility-links">
<a class="cochrane-link" href="http://www.cochrane.org/" target="_blank">Visit Cochrane.org</a>
</div>
</div>
</div>
<div class="menu-items child"></div>
</div>
</nav><div class="basic-login-form-content" data-modal-title="Sign in" style="display: none;">
<div class="form-content">
<div class="row-fluid">
<div class="span12">
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_MODAL_">
<span id="p_58_INSTANCE_MODAL"></span>
<section class="portlet" id="portlet_58_INSTANCE_MODAL">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="dbam__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_MODAL" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_MODAL&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_MODAL_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_MODAL_fm" method="post" name="_58_INSTANCE_MODAL_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_MODAL_formDate" type="hidden" value="1740720119878"> <input class="field" id="_58_INSTANCE_MODAL_saveLastPath" name="_58_INSTANCE_MODAL_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_MODAL_redirect" name="_58_INSTANCE_MODAL_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.MR000033.pub3/full"> <input class="field" id="_58_INSTANCE_MODAL_doActionAfterLogin" name="_58_INSTANCE_MODAL_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_login"> Email Address </label> <input class="field clearable" id="_58_INSTANCE_MODAL_login" name="_58_INSTANCE_MODAL_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_password"> Password </label> <input class="field" id="_58_INSTANCE_MODAL_password" name="_58_INSTANCE_MODAL_password" type="password" value=""/> </div> <span id="_58_INSTANCE_MODAL_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="clearfix"> <div class="checkbox-list pull-left"> <div class="checkbox-list-item"> <div class="control-group form-inline input-checkbox-wrapper"> <label for="_58_INSTANCE_MODAL_rememberMeCheckbox"> <input id="_58_INSTANCE_MODAL_rememberMe" name="_58_INSTANCE_MODAL_rememberMe" type="hidden" value="true"/> <input checked="" class="field" id="_58_INSTANCE_MODAL_rememberMeCheckbox" name="_58_INSTANCE_MODAL_rememberMeCheckbox" onclick="Liferay.Util.updateCheckboxValue(this); " type="checkbox" value="true"/> Remember Me </label> </div> </div> </div> <div class="pull-right"> <a href="https://onlinelibrary.wiley.com/user/forgottenpassword" target="_blank">Forgotten password?</a> </div> </div> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> <a class="btn secondary" href="https://onlinelibrary.wiley.com/user-registration" target="_blank">Register</a> </div> <div class="pull-right"> <a class="institutional-login-form-button" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=0&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolariscontentdisplay_WAR_scolariscontentdisplay_action=institution-access">Institutional login</a> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div></div>
<div class="institution-login-form-content" data-modal-title="Institutional login" style="display: none;">
<div class="form-content">
<div class="row-fluid access-content-wrapper">
<div class="span12">
<div class="section">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="obft__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="access-content-section"> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/>
</div>
<button class="btn primary" name="button" type="submit">Go</button>
</div>
<div class="message error" id="institutionLookupErrorDiv" style="display:none">
                        '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access.
                    </div>
</div>
<input id="entityId" name="entityId" type="hidden" value=""/>
</form>
<h4>Previously accessed institutions</h4>
<ul class="plain" id="previousInstitutions">
<li>(none)</li>
</ul>
</div>
<div class="section-content">
<div class="open-athens-login">
                Login using <a href="/openathens">OpenAthens</a>
</div>
</div>
</div>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_4_">
<span id="p_58_INSTANCE_4"></span>
<section class="portlet" id="portlet_58_INSTANCE_4">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="joiu__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_4" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <p>If you have a <strong>Wiley Online Library</strong> institutional username and password, enter them here.</p> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_4&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_4_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_4_fm" method="post" name="_58_INSTANCE_4_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_4_formDate" type="hidden" value="1740720119882"> <input class="field" id="_58_INSTANCE_4_saveLastPath" name="_58_INSTANCE_4_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_4_redirect" name="_58_INSTANCE_4_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.MR000033.pub3/full"> <input class="field" id="_58_INSTANCE_4_doActionAfterLogin" name="_58_INSTANCE_4_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_login"> Username </label> <input class="field clearable" id="_58_INSTANCE_4_login" name="_58_INSTANCE_4_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_password"> Password </label> <input class="field" id="_58_INSTANCE_4_password" name="_58_INSTANCE_4_password" type="password" value=""> </input></div> <input class="field" id="_58_INSTANCE_4_institutionalLogin" name="_58_INSTANCE_4_institutionalLogin" type="hidden" value="true"/> <span id="_58_INSTANCE_4_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div></div>
<div class="get-access-form-content" data-modal-title="Unlock gold-standard Cochrane evidence" style="display: none;">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="wpdq__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="readcube-checkout-container-outer"> <div class="row-fluid access-content-wrapper"> <div class="span6 access-left-content"> <div class="section"> <div class="section-content"> <p>Improve your health decisions with access to trusted, independent evidence from the Cochrane Library. Unlock this review for uninterrupted access.</p> <p>Still deciding? <a href="https://m.info.wiley.com/webApp/cochranenewsletter"> Sign up to our newsletter to learn more </a> </p> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title">Institutional users</h3> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/> </div> <button class="btn primary" name="button" type="submit">Go</button> </div> <div class="message error" id="institutionLookupErrorDiv" style="display:none"> '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access. </div> </div> <input id="entityId" name="entityId" type="hidden" value=""/> </form> <h4>Previously accessed institutions</h4> <ul class="plain" id="previousInstitutions"> <li>(none)</li> </ul> </div> <div class="section-content"> <div class="open-athens-login"> Login using <a href="/openathens">OpenAthens</a> </div> </div> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title"> Other access options </h3> <div class="section-content"> <ul class="plain"> <li> <a class="get-access-individual-login-button" href="/c/portal/login"> Individual access - via Wiley Online Library </a> </li> </ul> </div> </div> </div> </div> <div class="span6 access-right-content readcube-checkout-container"> <div class="section"> </div> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/> <input id="openlabel" name="openlabel" type="hidden" value="Open access"/> </div> </section> </div> </div> <!-- Scolaris Version: --> <script type="text/javascript">if(window._satellite){_satellite.pageBottom()};</script> </div> <script>(function(){function c(){var b=a.contentDocument||a.contentWindow.document;if(b){var d=b.createElement('script');d.innerHTML="window.__CF$cv$params={r:'918df963bad69377',t:'MTc0MDcyMDEyMC4wMDAwMDA='};var a=document.createElement('script');a.nonce='';a.src='/cdn-cgi/challenge-platform/scripts/jsd/main.js';document.getElementsByTagName('head')[0].appendChild(a);";b.getElementsByTagName('head')[0].appendChild(d)}}if(document.body){var a=document.createElement('iframe');a.height=1;a.width=1;a.style.position='absolute';a.style.top=0;a.style.left=0;a.style.border='none';a.style.visibility='hidden';document.body.appendChild(a);if('loading'!==document.readyState)c();else if(window.addEventListener)document.addEventListener('DOMContentLoaded',c);else{var e=document.onreadystatechange||function(){};document.onreadystatechange=function(b){e(b);'loading'!==document.readyState&&(document.onreadystatechange=e,c())}}}})();</script></body> </html> 